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The findings of the CARPE project are described in two theses. The emphasis in the present
thesis lies on the assessment and improvement of clinical decision making.
Claudia Lobo, general practitioner, focuses in her thesis on the implementation process and the
effects on practice organisation and patients’ quality of life.
Chapter 1
Introduction
8 Chapter 1
This thesis concerns improvement in the general-practice management of patients at high
cardiovascular risk. Previous studies have shown substantial gaps in the quality of
cardiovascular and diabetes care in general practice.1-7 The management of patients at high
cardiovascular risk involves both the organisation and process of care; in the present study,
critical aspects of the care process are further explored. The main goal is to test the
effectiveness of the provision of multifaceted and intensive support to optimise the quality
of care.
This chapter introduces the thesis. To start with, the area of health care and clinical
setting addressed in this thesis will be described, namely cardiovascular and diabetes care
in general practice. Cardiovascular care is defined as the care delivered to patients with
hypertension, hypercholesterolaemia or cardiovascular disease. Thereafter, some important
issues for the assessment and improvement of the quality of care will be introduced:
structure, process, and outcome of care; guidelines, quality assessment, and quality
improvement. The latter three issues will then be further explored with an emphasis on the
results of available research, implementation projects, and other activities. Finally, specific
aims of the present study and research questions will be outlined along with the structure of
the thesis.
Health care area: cardiovascular and diabetes care
Cardiovascular disease (CVD) and diabetes are important health problems. In industrialised
countries, CVD is the principal cause of death.8 Moreover, coronary artery disease, heart
failure, stroke and peripheral arterial disease are the main causes of disability in the elderly
and a great burden to health care provision and health care budgets.8 Diabetes mellitus can
cause hyperglycaemic complaints but is especially known for its microvascular
complications (e.g., blindness, kidney failure, feet and leg amputations) and macrovascular
complications (e.g., myocardial infarction).9,10
Adequate health care for patients at high cardiovascular risk can reduce morbidity and
mortality, and improve the quality of life. Multiple drugs such as aspirin, statins,
antihypertensive drugs, and angiotensin-converting enzyme (ACE) inhibitors have been
found to reduce the risk of cardiovascular morbidity and mortality.11-14 Cessation of
smoking, physical exercise and weight reduction also prevent CVD.15-17
Antihyperglycaemic drugs lower the risk of microvascular complications18,19 while treat-
ment of established CVD can mitigate complaints and foster quality of life.20,21
Targeting high-risk patients is in line with the results of pragmatic trials. Multiple risk-
factor interventions for the prevention of coronary heart disease have been found to have
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limited effects for the general population,22-24 moderate effects for people with
hypertension, 22 and substantial effects for patients with coronary heart disease. 20-22
Clinical setting: general practice
General practitioners (GPs) are in a favourable position for the management of patients at
high cardiovascular risk. The continuous contact with patients places GPs in a position to
effectively manage patients with such chronic medical conditions as hypertension,
hypercholesterolaemia, CVD, and diabetes. In many countries, the care for these high-risk
patients constitutes a substantial part of the GP’s daily work; the prevalence of
hypertension, angina pectoris, diabetes, and heart failure in general practice are 5%, 3%,
2% and 1%, respectively.7,25,26 In addition, a GP is often the first health care provider to
confront the onset of CVD or occurrence of acute symptoms and, with the increasing
number of elderly patients, GPs have to deal with more and more patients at high
cardiovascular risk.
In The Netherlands, GPs are the gatekeepers of the health care system. Sixty per cent of
patients are insured via a national fund, registered with a practice and require a referral
from their GP to secondary care. The other patients are privately insured and do not need a
GP’s referral but nevertheless use their GP as a gatekeeper. The average GP has 2250
patients.27 Nearly 50% of the Dutch GPs work in single-handed practices, 30% share their
practice with one partner, and 20% work together in group practices.27 A standard practice
employs 0.8 full-time equivalent practice assistant per full-time GP. The practice assistants
perform administrative and organisational tasks as well as medical activities such as blood
pressure measurement. Nowadays, more and more practice assistants are involved in the
management of high-risk patients and may perform routine follow-up consultations with
patients with diabetes, for example. In 1986, the National Association of General
Practitioners formulated the tasks of the Dutch GP in The Basic Job Description of the
General Practitioner.28 The Basic Job Description states that the domain of general
practice includes preventive care for patients with hypertension, diabetes, or cardiovascular
disease.
Structure, process and outcome of care
Donabedian has provided a three-stage model of health care which includes the structure,
process, and outcome of care.29 Structure refers to the organisation of the health care
whereas process refers to the actual delivery of the care by health care professionals.
Outcome refers to the results of the health care for patients. Structure, process and outcome
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are not independent, however. Structure and process interact whereas outcome may
influence the behaviour of health care professionals and thereby the structure and quality of
the health care process. This three stage-model can be applied to different areas of health
care (in our case, cardiovascular and diabetes care) within different types of settings (in our
case, general practice). While several issues relevant to the structure and outcome of care
will be addressed in this thesis, the emphasis lies on the care process.
The care delivered by a physician is often spoken of in terms of clinical decision
making, clinical performance, and clinical behaviour. Speaking of the care process in terms
of clinical decision making emphasises the multiplicity and complexity of the decisions
which physicians must make during daily practice. Clinical decision making refers to ‘what
a physician does in day-to-day practice’ and thus differs from clinical competence which
has been defined as ‘what a physician is capable of doing’.30
Guidelines, quality assessment, and quality improvement
During the last decades, a great number of clinical practice guidelines have been developed
on the basis of research findings and expert opinions. The guidelines provide clinicians
with evidence-based recommendations for everyday clinical practice and the
recommendations can also be used as indicators to assess the quality of care and those areas
in need of improvement. Experiments can then be conducted to explore the effectiveness of
different types of interventions intended to promote implementation of the guidelines and
thereby improve the quality of care. Guidelines, quality assessment, and quality
improvement are not separate entities, however. They constantly interact and influence
each other. The emphasis in this thesis lies on quality assessment and improvement, but
clear links to the evidence-based recommendations contained in the relevant guidelines will
also be made.
Guidelines
Many national and international committees have developed guidelines for cardiovascular
and diabetes care. Examples of the comprehensive guidelines developed on the basis of
rigorous procedures are the WHO guidelines on hypertension; the guidelines from the
American Diabetes Association; and, the European Task Force guidelines for the
prevention of coronary artery disease, the management of stable angina pectoris, and the
management of heart failure.31-35 The key recommendations contained in these guidelines
include:
- target high-risk patients;
- check the patient regularly for the presence of CVD risk factors;
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- check regularly for microvascular and macrovascular complications;
- provide the patient with lifestyle advice and information;
- initiate lipid lowering or antihypertensive drug treatment when a patients’ absolute risk
of cardiovascular disease exceeds a specific threshold;
- target specific levels of blood pressure, cholesterol, and blood glucose;
- prescribe aspirin to patients with a history of coronary heart disease or stroke, and ACE-
inhibitors to patients with heart failure; and,
- make arrangements for regular re-assessment and proper recording of risk factors and
health parameters.
These key recommendations make clear that the management of patients at high
cardiovascular risk involves multiple clinical elements. The recommendations also show
monitoring to be of particular interest. Proper monitoring demands specific arrangements
within the general practice (structure of care). It is essential that a (computer) system be
used to record the status of health parameters and all of the different risk factors and that
the GPs and their staff schedule follow-up visits and encourage their patients to attend
these. In addition to this, it is also essential that the appropriate medical instruments and
other materials be used. Furthermore, high-risk patients can be managed more efficiently
when GPs delegate certain tasks to their assistants. A prerequisite for adequate task
delegation, however, is the arrangement of good teamwork within the practice which may
include regular meetings and written protocols. In addition, practice assistants may perform
their tasks more effectively and efficiently when the practice organises separate clinics for
patients with hypertension or diabetes. 
In The Netherlands, the Dutch College of General Practitioners (DCGP) has issued national
guidelines on numerous topics relevant to general practice. The series started in 1989 with
guidelines for the management of Type 2 diabetes mellitus. After twelve years, more than
70 different guidelines have been developed. Seven of these guidelines address
cardiovascular-related topics: Hypertension (issued in 1991, revised in 1997), Cholesterol
(1991, revised in 1999), Type 2 Diabetes Mellitus (1989, revised in 1998), Heart Failure
(1995), Angina Pectoris (1994), Transient Ischaemic Attack (1995) and Peripheral Arterial
Disease (1990, updated in 1999).36.37 The key recommendations contained in the national
guidelines are in line with those contained in the international guidelines.
The DCGP guidelines are written in a standardised format. After an introduction
describing the relevance of the guideline and clarifying the relevant terms and concepts,
information is provided under the following headers: history taking, physical examination,
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laboratory and other tests, evaluation, provision of information and advice,
pharmacological treatment, follow-up, and referral. Additional information and references
to the relevant literature are presented in an appendix. In each guideline, it is emphasised
that relevant factors in the individual patient may justify a reasonable departure from the
recommended care.36-38
The guidelines are developed following a highly structured procedure. An independent
advisory board of experienced GPs selects the topic and goals of each guideline. A working
party consisting of five to ten GPs and researchers with a special interest in or knowledge
of the specific topic then develops the guideline. Discussion of the relevant scientific
evidence, clinical experiences, and both the feasibility and acceptability of the
recommendations for normal practice are undertaken to establish consensus. Members of
the staff of the DCGP provide support and help write the guideline. A draft of the guideline
is then sent for comment to fifty randomly selected members of the DCGP and a number of
the relevant specialists. The final adjustments are made, and a scientific committee of
experts including experienced GPs and professors of general practice then judges the
product. After approval, the committee authorises the guideline for publication in the
scientific journal of the DCGP. This journal is sent to all members of the DCGP, which
means about 80% of all Dutch GPs. The guidelines are revised regularly in order to adjust
the recommendations to new research findings.36-38
Quality assessment: A brief overview of the state of the art
Several studies have been performed to assess the actual quality of cardiovascular and
diabetes care in general practice. These studies have used a variety of measurement tools
and indicators. In Table 1, an overview of the state of the art in Europe with respect to the
indicators used in our research project is presented. Indicators pertaining to microvascular
or macrovascular complications among high-risk patients are not included, because there
are no criteria available to relate these complications to the quality of care provided.
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Table 1. Brief overview of current structure, process and outcome of cardiovascular and diabetes care in 
general practice in European countries
Topic Country Indicator % (range)
Structure of care
Netherlands Practices with follow-up arrangements39CVD
prevention Make a CVD follow-up appointment immediately after the 
consultation
70
Provide a CVD appointment card as a reminder to the patient 39
Register the reason for follow-up in the appointment book 32
Contact patients who fail to attend a CVD appointment 14
Practices with teamwork within the practice39
Hold regular, scheduled meetings 31
Delegate CVD preventive activities to the practice assistant 19
Have written CVD protocols available for all team members   5
Diabetes Practices with arrangements40UK
Diabetes register 96
Call/recall register 82
Diabetes-only clinics 71
Diabetes Netherlands GPs with arrangements41
Specific charts for the clinical notes 51
Specific protocol for annual follow-up 32
Participation in a call system 19
Diabetes-only clinics   6
Process of care
Patients
Aspirin prescribed5 72 (49-92)
Cholesterol recorded4 58
Coronary
heart disease
UK
Lipid lowering agent prescribed in cases of an elevated total 
cholesterol5
27 (11-59)
Heart failure Urea and electrolytes recorded in the last year7 59UK
ACE-inhibitors prescribed5 50 (40-65)
Diabetes UK Lipids checked42 38 (16-47)
Parameter checked in the last 12 months42
Blood pressure 88 (77-97)
Blood sugar 84 (81-90)
Body weight 73 (66-77)
Smoking 71 (22-86)
Feet 68 (40-91)
Fundi 68 (58-87)
Diabetes Norway Blood pressure recorded in the last 12 months43 79
Diabetes Netherlands Diabetes variables adequately recorded in the last two years44
Annual record of blood pressure 67
Quarterly record of blood sugar 43
Record of fundi examination 37
Quarterly record of body weight 12
Annual record of foot examination   3
Hypertension Information or advice provided45UK
Stop smoking (for current smokers) 63
Weight control 60
Diet 47
Exercise 38
Alcohol consumption 36
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Topic Country Indicator % (range)
Outcome of care
PatientsCoronary
heart disease Non-smokers4 77
Use of aspirin2 69
UK
Blood pressure controlled (£160/90 mmHg)4 60
Diabetes UK HbA1c controlled (<7.8%)3,46 47
Diabetes Norway Diastolic blood pressure controlled (£ 90 mmHg)43 78
HbA1c controlled (<7.5% when <70 years; <8.5% when ³70 years)43 54
Diabetes Netherlands Blood pressure controlled (£160/95 mmHg)47 90
Non-smokers47 79
HbA1c controlled (£8.5%)47 72
Total cholesterol controlled (£6.5 mmol/l)47 69
Body mass index controlled (£27 kg/m2 in men and £26 kg/m2 in 
women)47
45
Hypertension England Diastolic blood pressure controlled (< 90 mmHg)1 50
Hypertension Norway Diastolic blood pressure controlled (£ 90 mmHg)48 61
The associations within the three-stage model have been investigated for diabetes care in
particular. Two studies in the United Kingdom (UK) have shown larger and better
equipped practices, practices with access to a community dietician and practices with
diabetes-only clinics to have patients with significantly better glycaemic control. Practices
with a doctor with postgraduate training in diabetes have significantly fewer patients with
an elevated cholesterol level. The other indicators of structure and all of the process
indicators in these studies, however, did not relate to patient outcome.49,50 The presence of
a diabetes register has been found to positively relate to the recording of parameters for
diabetic patients.50 In The Netherlands, participation in a call system, presence of diabetes-
only clinics, use of a specific protocol for annual follow-up, and postgraduate diabetes
training of the GP have also been found to predict better recording of parameters for
diabetic patients.41 In addition, the presence of a system of proactive invitation for primary
CVD prevention has been shown to positively relate to the recording of cardiovascular risk
factors.51
In conclusion, the state of the art with regard to the quality of care shows substantial
variation across indicators, patients, and professionals. There is clearly room for
improvement on several aspects of cardiovascular and diabetes care. The amount of
research is also rather small and certain areas are in need of further exploration. One such
area is uncontrolled hypertension; more than half of treated hypertensive patients continue
to have an elevated blood pressure level, which means that the clinical decision making of
GPs should be examined more carefully. Another area relevant for the provision of optimal
care are patients’ perceptions of absolute cardiovascular risk and these perceptions should
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therefore also be clearly assessed. When a physician has insight into the risk perceptions of
patients, he or she can better involve patients in the decisions concerning the use of aspirin,
statins, and antihypertensive drugs because the benefits of these drugs depend on the
patient’s absolute risk. Shared decision making is particularly relevant for patients with
hypertension or diabetes but no known atherosclerotic disease because these patients are at
moderate to high risk and therefore stand to gain a moderate absolute risk reduction from
preventive drug treatment. The absolute risk of patients with established atherosclerotic
disease is very high and the benefits of preventive drug treatment are therefore quite clear
and generally surpass any arguments against such treatment.
Methods to assess clinical decision making
The focus of this thesis is on the clinical decision making of GPs. Such decision making
plays an important role in the utilisation of health care resources52 and inadequate decisions
making may obviously influence patients’ health negatively. Investigations of the clinical
decision making of GPs can give us insight into the quality of the care provided, the
variation across GPs, the determinants of such variation, and thus potential targets for
quality improvement.
In the field of cardiovascular and diabetes care, researchers have predominantly used
indirect measurement methods to assess the clinical decision making of GPs: postal
questionnaires, patient reports, and chart review. Such indirect methods nevertheless
provide an unreliable and often invalid picture of actual decision making due in part to a
lack of detailed information on the clinical situation.53-56 Direct measurement methods such
as the prospective recording of consultations by GPs, video/audiotapes of consultations, or
observations by simulated patients are more likely to produce detailed accounts of the
entire clinical situation and therefore more valid results.30
The aforementioned considerations hold in particular for assessments of the actual
provision of information and advice by GPs. Assessment via clinical notes or patient self-
report may underestimate this clinical activity.54,57 Furthermore, self-report of professional
performance only provides a general impression of actual performance.55 A valid picture of
the provision of information and advice by GPs is nevertheless critical, as many patients at
high cardiovascular risk display one or more unhealthy behaviours,2,45 while lifestyle
interventions targeted at high-risk patients have been shown to reduce morbidity and
mortality.58 Assessment using more direct methods of measurement are therefore urgently
needed.
As already mentioned, a more direct method for assessing clinical decision making is the
prospective recording of patient encounters by health care professionals using special
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forms. The items in these forms pertain to evidence-based performance indicators, which
describe the recommended clinical actions and clinical situations calling for those actions.
Such recording of patient encounters provides comprehensive data on both the decisions
made and the clinical information used to make the decisions and therefore enables valid
assessment of the clinical decision making by health care professionals. During certain
encounters, there may be good reasons for not complying with the content of the indicators.
This method of measurement includes nevertheless multiple observations per health care
professional, which means reliable assessment of the actual performance of a particular
professional or group of professionals. A computer program containing the algorithms of
the indicators enables to evaluate a great number of clinical decisions. Furthermore, GPs
have been found to complete encounter forms reliably (average kappa of 0.79) and the
logistics of the method have proved quite feasible.59
Quality improvement
Improvement of the quality of health care can be achieved in different ways including the
development of effective drugs, the input of extra resources, and the implementation of
research findings. The focus of the present thesis is on the implementation of guidelines.
Implementation of such guidelines has been shown to improve the organisation of health
care services and optimise professional’s knowledge, attitudes, skills, and performance, but
further research on the effectiveness of implementation strategies is required.60,61
Several strategies for the implementation of clinical guidelines have been tested. For
example, passive dissemination of guidelines, conferences, audit with feedback, reminders,
outreach visits by facilitators, and reimbursement have been tried either alone or in
combination.61 Most of the interventions have been found to be effective in at least some
situations although the effects have proved only small to moderate.60 The results of
interventions intended to improve the delivery of preventive services in primary care are
consistent with these findings.62 Multifaceted interventions targeting different barriers to
change are more likely to be effective than single interventions but typically involve greater
costs.61-64 Educational outreach visits combined with social marketing show particularly
promising results.65 Outreach visiting is defined as ‘the use of a trained person who meets
with providers in their practice settings to provide information with the intent of changing
the provider’s performance’,65 and such a trained person is often called a ‘facilitator’. The
concept of facilitators in general practice was introduced in 1984 by Fullard within the
context of facilitating cardiovascular disease prevention.66,67
Although multifaceted interventions for the implementation of guidelines have been
shown effective, just how the change process should be managed is not at all clear. Based
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on the available empirical evidence, theoretical perspectives, and practical experience, Grol
and Grimshaw have proposed a cyclic, stepwise model for bringing evidence into
practice.68 The model consists of the following steps.
· Develop a guideline, protocol, or change proposal. The innovation should be
evidence-based, feasible, and attractive.
· Analyse the target group and target setting. The essential elements of this analysis are
the current clinical practice and any barriers to change, which may involve:
- the care providers including attitudes, knowledge, and skills;
- the social context including attitudes of colleagues and reactions of patients; and
- the organisational context including time, equipment, recording system, and
reimbursement.
· Develop or select the implementation strategies. The interventions should be linked to
current clinical practice and the barriers to change, which can differ from stage to
stage in the change process and therefore call for different strategies. This also means
that single interventions are usually not enough and that a combination of
interventions may be needed. Do the following:
- improve interest and understanding, via, for example, the dissemination of
guidelines;
- improve attitude and willingness to change, via, for example, audit and feedback;
- improve actual care, via, for example, support of facilitators; and
- maintain desired performance, via, for example, discussions of repeated audits.
· Develop, test, and conduct a change plan. A plan with a distribution of tasks, a clear
timetable, and concrete goals should be established.
· Evaluate progress and results of change plan. Continuous evaluation provides
information on whether the plan needs to be modified or not.
As already mentioned, the model is cyclic and the completion of a particular step may
therefore prompt modification of the decisions made in previous steps. The model or
‘quality circle’ can be used to manage an improvement project across a number of practices
but also applied on a small-scale to a single general practice.69,70
In The Netherlands, the DCGP and the National Association of GPs (NAGP) have been
using a number of single interventions to implement the DCGP guidelines. After
dissemination of the guidelines, packages for continuous medical education are sent to the
District Offices for General Practice to support postgraduate training activities for groups
of GPs. In addition, local groups of GPs can order well-designed conferences led by well-
trained teachers. GPs and pharmacists are called to discuss the prescription of medication
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in several small-group meetings per year with the support of a DCGP book on
pharmacotherapy. There are booklets for individual GP education and manuals for the
proper use of instruments and materials. Moreover, there are patient letters to supplement
the information provided during the consultation and patient leaflets for the waiting room.
The DCGP has also made written protocols with the specialist associations for several
medical conditions. Nowadays, 70% of the clinical decisions of GPs (depending on the
guideline studied) are in line with the DCGP guidelines on average.59
In 1995, the NAGP and DCGP started the nationwide Tailored Made Prevention project
aimed at the improvement of influenza vaccination and cervical cancer screening.
Prevention teams in the 23 District Offices for General Practice provided a multifaceted
intervention which included educational meetings, educational materials, and outreach
visits to optimise the conduct of the preventive activities. The influenza vaccination rate
and the screening rate for cervical cancer were found to increase considerably.71,72
One of the first research projects to use facilitators to improve preventive cardiovascular
care in Dutch general practice was initiated in 1988. The aim of the project was to
implement a programme for the assessment and management of cardiovascular risk factors
in middle-aged people (30-60 years). In two years time, 72% of this population was
reached. The GPs (n=116) were positive about the support provided by the facilitators but
perceived a definite lack of time and did not achieve adequate follow-up results for high-
risk patients.73 In 1989, the Centre for Quality of Care Research (Universities of Nijmegen
and Maastricht) together with the Department of General Practice from the Erasmus
University Rotterdam undertook a second project to improve preventive cardiovascular
care in general practice (n=95 practices). The aim of this controlled trial was to evaluate the
effects of outreach visits by trained facilitators on the implementation of guidelines for the
assessment of cardiovascular risk factors in, again, people 30 to 60 years of age. The
principles underlying the project were as follows74:
· the implementation of innovations is a step-by-step process;
· adaptation of the intervention to the specific target group, setting, and any barriers is
important;
· multifaceted interventions aimed at multiple barriers are particularly effective;
· clear guidelines are important;
· improved organisation of the health care services is important; and
· outreach visits by a trained person providing individual assistance at the physician’s
office is a promising method for promoting the implementation of preventive
activities in general practice.
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The outreach visits combined with feedback proved to be more effective for improving
practice organisation and risk factor recording when compared to written feedback alone or
no intervention.75,76
The effects of outreach visits on the process of care for patients at high cardiovascular risk
remained largely unclear, because most outreach-visit studies were concentrated on the
structure of care. Outreach visits have been found to improve the prescribing of lipid
lowering drugs for women (but not for men) with hyperlipidaemia.77 However, the
management of patients at high cardiovascular risk also includes monitoring of complaints
and symptoms, assessment of risk factors, provision of information and advice, adjustment
of previously prescribed drugs, referral, and scheduling of follow-up appointments. Until
1995, the effects of outreach visits on such elements of the process of care were not
investigated very closely. Moreover, all of the aforementioned outreach-visits projects on
CVD prevention were not randomised controlled trials and not exclusively directed at high-
risk patients, and therefore preparations for the study presented in this thesis were
undertaken.
Aim and outline of the study
In 1995/1996, the research groups from the Centre for Quality of Care Research in
Nijmegen and the Department of General Practice in Rotterdam designed a new trial called
CARPE: CArdiovascular Risk reduction in Primary carE. In light of the positive results of
their previous study, the use of outreach visits and a stepwise approach were again adopted.
Facing national and international developments, the focus was shifted from low-risk to
high-risk patients. In addition, the new trial addressed not only support for the practice
organisation but also the more complex issue of clinic decision making. The key elements
of CARPE were:
· a randomised controlled design;
· aimed at improving the management (i.e., the structure and process of care) of
patients at high cardiovascular risk;
· use of clear recommendations based on the national guidelines from the DCGP and
consensus procedures;
· application of a multifaceted implementation strategy involving feedback and
outreach visits from trained non-physicians;
· protocol based on a stepwise and cyclic model for quality improvement; and
· evaluation of the effects on practice organisation, clinical decision making, and
patient outcome.
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The trial ran from 1996 to 1999 with a total of 124 practices, 185 GPs, and about 250
practice assistants. The intervention programme was highly standardised to enable firm
conclusions with regard to its effectiveness and involved 15 outreach visits per practice
across a period of 21 months. The programme was also innovative in its complexity as all
aspects of cardiovascular and diabetes care were addressed.
A first objective of the present thesis was to assess current clinical decision making (i.e.,
the process of care) for several important aspects of cardiovascular care. For this purpose,
we used the baseline data from the CARPE trial based on the prospective recording of
patient encounters by the participating GPs. More specifically, we investigated the
provision of information and advice to patients at high cardiovascular risk. In addition, we
investigated the clinical performance of GPs with respect to blood pressure control for
treated hypertensive patients. The second objective was to assess the perceptions of
absolute cardiovascular risk among patients with hypertension or diabetes but no known
atherosclerotic disease. For this purpose, we used data collected via postal questionnaires
after the intervention.
The main goal of this thesis was to describe the effects of the trial on the structure and
process of cardiovascular and diabetes care. The focus was on the effects of intensive
support by non-physicians on the clinical decision making of GPs. Measurement of patient
outcome was beyond the scope of the thesis due to a lack of time and resources. The effect
measures used were nevertheless generated with use of evidence-based guidelines and
rigorous consensus procedures, and may therefore relate to patient outcome.
It was also attempted to identify the relevant predictors of our results. When applicable,
we estimated the influence of patient, practitioner, and practice characteristics on the
measures in the different studies. Insight into such predictors can help us select the most
appropriate means for improvement of care and to tailor future interventions.
Research questions
The following research questions were addressed.
1. To what extent do GPs provide information and advice to patients at high cardiovascular
risk? Which patient and GP characteristics relate to this performance?
2. Are patients with hypertension or diabetes but no known atherosclerotic disease able to
estimate their absolute risk of cardiovascular events and, if so, what are the levels and
accuracy of these estimations? Which patient characteristics relate to patient risk
perceptions?
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3. How and to what extent do GPs try to control diastolic blood pressure in treated
hypertensive patients? Which patient and GP characteristics relate to this performance?
4. What are the effects of a multifaceted outreach-visits intervention on practice
management and the organisation of preventive activities in cardiovascular and diabetes
care? Which practice characteristics relate to effective implementation?
5. What are the effects of a multifaceted outreach-visits intervention on the clinical
decision making of GPs for patients with hypertension, hypercholesterolaemia, angina
pectoris, or heart failure? Which practice characteristics relate to effective
implementation?
6. What are the effects of a multifaceted outreach-visits intervention on the clinical
decision making of GPs for patients with diabetes? Which practice characteristics relate
to effective implementation?
Structure of the thesis
After the present general introduction (Chapter One), three chapters address the issue of
quality assessment. In Chapter Two, the clinical performance of GPs with respect to the
provision of information and advice to patients at high cardiovascular risk is considered. In
Chapter Three, the perceptions which high-risk patients have of their susceptibility to the
development of cardiovascular events are discussed. In Chapter Four, just how and the
extent to which GPs try to achieve blood pressure targets for already treated hypertensive
patients are considered.
The next three chapters address the issue of quality improvement. In Chapter Five, the
effects of the implementation programme on practice management and preventive activities
are considered. In Chapter Six, the extent to which intensive support improves the clinical
decision making of GPs for patients with hypertension, hypercholesterolaemia, heart
failure, or angina pectoris is discussed. In Chapter Seven, the effects of intensive support
on the clinical decision making of GPs for patients with diabetes are considered. Finally, in
Chapter Eight, a general discussion of the findings is presented along with a number of
recommendations.
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Abstract
The aim of this study was to assess the provision of information and advice by general
practitioners (GPs) with respect to patients with hypertension, hypercholesterolaemia, or
cardiovascular disease. The study relied on the prospective recording of patient encounters
by GPs. Performance indicators were selected from the Dutch national guidelines for
general practice. The GPs (n=195) completed 5330 encounter forms. High levels of
performance were found with regard to advice on smoking cessation and the provision of
information (for example, information about alarm symptoms or the aim of treatment).
Low levels of performance were found with regard to advice on salt consumption, alcohol
consumption, weight reduction, and physical exercise for patients with hypertension.
Discussion of compliance with the therapy in case of hypercholesterolaemia, advice on
physical exercise in case of angina pectoris, and advice on foot care in case of peripheral
arterial disease also showed a substantial gap between recommended and actual care.
Performance rates varied considerably across GPs. The patient and GP characteristics
examined in this study contributed very little to the clinical performance.
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Introduction
International committees on preventive and curative cardiology explicitly recommend that
physicians provide high-risk patients with information and advice.1-5 Medical priority for
the prevention of cardiovascular disease is given to high-risk individuals such as patients
with hypertension or atherosclerotic disease.1 Many high-risk patients display one of more
unhealthy behaviours.6,7 Lifestyle interventions targeted at patients with high
cardiovascular risk have been shown to reduce mortality and morbidity.8 In addition, the
provision of information on the content and management of risk factors and the disease
itself has been found to improve compliance with therapy, satisfaction with the care
delivered, and health outcomes.9-11
General practitioners (GPs) are in a favourable position to provide cardiovascular care
and such care constitutes a substantial part of their daily work. In many countries, GPs
have a continuous relation with their patients and this continuity offers the GPs an
opportunity to effectively manage risk factors and chronic disease conditions. The
prevalence of hypertension, angina pectoris, and heart failure in general practice is 5%,
3%, and 1%, respectively.12-14 With an increasing number of elderly patients, GPs are
confronted more and more with the prevention and management of cardiovascular disease.
Assessment of the actual clinical performance of GPs may identify useful targets for
quality improvement.
The actual provision of lifestyle advice to high-risk patients in general practice has been
assessed using different methods. Using postal questionnaires, all GPs have reported
offering lifestyle advice to hypertensive patients prior to drug therapy.15,16 Studies based on
patient reports or clinical notes have shown poor coverage of lifestyle advice for high-risk
patients.6,17,18 Postal questionnaires, patient reports, and clinical notes may all provide an
invalid and unreliable representation of the actual provision of lifestyle advice, partly due
to a lack of a detailed account of the clinical situations.18-22 The actual provision of
information, regarding for instance the aim of treatment for hypertension or
hypercholesterolaemia, the importance of compliance with therapy, or alarm symptoms,
has not been studied very intensively. Prospective recording of patient encounters by GPs
is a potentially valid method for the assessment of actual clinical performance.23 This
method can provide detailed information on the GPs’ professional actions and also on the
specific clinical situations.
The present study examined the provision of information and advice by GPs in
cardiovascular care. The study also determined the influence of patient and GP
characteristics on such performance. Insight into the determinants of variation in the
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performance of GPs may help us select the most appropriate means for the improvement of
care.
Method
Study design and subjects
We conducted a prospective cross-sectional study on 195 GPs in 132 practices in The
Netherlands in 1997. This study served as a baseline for an intervention trial to optimise
the quality of cardiovascular care. Practices in the southern half of the country were
recruited via bulletins and by letter until an adequate number of practices were sampled.
The participating GPs included encounters with patients with one or more of the following
medical conditions: hypertension, hypercholesterolaemia, heart failure, angina pectoris,
and peripheral arterial disease. Optimal management of these risk factors and disease
conditions is described in the Dutch evidence-based guidelines for general practice.24-28
Both encounters with newly diagnosed patients and encounters with patients coming for
follow-up were eligible. We excluded all encounters for hypertension with patients under
18 and over 80 years and all encounters for hypercholesterolaemia with patients under 18
and over 65 years, because no Dutch national recommendations for general practice were
available for these subgroups at the time of the study. We also excluded the encounters for
acute heart failure and unstable angina pectoris, because the provision of information and
advice had no priority during those encounters.
Measures
We used the national clinical guidelines issued by the Dutch College of General
Practitioners (DCGP) to identify indicators for the clinical performance in cardiovascular
care.24-28 The guidelines are based on scientific evidence, broad consensus, and clinical
experience.29 The guidelines are disseminated via the journal of the DCGP, educational
materials, quality improvement meetings, and other channels. We asked a group of five
GPs involved in research and guideline development to select the key recommendations
from the guidelines for cardiovascular care. We used the key recommendations to
formulate performance indicators. Thirty-four indicators are detailed descriptions of
specific information or advice along with the clinical situations calling for the provision of
such information or advice (Table 2).
We next developed structured forms for the prospective recording of patient encounters
for each of the medical conditions considered in this study. Due to the high incidence of
hypertension, separate forms were created for newly diagnosed hypertension versus treated
(with or without medication) hypertension. The encounter forms included items pertaining
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to the age, sex, and clinical characteristics of the patient and also to the performance
(yes/no) of specific clinical actions which included the provision of information or advice.
For several of the items, it was also possible to indicate that the information or advice was
not provided during the present encounter but during a previous encounter. The interval
between the encounters for heart failure, angina pectoris, or peripheral arterial disease
could be several days or weeks, which means that it was not always necessary to repeat
previously provided information or advice during the present encounter. All of the items
were based on the performance indicators.
Each GP recorded his or her performance during routine consultation hours for a period
of two months. Research assistants visited the practices at the start of the recording period
to explain the use of the forms. The GPs were asked to complete the forms immediately
after eligible encounters.
The characteristics of the GPs were derived from a questionnaire completed by one GP
per practice. Data were collected on age, sex and working hours of the GPs, involvement in
GP vocational training, number and working hours of the practice assistants, patient list
size, type of practice (single-handed or partnership), and practice location.
Analysis
We calculated indicator scores. For each performance indicator, the number of clinical
situations in which the GPs actually offered the specific information or advice was divided
by the total number of situations calling for the provision of such information or advice.
For several of the indicators, information or advice was considered to be provided
irrespective of whether this was during the present encounter or a previous encounter. We
also calculated performance rates (i.e. aggregate indicator scores) with the GP as unit of
analysis to assess the variation across GPs for each medical condition. Due to non-normal
distributions, the performance rates were expressed as quartiles.
Multilevel logistic regression analysis (GLMMIX procedure in SAS) was used to
identify determinants of clinical performance and to calculate variance parameters. The
GPs could perform multiple clinical actions per patient and our study therefore comprised
three levels: the GP, the patient, and the clinical action. Multilevel analysis takes into
account the relatedness of patients within the practice of a particular GP and the
relatedness of the clinical actions for a single patient. The degree of patient relatedness was
found to be (almost) zero for the different medical conditions. Therefore, we did not
include the patient level in the definite multilevel analyses. For each medical condition, the
provision of information or advice in specific clinical situations was treated as a binary
dependent variable: either the information or advice was provided or not. The independent
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variables were the GP, age and sex of the patients, and characteristics of the GP. The GP
was entered into the models as a random effect and the other variables as fixed effects. For
each medical condition, we calculated the intracluster correlation coefficient (the variance
between GPs divided by the total variance) along with the variance explained by the
statistically significant independent variables (P<0.05).
Results
Participating GPs and patients
The 195 participating GPs (Table 1) constituted a representative sample of all Dutch GPs
with regard to age, sex, type of practice, and practice location. However, the sample
included fewer GPs who were full-time or who were employed for more than 0.8 full-time
equivalents (65% versus 74% on a national level, P<0.01, chi-square test).30 National
figures for the other GP variables in this study are not available.
Table 1. Characteristics of the participating general practitioners and patients
Characteristic Perentage of participants
General practitioners (n=195)
Aged ³45 years 47
Male 78
Single-handed practice 42
Urban practice locationa 47
Employment >0.8 full-time equivalent 65
³ 2500 patients per full-time equivalent general practitioner 60
Involvement in general practitioner vocational training 22
³ 0.8 full-time equivalent practice-assistant employed per 2500 patients 65
Patientsb
Newly diagnosed hypertension (18-80 years; n=285)
Male 47
Aged ³60 years 31
Treated hypertension (18-80 years; n=3825)
Male 40
Aged ³60 years 57
Hypercholesterolaemia (18-65 years; n=538)
Male 54
Aged ³60 years 29
Heart failure (n=236)
Male 47
Aged ³75 years 55
Angina pectoris (n=300)
Male 53
Aged ³70 years 51
Peripheral arterial disease (n=146)
Male 66
Aged ³70 years 44
a ³1500 addresses per km2.
b For patients with more than one form recorded, each form was counted separately.
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The patients in the encounters for heart failure, angina pectoris, or peripheral arterial
disease were on average older than the patients in the encounters for hypertension or
hypercholesterolaemia. Males were in the minority (40%) in encounters for treated hyper-
tension and in the majority (66%) in encounters for peripheral arterial disease (Table 1).
Actual provision of information and advice
The study comprised 5330 patient encounters with a total of 16 616 situations calling for
the provision of specific information or advice. The 34 indicator scores varied from 31% to
93% (Table 2). Scores for advice on smoking cessation and scores for the provision of
information (for example, information about alarm symptoms or the aim of treatment) were
generally above 70%. Eleven indicator scores were 60% or lower. For newly diagnosed
hypertensive patients, indicator scores of 60% or lower were found for advice on salt
consumption, alcohol consumption, and physical exercise. The GPs addressed salt
consumption, alcohol consumption, and body weight in less than half of the encounters
with treated hypertensive patients with an elevated diastolic blood pressure. For patients
with hypercholesterolaemia, the GPs discussed diet and compliance with cholesterol
lowering medication in 55% and 58% of the relevant clinical situations, respectively. The
indicator score for advice on physical exercise to patients with angina pectoris and the
score for advice on foot care to patients with peripheral arterial disease were 49% and
51%, respectively. Several indicators included also information or advice provided during
a previous encounter; the proportions previously provided information or advice were an
average of 50% and varied from 89% (advice on influenza vaccination to patients with
heart failure) to 16% (advice on smoking cessation to patients with angina pectoris).
Table 3 shows the performance rates of the GPs for the different medical conditions.
The median performance rates ranged from 61% (treated hypertension) to 83% (heart
failure). The differences between the 75th percentiles and 25th percentiles, reflecting
variation across GPs, varied from 23% (hypercholesterolaemia) to 56% (peripheral arterial
disease). For hypertension, angina pectoris, and peripheral disease, one fourth of the GPs
had a performance rate of 50% or lower. The intracluster correlation coefficient for the
different medical conditions ranged from 0.14 (angina pectoris ) to 0.30 (peripheral arterial
disease).
Table 2. General practitioners’ provision of information and advice in cardiovascular care
 N
NR Performance indicator
Clinical
situationa
Information or
advice provided Indicator score %
Encounters with patients with newly diagnosed hypertension (18-80 years)
 1 Explained current smokers that smoking is a strong risk factor for cardiovascular disease and that smoking
cessation gives far out the highest risk reduction
    66     53 80
 2 Advised current smokers to stop smoking     66     54 82
 3 Explained that hypertension is not a disease but a risk factor for cardiovascular disease   285   215 75
 4 Explained patients with a body mass index above 25 kg/m2 that there is a strong and positive relationship between
body weight and the level of blood pressure
    95     72 76
 5 Advised patients with a body mass index above 25 kg/m2 to reduce weight     95     79 83
 6 Explained that a strong reduction in salt intake reduces blood pressure   285   198 69
 7 Advised not to add salt during cooking and to use fresh products with little salt instead of industrially prepared
food products
  285   172 60
 8 Explained that physical exercise and sport reduce blood pressure   285   149 52
 9 Advised to exert physical exercise   285   146 51
10 Advised to limit alcohol consumption to two units per day   285     95 33
Encounters with treated hypertensive patients (18-80 years)
11 Discussed therapy compliance with patients on antihypertensive medication 3659 2737 75
12 Advised current smokers to stop smoking   571   413 72
13 Discussed body weight with patients with uncontrolled hypertensionb or a body mass index above 30 kg/m2 2039   975 48
Discussed body weight with patients with uncontrolled hypertensionb  1608    682 42
Discussed body weight with patients with a body mass index above 30 kg/m2    839    613 73
14 Discussed salt consumption with patients with uncontrolled hypertensionb 1608   743 46
15 Discussed alcohol consumption with patients with uncontrolled hypertensionb or excessive alcohol consumption 1654   506 31
Discussed alcohol consumption with patients with uncontrolled hypertensionb  1608    474 29
Discussed alcohol consumption with patients with excessive alcohol consumption      98      74 76
Encounters with patients with hypercholestesterolaemia (18-65 years)
16 Provided information about the aim of treatment   538   497c 92
17 Provided information about the importance of life style modifications   538   487c 91
18 Provided information about the importance of follow-up   538   471c 88
19 Provided information about the importance of compliance with therapy   538   428c 80
20 Advised current smokers to stop smoking   144   103 72
21 Discussed therapy compliance with patients on cholesterol lowering medication   332   191 58
22 Provided diet advice in accordance with national guidelines or discussed compliance with this advice   538   296 55
 N
NR Performance indicator
Clinical
situationa
Information or
advice provided Indicator score %
Encounters with patients with heart failure
23 Advised influenza vaccination   236   220c 93
24 Advised not to add salt to food and to refrain from industrially prepared food products with high salt content   236   183c 78
25 Advised to contact the GP when physical tolerance reduces, dyspnoe increases, or weight increases with two or
more kilograms in a few days
  236   165c 70
Encounters with patients with angina pectoris
26 Advised current smokers to stop smoking     36     32d 89
27 Advised what to do in case of ischaemic complaints (use nitroglycerin sublingually) and when to call for help   300   247d 82
28 Advised patients with a body mass index above 25 kg/m2 to reduce weight     65     44d 68
29 Advised to perform physical exercise (walking at a brisk pace, biking, swimming, or gardening)   300   146d 49
Encounters with patients with peripheral arterial disease
30 Advised current smokers to stop smoking     56     52d 93
31 Advised patients without devastating symptomse to walk or discussed compliance with this advice     92     84d 91
32 Informed patients without devastating symptomse about the mostly benign course of peripheral arterial disease     92     70d 76
33 Advised patients without devastating symptomse to contact the GP in case of alarm symptoms (acute pain, rapid
progression of symptoms, or pain at rest)
    92     62d 67
34 Advised foot care or discussed compliance with this advice   146     75d 51
a Clinical situation calling for the provision of specific information or advice.
b Diastolic blood pressure above 90 mmHg (95 mmHg or above for patients without antihypertensive medication).
c Provided during the present encounter or a previous encounter.
d Provided during the present encounter or a recent encounter.
e Rapid increase of (pain) complaints, rapid decrease of action radius, ischaemic leg complaints in rest, necrosis, or gangrene.
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Table 3. Performance rates of general practitioners with regard to the provision of information and advice in 
cardiovascular care; intracluster correlation coefficients
Performance rate %
Medical condition
Number
of GPs
Mean number (SD) of
clinical situationsa
per GP 25th percentile Median 75th percentile ICC
Newly diagnosed
hypertension
125 16 (10) 40 64   80 0.23
Treated hypertension 195 49 (24) 47 61   78 0.21
Hypercholesterolaemia 155 20 (14) 67 80   90 0.19
Heart failure   97 7 (6) 67 83 100 0.29
Angina pectoris 126 6 (4) 50 67 100 0.14
Peripheral arterial disease   88 5 (4) 44 75 100 0.30
a Clinical situations calling for the provision of specific information or advice.
ICC Intracluster correlation coefficient.
Determinants of the provision of information and advice
GPs aged 45 years or older provided information and advice to treated hypertensive
patients significantly more often than younger GPs. Female GPs and GPs involved in GP
vocational training showed better performance for patients with peripheral arterial disease
(Table 4). In concordance with the absence or very low degree of variance at the patient
level, patient’s age and sex did not predict performance for most medical conditions. Male
sex and an age under 60 years on the part of patients predicted better performance in
encounters for treated hypertension (Table 4). The statistically significant determinants
explained 2% of the total variance in encounters for treated hypertension and 6% in
encounters for peripheral arterial disease. No statistically significant determinants were
found for the other medical conditions studied.
Table 4. Odds ratios for determinants (P < 0.05) of provision of information and advice in cardiovascular care
Medical condition
Determinant Odds ratio 95% CI P value
Treated hypertension
General practitioner: age ³45 years 1.50 1.13 to 1.99 0.004
Patient: age <60 years 1.22 1.11 to 1.34 0.000
Patient: male 1.11 1.01 to 1.22 0.027
Peripheral arterial disease
General practitioner: female 3.25 1.22 to 8.65 0.016
General practitioner: involvement in GP vocational training 2.42 1.08 to 5.44 0.030
Discussion
GPs provided information or advice in 31% to 93% of the specific clinical situations
studied here. Twenty-three of the 34 indicator scores were above 60%. The variance across
GPs was considerable and comprised 14% to 30% of the total variance. GP and patient
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characteristics contributed very little to the variance in the provision of information and
advice. 
An indicator score of 60% or below can be viewed as low quality of care. In the present
study we did, however, not ask about the motives of the GPs for apparently ignoring
certain recommendations. All kinds of professional, patient and environmental barriers
may undermine clinical performance.31 GPs show a good level of knowledge of healthy
lifestyle,15,16,32,33 but report a lack of training in lifestyle counselling.33-35 Many GPs have
doubts about the effectiveness of lifestyle advice32-38; their believes seem to be more
positive when the advice is linked to patients’ presenting problems.32,38 For treated
hypertensive patients, female and older patients were less likely to be given information
and advice. This confirms the results of Foss et al.6 It should be noted, moreover, that the
evidence-based hypertension guidelines recommend non-pharmacological treatment
irrespective of age and sex.2 The high differences between the 75th percentiles and 25th
percentiles of the GP performance rates together with intracluster correlation coefficients
between 0.14 and 0.30 show substantial groups of GPs to perform at lower levels when
compared to other GPs.
The selection and content of the indicators used in this study resulted, in our opinion, in
a valid assessment of clinical performance. The indicators were selected from evidence-
based guidelines and are well-accepted measures of the quality of care.1-5 The content of
the indicators allowed us to examine clinical actions in relation to specific clinical
circumstances.
Several factors may nevertheless have biased our results. The GPs were included only
after they agreed to take part in an intervention trial to optimise cardiovascular care.
Therefore, the GPs may have had a special interest in cardiovascular care and they may
have performed more favourably. It also cannot be ruled out that the GPs selectively
recorded encounters in which they indeed adhered to the guidelines. In addition, the
recording of patient encounters may have positively influenced clinical performance,
especially if repeated recording guides the doctor in the required direction. In all of these
cases, the reported performance rates may overestimate actual performance. Furthermore,
the GPs may have reported their actual performance inaccurately. Several indicators
included information or advice provided during a previous encounter, and the report of
previously and even recently performed actions may be biased in particular. The report of
clinical performance was nevertheless linked to unique, living patients and not to
imaginary patients as in postal questionnaires. Moreover, the prospective recording of
patient encounters by GPs has been found to reliably assess the provision of information
and advice by GPs; comparison with an assessment via direct observation has been shown
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a kappa of 0.67 (Spies TH, personal communication). Finally, practice assistants may also
provide information and advice, which means that our results based on GPs alone may
underestimate the total provision in general practice.
The present study was a quantitative assessment. We did not examine the consulting
styles of GPs or the extent to which GPs take account of a patient’s motivation and
capacity to change his/her lifestyle or adopt clinical information. A patient-centred style of
consulting and the use of the stage of change model appear to be critical to actually
improve patient outcome, however.11 Both qualitative and quantitative studies are therefore
needed to get a complete picture of the GPs’ clinical performance.
Our findings have implications for practitioners, people involved in guideline
development, and people involved in quality improvement. Making practitioners aware of
low scores for the provision of information and advice provides them with an opportunity
to improve their clinical performance.39 People involved in guideline development can
check the evidence for recommendations having low performance scores and then either
clarify, emphasise or adapt the recommendations as needed. Furthermore, our findings
provide useful targets for quality improvement projects. Ultimately, the patients will gain
the benefits from all of these activities.
The present study calls also for further research. Greater insight into the prevalence and
impact of the different barriers to the provision of information or advice is demanded in
order to judge better the GPs’ clinical performance. It is very well possible that the GPs in
our study had relevant motivations not to adhere to the guidelines in some patient
encounters. Furthermore, research is needed to elucidate which groups of GPs appear to
have particularly low performance levels and also the extent to which (repeated) recording
of the encounter forms influences the provision of information and advice.
In conclusion, the GPs in this study were found to frequently provide information and
advice in cardiovascular care. Nevertheless, for several medical conditions, one fourth of
the GPs performed less favourably. Two-thirds of the indicators showed high to very high
scores while one third showed clear room for improvement.
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Abstract
Objective. To examine the perceptions of absolute cardiovascular risk among patients at
moderate to high cardiovascular risk and to identify the determinants of these perceptions.
Design. Postal questionnaire survey in 1999.
Setting. General practices in the Netherlands.
Patients. 1557 patients with hypertension or diabetes but no known atherosclerotic disease.
Main outcome measures. Patients’ ability to estimate their 10-year absolute risk of
myocardial infarction and stroke, the levels of perceived absolute risk, and the accuracy of
these perceptions.
Results. Response rate was 86.3%. One fourth of the 1557 eligible patients did not provide
any risk estimate and these were particularly older patients, patients with a lower
educational level, and patients reporting no alcohol consumption. The mean perceived 10-
year risk of myocardial infarction and stroke reported by the remaining patients was 30.5%
(SD 24.2%) and 29.8% (24.0%), respectively. Almost 50% of the patients either
overestimated or underestimated their risk by more than 20%. Older age, smoking, familial
history of cardiovascular disease, and actual absolute risk predicted higher levels of
perceived absolute risk. Males were significantly more accurate than females when
estimating absolute risk of myocardial infarction. Higher scores for an internal health locus
of control and lower scores for a physician locus of control were positively related to
ability and accuracy. Self-rated fair/poor health predicted higher levels of perceived
absolute risk and lower accuracy.
Conclusions. Patients showed inadequate perceptions of their absolute risk of
cardiovascular events. Physicians should thus provide greater information about the
concept and exact level of absolute risk when offering treatment to reduce the risk of
cardiovascular disease.
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Introduction
The benefits of treatment with aspirin, statins, or antihypertensive drugs depend on a
patient’s absolute risk of cardiovascular disease. The relative risk reduction by such
treatment is largely independent of the absolute risk before treatment.1-3 That is, absolute
risk reduction increases with pretreatment absolute risk, and, as a consequence, current
recommendations for the use of aspirin, statins, and antihypertensive drugs are based on
specific thresholds of absolute risk.4,5
Decisions with regard to whether to take medication or not should be jointly made
between patients and physicians.6 Shared decision making respects the autonomy of the
patient and may improve patient satisfaction,7,8 well-being,9 and even health outcomes.9
Shared decision making is considered particularly appropriate for problems involving
medical uncertainty.10 Whether an individual patient will actually benefit from preventive
therapy is often uncertain and shared decision making is therefore an important issue in
preventive cardiology. The patient and the physician should discuss the level of the
patient’s absolute cardiovascular risk, the actual harm of cardiovascular events, and the
absolute risk reduction which can be achieved by treatment. The decision to take
medication should be jointly made and physicians may handle the process of shared
decision making better when given insight into patient’s perceptions of absolute risk.
Insight into risk perceptions is particularly relevant with regard to patients with
hypertension or diabetes but no known atherosclerotic disease. The absolute risk of patients
with atherosclerotic disease is very high and their benefits of preventive drug treatment
will therefore generally surpass any arguments against such treatment. Patients with
hypertension or diabetes but no known atherosclerotic disease are at moderate to high
cardiovascular risk and thus require jointly made decisions with regard to the initiation,
continuation and adjustment of treatment with aspirin, statins, or antihypertensive drugs.
People selected from the general population have been found to be overly optimistic when
estimating their relative risk of having a cardiovascular event (i.e. their risk compared to
other people of the same age and sex).11,12 Healthy people between the ages of 65 and 79
have been found to overestimate the absolute risk of stroke for hypothetical patients with
hypertension.13 In the latter study, the people estimated the risk with help of a visual aid
and trained research assistants. Just how accurately patients with hypertension or diabetes
but no known atherosclerotic disease estimate their absolute risk of a cardiovascular event
without the help of a health professional is simply unknown.
Physicians may be better able to tailor the provision of information to patients when
better informed about the factors which determine the risk perceptions of patients. Self-
reported risk factors and actual absolute risk have been found to be related to the level of
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perceived relative risk, while age, self-rated health, and educational level have been found
to be related to the accuracy of perceived relative risk.11,12 It is very possible that these
factors are also related to the level and accuracy of perceived absolute risk, and we have
assumed that health locus of control (i.e. the extent to which patients attribute health and
disease to internal and external factors) may be related to risk perception as well.
The purpose of the present study was to examine the ability to estimate absolute
cardiovascular risk, the levels of perceived absolute risk and the accuracy of these
perceptions among patients with hypertension or diabetes but no known atherosclerotic
disease. We also explored the influence of patient characteristics on the different outcome
measures. Of particular interest were patients’ perceptions of personal 10-year risk of
myocardial infarction and stroke. Most recommendations for aspirin, statins, and
antihypertensive drug treatment are based on the risk of coronary heart disease (CHD) or
CVD.4,5 Assessment of patients’ perceptions of their risk of myocardial infarction and
stroke appears to be more valid, however, because patients probably do not understand
what exactly comprises CHD or CVD.
Methods
Study design and patients
The survey was carried out in 1999 after a randomised controlled trial was conducted in
124 general practices in The Netherlands. The 21-month trial examined the effects of a
multifaceted intervention on the structure and process of cardiovascular and diabetes
care.14 At baseline, the participating general practitioners and their practice assistants
handed out consent forms with stamped return envelopes to patients visiting the practice
and known to have hypertension or diabetes. The envelopes were addressed to the research
team and the forms were labelled hypertension or diabetes. A total of 2578 patients
returned the consent form and agreed to receive the questionnaire for the present survey.
Just prior to the mailing of the questionnaire, the general practitioners were asked to
exclude patients who had died, had established life-threatening morbidity, left the practice
or were unsuitable for participation due to psychosocial problems. The questionnaires with
a stamped return envelope were sent to the remaining 2424 patients. One postal reminder
was sent after two weeks. Patients reporting a history of atherosclerotic disease were
excluded for reasons mentioned in the introduction. We also excluded all patients over 80
years of age because the perceptions of absolute cardiovascular risk among such patients
are not considered particularly relevant.
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Variables
Patients were asked to estimate their personal 10-year risk of myocardial infarction and
stroke, respectively, along a 100-millimeter visual analogue scale with 0% and 100% at the
ends of the continuum. Patients were construed as capable of estimating their absolute risk
when at least one of the two estimates was provided. Background data reported by the
patients were: history of high blood pressure, high cholesterol, myocardial infarction,
angina pectoris, stroke, transient ischaemic attack, and/or peripheral arterial disease; the
presence of diabetes; treatment for high blood pressure, high cholesterol, and/or diabetes.
Furthermore, the patients reported age, sex, educational level, smoking (yes/no), alcohol
consumption (yes/no), weight and height, and familial history of CVD (i.e. a parent or
sibling who suffered from cardiovascular disease before the age of 60) (yes/no). Self-rated
health was measured with the question: “Would you say your health is generally: excellent,
very good, good, fair, or poor?” This question is widely used in studies involving self-
ratings of health.15 Health locus of control was measured using a 10-item version of the
Multi-dimensional Health Locus of Control scale.16 Four items referred to an internal locus
of control, three to an external locus of control attributed to the physician, and three to an
external locus of control attributed to chance. The items were responded to along a 5-point
scale ranging from strongly disagree (one point) to strongly agree (five points). The score
per patient for a particular locus of control was expressed as a percentage of the maximum
possible score, such that a high percentage indicates high attribution to that locus of
control.
The accuracy of the risk perceptions was inversely related to the absolute difference
between perceived and actual risk. We used Framingham risk functions to calculate 10-
year actual risk.17 The factors in these functions are: age, sex, diabetes (yes/no), smoking
(yes/no), systolic blood pressure, cholesterol/HDL ratio, and left ventricular hypertrophy
(yes/no). We calculated the actual risk using the data provided by the patients and thus
took the patients’ awareness of the presence or absence of the different factors into
account. The patient questionnaires did not provide information on blood pressure,
cholesterol/HDL ratio, and the presence or absence of left ventricular hypertrophy. We
therefore had to make several assumptions. Based on previous observational studies,18-20 a
patient with a history of high blood pressure was assumed to have a systolic blood pressure
of 160 mmHg while all other patients were assumed to have a systolic blood pressure of
130 mmHg. A patient with a history of high cholesterol was assumed to have a
cholesterol/HDL ratio of 7.0 while all other patients were assumed to have a ratio of 5.0.
All of the patients were considered free of left ventricular hypertrophy because we
assumed that most patients are simply unaware of this factor when present. A familial
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history of CVD is not included in the Framingham risk equations but provides an
additional risk.21 For this reason, patients were assumed to have a 5% higher risk of
cardiovascular disease endpoints when they had a familial history of CVD; which is an
assumption consistent with the Dutch national guidelines.22
Analysis
Multilevel regression analysis (GLMMIX procedure in SAS) was used to assess the
associations between the patient characteristics and risk perceptions. Multilevel analyses
take into account the relatedness of the patients within a particular practice. The dependent
variables were: ability to estimate absolute risk; level of perceived risk of myocardial
infarction and stroke, respectively; and, accuracy of the two risk perceptions. The
independent variables were: age, sex, educational level, history of high blood pressure,
history of high cholesterol, diabetes, familial history of CVD, smoking habit, alcohol
consumption, body mass index, self-rated health, and locus of control. We controlled for
assignment to the intervention or control groups in the randomised trial (the P values for
the influence of assignment proved to be 0.37 or higher for all of the models). We also
explored the influence of actual risk on the level and accuracy of perceived risk; the risk
factors used to calculate actual risk were later replaced by the actual risk level in a second
set of models. P values less than 0.05 were considered statistically significant.
Results
Study population
A total of 2093 patients returned their questionnaires, which represents a response rate of
86.3%. A total of 1557 patients remained after inclusion of only those patients 80 years or
younger and not reporting a history of atherosclerotic disease. Patient characteristics
including actual risk are displayed in Table 1. A total of 1130 patients were labelled by the
practice teams as having hypertension and 1102 (97.0%) of these patients reported a
history of high blood pressure; 450 were labelled as having diabetes and 376 (83.6%) of
these patients reported a presence of diabetes.
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Table 1. Characteristics of the study population (1557 patients with hypertension or diabetes but no known
atherosclerotic disease)
Characteristic % Mean ± SD
Age (years) 62.5 ± 10.5
Sex (male) 42.2
Educational level
Primary education 26.6
Junior education 40.6
Secondary education 18.3
University or vocational college 11.1
Other  3.4
History of high blood pressure 84.1
History of high blood pressure on treatment 76.5
Diabetes 28.9
Diabetes on treatment 26.9
History of high cholesterol 24.8
History of high cholesterol on treatment 17.3
Familial history of cardiovascular disease 30.2
Current smoker 20.4
Alcohol consumption 64.6
Body mass index (kg/m2 ) 27.3 ±   4.0
Calculated 10-year risk (%)
Stroke   8.4 ±   5.0
Myocardial infarction 13.3 ±   7.0
Coronary heart disease 21.5 ±   8.6
Cardiovascular disease 33.0 ± 12.6
Score for locus of control (%)
Internal 64.1 ± 13.7
Physician 62.3 ± 14.8
Chance 57.8 ± 17.4
Self-rated health
Excellent   3.4
Very good   9.6
Good 66.5
Fair 19.2
Poor   1.3
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Ability to estimate absolute risk
A total of 363 (23.3%) of the patients did not provide at least one of the two absolute risk
estimates. Younger age, higher educational level (university or vocational college), and
alcohol consumption predicted the ability to provide such estimates. Higher scores for an
internal locus of control and lower scores for a physician locus of control also predicted the
ability to estimate absolute risk (Table 2).
Table 2. Multilevel regression analysis: associations (P < 0.05) between ability to estimate absolute
cardiovascular risk and characteristics of 1557 patients with hypertension or diabetes but no known
atherosclerotic disease
Variable ß SE P
Sex (men versus women) -0.025 0.008 ***
Educational level
Primary education   0.366 0.376
Junior education   0.676 0.366
Secondary education   0.378 0.383
University or vocational college   1.369 0.463
Other   0.000 -
**
Alcohol consumption (yes versus no)   0.717 0.165 ***
Locus of control (%)
Internal   0.152 0.030 ***
Physician -0.091 0.040 *
Intracluster correlation coefficient 0.09
R2 0.14
ß paramater estimate
SE standard error
* P < 0.05; ** P < 0.01; *** P < 0.001
Levels of perceived absolute risk
The mean levels of perceived 10-year risk were 30.5% (SD 24.2%) for myocardial
infarction and 29.8% (24.0%) for stroke. The levels of perceived risk of myocardial
infarction and stroke were highly correlated (Pearson correlation coefficient of 0.86, mean
difference 0.6% (SD 12.7%)). Older age, smoking, familial history of CVD and self-rated
fair/poor health predicted higher levels of perceived risk. Lower scores for an internal or a
chance locus of control and higher scores for a physician locus of control also predicted
higher levels of perceived risk (Table 3). In the second set of models with the level of
actual 10-year risk replacing the risk factors, actual risk was found to positively relate to
perceived risk (for myocardial infarction ß = 0.335, SE = 0.109, P < 0.01; for stroke ß =
0.440, SE =0.157, P < 0.01).
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Table 3. Multilevel regression analysis: associations (P < 0.05) between level of perceived absolute risk of
myocardial infarction or stroke and characteristics of 1141 patients with hypertension or diabetes but
no known atherosclerotic disease
Myocardial infarction Stroke
Variable ß SE P ß SE P
Age (years)   0.251 0.077 ***   0.302 0.077 ***
Current smoker (yes versus no)   4.584 1.824 *   3.997 1.836 *
Familial history of cardiovascular disease
(yes versus no)
  5.700 1.582 ***   3.873 1.591 *
Locus of control (%)
Internal -1.386 0.308 *** -1.110 0.312 ***
Physician   0.886 0.397 *   0.756 0.404 0.062
Chance -0.650 0.323 * -0.728 0.324 *
Self-rated health
(excellent/very good/good versus fair/poor)
-5.347 1.886 ** -5.070 1.901 **
Intracluster correlation coefficient  0.00  0.00
R2  0.06  0.05
ß paramater estimate
SE standard error
* P < 0.05; ** P < 0.01; *** P < 0.001
Accuracy of the levels of perceived absolute risk
A total of 68.7% and 76.4% of the patients who provided estimates of the level of absolute
risk of myocardial infarction and stroke, respectively, overestimated their risk; 45.1% and
47.7% either overestimated or underestimated their absolute risk by more than 20%,
respectively. The mean absolute differences between the levels of perceived and actual 10-
year risk were found to be 22.9% (SD 19.3%) for myocardial infarction and 24.6%
(21.0%) for stroke. Male sex predicted higher accuracy of perceived risk of myocardial
infarction. Higher scores for an internal locus of control and lower scores for a physician
locus of control also predicted higher accuracy, while self-rated fair/poor health predicted
lower accuracy (Table 4). In the second set of models, the levels of actual 10-year risk of
myocardial infarction were positively related to the accuracy of risk perception (ß = 0.201,
SE = 0.089, P < 0.05); for stroke, the association was also positive but not statistically
significant (ß = 0.069, SE = 0.139, P = 0.621).
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Table 4. Multilevel regression analysis: associations (P < 0.05) between accuracy of perceived absolute risk of
myocardial infarction or stroke and characteristics of 1141 patients with hypertension or diabetes but
no known atherosclerotic disease
Myocardial infarction Stroke
Variable ß SE P ß SE P
Sex (men versus women)  4.175 1.295 **   2.100 1.433 0.143
Locus of control (%)
Internal   0.820 0.250 **   0.839 0.278 **
Physician -0.695 0.323 * -0.815 0.359 *
Self-rated health
(excellent/very good/good versus fair/poor)
 4.257 1.534 **   4.311 1.693 *
Intracluster correlation coefficient 0.00 0.00
R2 0.04 0.02
ß paramater estimate
SE standard error
* P < 0.05; ** P < 0.01; *** P < 0.001
Discussion
Patients with hypertension or diabetes but no known atherosclerotic disease proved to have
inadequate perceptions of their absolute risk of cardiovascular events. One fourth of the
patients did not provide any risk estimate and these were particularly older patients,
patients with a lower educational level, and patients reporting no alcohol consumption.
Almost 50% of the remaining patients either overestimated or underestimated their
absolute risk by more than 20%. The level of perceived absolute risk of myocardial
infarction was almost equal to the perceived level of absolute risk of stroke while the risk
of myocardial infarction is actually higher. Sex and body mass index are cardiovascular
risk factors but were not found to be associated with the levels of perceived absolute risk.
Male sex, however, was related to higher accuracy of perceived absolute risk of myocardial
infarction. Lower scores for an internal locus of control and higher scores for a physician
locus of control were positively associated with an inability to estimate and inaccuracy.
Furthermore, self-rated fair/poor health was related to higher levels of perceived absolute
risk and lower levels of accuracy. The amount of variance explained by the various patient
characteristics was low, however (2% to 14%). The intracluster correlation coefficients for
the level and accuracy of perceived absolute risk were zero which also suggests that the
GPs had not effectively informed patients of personal cardiovascular risk.
Several results call for special attention. Firstly, diabetes, a history of high blood
pressure, and a history of high cholesterol did not relate to patient estimates of absolute
risk. In most of these cases, the medical condition was being treated and the patients
appeared to not perceive themselves as at risk. Secondly, patients who tend to attribute
their health condition to physicians may prefer more a “directive” than a “sharing” style of
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consulting. Our results indicate, however, that these same patients have a particular need
for information with regard to their absolute cardiovascular risk. Thirdly, self-rated
fair/poor health was related to higher levels of perceived absolute risk. In previous studies,
self-rated fair/poor health has consistently been found to be an independent predictor of all-
cause mortality,15 but Pijls et al.23 did not find a relation to the incidence of cardiovascular
disease among elderly Dutch men. Self-rated fair/poor health appears thus not to be related
to actual absolute cardiovascular risk.
Previous studies have shown physicians to also misclassify the absolute cardiovascular
risk of high-risk patients on occasion.13,24-27 In most studies, the majority of the physicians
(in particular, generalists) are found to overestimate absolute cardiovascular risk. The
accuracy of the risk estimates provided by physicians also varies widely. Unless physicians
use cardiovascular risk carts, tables, or computer programs, thus, they may not provide
accurate information with regard to the susceptibility of a particular patient to CVD.
The present study has some limitations. We assessed the perceptions of absolute risk via
self-report using a visual analogue scale. While the provision of support to attain risk
estimates may cause bias, no provision of such support may mean that certain patients did
not understand the visual analogue scale. The psychometric properties of such a visual
analogue scale and other instruments for the assessment of perceived absolute
cardiovascular risk should be undertaken. Another possible limitation is that we did not
address perceptions of risk of CHD or CVD, while the current guidelines on preventive
cardiology are based on those endpoints. Myocardial infarction and stroke are nevertheless
important components of CHD and CVD. Finally, the patients were not randomly sampled.
Selection bias is nevertheless unlikely, because the age, educational level, body mass
index, and smoking habits of the patients and also the proportions of the patients with
diabetes having hypertension or hypercholesterolaemia were found to be much the same as
in previous general practice studies in The Netherlands.19,20 In the latter studies, all patients
with hypertension or all patients with diabetes treated by the general practitioners were
invited to participate. We are also convinced that our study addressed patients with
hypertension or diabetes because a good concordance was observed between the
physicians’ labels and the patients’ self-reports of a history of high blood pressure or
diabetes.
In conclusion, patients with hypertension or diabetes but no known atherosclerotic
disease appear to have inadequate perceptions of their absolute cardiovascular risk. This
means that health professionals should try to provide such patients with greater information
with regard to absolute cardiovascular risk. Such information is a prerequisite for shared
decision making with regard to preventive drug treatment.
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Summary
Background. The blood pressure of many treated hypertensive patients remains above
recommended target levels. This discrepancy may be related to general practitioners’
Aim. To assess clinical performance of GPs in blood pressure control in treated
hypertensive patients and to explore the influence of patient and GP characteristics on
clinical performance.
Design of study. Cross-sectional study conducted on 195 GPs with invitations to
participate made via bulletins and by letter.
Setting. One hundred and thirty-two practices in the southern half of The Netherlands from
November 1996 to April 1997.
Method. Performance criteria were selected from Dutch national hypertension guidelines
for general practice. GPs completed self-report forms immediately after follow-up visits of
hypertensive patients treated with antihypertensive medication.
Results. The GPs recorded 3526 follow-up visits. In 63% of these consultations the
diastolic blood pressure (DBP) was 90 mmHg or above. The median performance rates of
the GPs were less than 51% for most of the recommended actions, even at a DBP of ³100
mmHg. Performance of non-pharmacological actions increased gradually with increasing
DBP; prescribing an increase in antihypertensive medication and making a follow-up
appointment scheduled within six weeks rose steeply at a DBP of ³100 mmHg. Patient and
GP characteristics contributed little to clinical performance. Action performance rates
varied considerably between GPs.
Conclusion. GPs seem to target their actions at a DBP of below 100 mmHg, whereas
guidelines recommend targeting at a DBP of below 90 mmHg.
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Introduction
Guidelines from national and international committees recommend blood pressure targets
for the pharmacological treatment of hypertension.1-3 Treatment of hypertension aims to
reduce a patient’s risk of developing coronary artery disease and stroke.4,5 A major
determinant of the risk reduction is the level of blood pressure achieved.6 The guidelines
recommend that systolic blood pressure (SBP) should be reduced to below 130-150 mmHg
and diastolic blood pressure (DBP) should be reduced to below 85-90 mmHg. These target
values were derived from trials that studied the efficacy of antihypertensive drugs. The
targets are set to stimulate doctors and patients to actually reach these levels and to achieve
optimal benefit from pharmacological treatment. However, studies show that 60-69% of
treated hypertensive patients in general practice do not reach the recommended targets;
they have a DBP of ³90 mmHg or a SBP of ³160 mmHg.7-9 Hypertension is a common
condition in general practice with a prevalence of 5%.10 Therefore, treated but uncontrolled
hypertension is a major problem in preventive health care.
The discrepancy between recommended blood pressure targets and actual levels may be
related to doctors clinical performance. In many countries, hypertension is almost entirely
managed by general practitioners (GPs). It would therefore be worthwhile to investigate
which blood pressure targets GPs apply in daily clinical practice and how and to which
extent they try to achieve these targets.
The primary objective of this study was to assess clinical performance of GPs in blood
pressure control in treated hypertensive patients and the variation between GPs. The
secondary objective was to estimate the influence of patient and GP characteristics on
clinical performance. Assessment of clinical performance may provide insight into the
quality of actual care, the pursuit of recommended targets, and the effectiveness of clinical
actions.
Method
Study design and subjects
We conducted a cross-sectional study on 195 GPs in 132 practices in The Netherlands
from November 1996 to April 1997. This study served as a baseline for an intervention
trial to optimise the quality of cardiovascular care. GPs in the southern half of The
Netherlands were invited via bulletins and by letter to participate. The participating GPs
identified hypertensive patients treated with antihypertensive medication who came for a
follow-up visit. We excluded all patients aged under 18 or over 80 years.
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Measurements
In 1991, the Dutch College of General Practitioners issued national guidelines for the
detection and management of hypertension.11 We used these clinical guidelines to select
key recommendations for the management of uncontrolled blood pressure in treated
hypertensive patients. These guidelines are based on scientific evidence, broad consensus,
and clinical experience.12 Most Dutch GPs are familiar with the guidelines six to 12
months after publication.13 The target for pharmacological treatment in the 1991 Dutch
hypertension guidelines is a DBP of £90 mmHg (whereas other national and international
guidelines recommend <90 mmHg 1-3). The selected key recommendations included four
recommendations for non-pharmacological measures, one for pharmacological treatment,
and one for follow-up (Box 1).
Box 1. Recommendations from 1991 Dutch national hypertension guidelines for general practice
The following aspects need attention at follow-up visits of hypertensive patients of 18-80 years with a
diastolic blood pressure >90 mmHg despite antihypertensive medication:
Potential causes of an elevated blood pressure
Discuss:
1. compliance with therapy
2. salt consumption
3. alcohol intake
4. body weight
Pharmacological treatment
5. increase the antihypertensive medication (increase the dose or start a drug from a different class)
Follow-up
6. make a follow-up appointment scheduled within six weeks
A self-report form was developed to assess clinical performance of GPs with respect to
the 1991 Dutch hypertension guidelines. This form included items to assess age, sex, and
clinical characteristics of the patient, as well as items to assess whether specific actions
were performed by the GP. The questions on patient characteristics could be answered with
yes (present), no (absent), and with a question mark (unknown); these items concerned
smoking, body mass index of ³30 kg/m2, excessive alcohol intake, and target organ
damage (heart failure, stroke, or impaired renal function). The actions could be scored with
yes (action performed) and no (action not performed). The DBP and the period until the
next follow-up appointment could be filled in as mmHg and weeks, respectively.
Characteristics of the GPs were determined using a questionnaire filled in by one GP per
practice. Data were collected on age, sex and working hours of the GPs, type of practice
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(single-handed versus partnership), and list size. The practice location was classified as
urban if the number of registered addresses in that area exceeded 1500 per square
kilometre.
Procedure
Each GP recorded follow-up visits of hypertensive patients during a period of two months.
Research assistants visited the practices at the start of the recording period to explain the
use of the self-report forms. The GPs were asked to complete the forms immediately after a
follow-up visit. The GPs were not allowed to screen the patient’s record after the visit;
only information that the GP was aware of during the visit was to be recorded on the form.
Another study showed that GPs complete these kinds of self-report forms reliably (average
kappa of 0.76).13
Analysis
Any visits in which the GP decided to consult a specialist or to refer the patient for
treatment of hypertension were excluded, as consulting a specialist may influence the
performance of other actions by a GP. Actions with a missing score (0.2-2.4%) were
considered not performed, whereas missing scores for patient characteristics (0-2.3%) were
excluded from the analyses. The scores for GP characteristics were complete.
The follow-up visit was the unit of analysis to describe clinical performance. DBP was
categorised into five groups, according to the presence of a substantial number of DBP
registrations of 90, 95, 100, and 105 mmHg. For each DBP category, the clinical
performance of the six recommended actions was expressed as the percentage of visits in
which the GPs had performed each recommended action. The performance of one
combination of actions was also studied: prescribing an increase in antihypertensive
medication (increasing the dose or starting a drug from a different class) is considered most
appropriate if combined with follow-up within six weeks.11
Multilevel logistic regression analysis (GLMMIX procedure in SAS) was used to assess
the influence of the independent variables on clinical performance and to calculate
variance parameters. Multilevel analysis takes into account the relatedness of patients
within the practice of one GP. The six actions and the single combination were used as
binary (i.e. either the action had been performed or it had not) dependent variables. The
independent variables in the stepwise procedures were the GP, the DBP, and the patient
and GP characteristics. Only GPs who had recorded nine or more visits were included in
the multilevel analysis to ensure enough within-GP observations. The DBP categories 100-
104 mmHg and ³105 mmHg were combined to ensure enough between-GP observations.
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After controlling for the independent variables, we calculated the intracluster correlation,
which is defined as the variance between GPs divided by the total variance.14 Furthermore,
we calculated the variance explained by the statistically significant variables (P<0.05).15
Furthermore, clinical performance was calculated with the GP as the unit of analysis to
assess the variation in action performance rates. For each action and the single combination
of actions, performance per DBP category was expressed as the 25th percentile, median,
and 75th percentile (owing to the non-normal distribution) of the rate of recommended
actions per individual GP. To enhance reliability, these calculations included only GPs
who had recorded three or more visits within each DBP category; the DBP categories 100-
104 mmHg and ³105 mmHg were combined.
Results
GPs, follow-up visits, and patients
The GPs (Table 1) constituted a representative sample (n=195) of all Dutch GPs with
regard to age, sex, type of practice, and practice location. However, the sample included
fewer GPs who were full-time or who were employed for more than 0.8 full-time
equivalents (65,1% versus 73,9% on a national level, P<0.01, chi-square test).16 National
figures for distribution of list size were not available.
The GPs reported 3704 follow-up visits with treated hypertensive patients aged between
18 and 80 years. A total of 161 forms (4.3%) were excluded because of a positive
statement or missing value about referral to a specialist for hypertension during that
particular visit. A further 17 forms (0.5%) were excluded, because the DBP value was
missing; this left 3526 forms from 3337 patients and 195 GPs for analysis (mean = 18
forms per GP, SD = 8; range = 1-49). Characteristics of the patients in these visits are
presented in Table 1. The mean DBP was 91.0 mmHg (SD = 9.6). The DBP was below 90
mmHg in 36.9% of the follow-up visits, 90 mmHg in 23.2%, and above 90 mmHg in
39.9%.
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Table 1. Characteristics of the participating general practitioners (n = 195) and patients (n = 3526)a
Characteristic Percentage of participants
General practitioners
Aged ³45 years 47.2
Male 77.9
Single-handed practice 42.1
Urban practice locationb 46.7
Employment >0.8 FTEc 65.1
List size (patients) per FTEc general practitioner
<2350
2350 – 2750
>2750
27.7
45.1
27.2
Patients
Diastolic blood pressure (mmHg) <90
90-94
95-99
100-104
 ³105
36.9
26.3
14.0
12.8
10.0
Aged ³60 years 58.3
Male 39.9
Smoking Yes
No
Unknown to general practitioner
14.3
80.0
  5.7
Body mass index ³30 kg/m2 Yes
No
Unknown to general practitioner
21.3
68.2
10.5
Excessive alcohol intake Yes
No
Unknown to general practitioner
  2.5
87.2
10.3
Heart failure, stroke, or impaired renal function
Yes
No
Unknown to general practitioner
  9.3
86.0
  4.7
a For patients with more than one follow-up visit, each visit was counted separately.
b ³1500 addresses per km2 .
c Full-time equivalent.
Clinical performance in relation to DBP
Table 2 shows the clinical performance in relation to the DBP categories. The compliance
of the patient with therapy was regularly discussed (69.6-83.5%), whereas other potential
causes of elevated blood pressure were explored less frequently (below 55% in all
categories). Application of non-pharmacological measures increased gradually with
increasing DBP. Prescribing an increase in antihypertensive medication, making a follow-
up appointment scheduled within six weeks, and a combination of these actions rose
steeply at a DBP of ³100 mmHg to 46.3%, 67.2%, and 39.5%, respectively.
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Table 2. Clinical performance in relation to diastolic blood pressure (DBP, mmHg). Percentage of follow-up
visits in which the general practitioners performed the recommended action
Action
DBP <90
n=1302
(190 GPs)
DBP=90-94
n=927
(184 GPs)
DBP=95-99
n=492
(166 GPs)
DBP=100-104
n=454
(161 GPs)
DBP ³105
n=351
(134 GPs)
DBP ³100
n=805
(176 GPs)
Discussion of compliance with therapy 69.6 74.4 76.4 79.1 83.5 81.0
Discussion of salt consumption 31.7 37.0 40.7 46.3 54.1 49.7
Discussion of alcohol intake 22.3 25.4 29.5 28.9 28.5 28.7
Discussion of body weight 32.3 38.7 40.7 42.1 42.7 42.4
Increase in antihypertensive medication   3.4   6.2 15.0 39.4 55.3 46.3
Follow-up appointment within six weeks 10.5 13.4 29.7 58.6 78.3 67.2
Increase in antihypertensive medication 
combined with a follow-up appointment
within six weeks
  1.8   4.2 10.2 32.4 48.7 39.5
Attributes of clinical performance
Twenty-five GPs (12.8%) had recorded less than nine visits and so their 117 forms (3.3%)
were excluded from the multilevel analysis. These 25 GPs had more often a single-handed
practice, an urban practice location, and were more often employed for 0.8 full-time
equivalents or less, compared with the other 170 GPs (P<0.05, chi-square test).
Attributes (P<0.05) of clinical performance are presented in Table 3. Statistically
significant GP characteristics in the 195 participants and the 25 exclusions did not predict
clinical performance. A DBP of ³100 mmHg proved to be a strong predictor of prescribing
an increase in antihypertensive medication, making a follow-up appointment scheduled
within six weeks, and a combination of these actions (odds ratios = 20.4-36.2). As
expected, excessive alcohol intake and a body mass index of ³30 kg/m2 were strong
predictors of discussions about alcohol intake (odds ratio = 10.2) and body weight (odds
ratio = 11.2), respectively. GPs aged 45 years or more applied non-pharmacological
measures more frequently than younger GPs. Conversely, patients aged 60 years ore more
received non-pharmacological measures less frequently than younger patients. The
intracluster correlation in the final step of the models was higher for non-pharmacological
measures (0.30-0.40) than for pharmacological treatment and follow-up (0.10-0.16).
Conversely, the explained variance for pharmacological treatment and follow-up (31-32%)
was higher than for non-pharmacological measures (4-22%).
We explored whether interaction of DBP level with the number of additional risk factors
(60 years of age or more; male; smoker; body mass index ³30 kg/m2; target organ damage)
predicted performance of prescribing an increase in antihypertensive medication and
making a follow-up appointment scheduled within six weeks, respectively. The number of
additional risk factors was categorised in three classes: no risk factor (n = 471); 1 to 2 risk
factors (n = 2551); three or more risk factors (n = 387). The interaction term was not
statistically significant (P<0.05) associated with the two clinical actions.
Table 3. Odds ratios (95% confidence intervals) for attributes (P<0.05) of clinical performance; variance parameters
Action
Attribute
Discussion of
compliance
with therapy
Discussion of
salt
consumption
Discussion of
alcohol intake
Discussion of
body weight
Increase in
medication
Follow-up
appointment
£ 6 weeks
Increase in medication
combined with a
follow-up appointment
£ 6 weeks
General practitioners (n=195)
Age ³45 years 1.89 (1.16-3.13) 1.92 (1.18-3.13) 1.82 (1.23-2.70)
Urban practice locationa 0.50 (0.33-0.74)
Patients (n=3526b)
Diastolic blood pressure (mmHg)
<90
90-94
95-99
³100
1.00
1.18 (0.95-1.47)
1.62 (1.23-2.13)
2.58 (2.01-3.31)
1.00
1.33 (1.08-1.63)
1.72 (1.33-2.22)
2.78 (2.23-3.48)
1.00
1.17 (0.92-1.47)
1.50 (1.13-1.99)
1.53 (1.20-1.96)
1.00
1.22 (0.98-1.52)
1.51 (1.16-1.97)
1.42 (1.13-1.79)
1.00
1.82 (1.24-2.69)
4.98 (3.40-7.28)
26.7 (19.3-37.0)
1.00
1.36 (1.04-1.77)
3.89 (2.96-5.12)
20.4 (16.0-26.1)
1.00
2.32 (1.39-3.87)
5.86 (3.56-9.65)
36.2 (23.6-55.6)
Age ³60 years 0.76 (0.63-0.91) 0.72 (0.60-0.88) 0.71 (0.60-0.85)
Male 1.43 (1.18-1.72)
Smoking
Yes
No
Unknown to GP
1.38 (1.06-1.80)
1.00
0.67 (0.46-0.96)
1.59 (1.26-2.00)
1.00
0.68 (0.46-1.00)
1.97 (1.54-2.53)
1.00
0.25 (0.13-0.47)
1.08 (0.85-1.38)
1.00
0.61 (0.40-0.91)
1.27 (0.95-1.69)
1.00
1.64 (1.05-2.57)
1.28 (0.99-1.64)
1.00
1.67 (1.15-2.41)
Body mass index ³30 kg/m2
Yes
No
Unknown to GP
1.41 (1.15-1.72)
1.00
1.02 (0.75-1.38)
11.2 (8.94-14.0)
1.00
1.49 (1.09-2.04)
Excessive alcohol intake
Yes
No
Unknown to GP
10.2 (5.58-18.6)
1.00
0.24 (0.15-0.39)
1.64 (0.95-2.83)
1.00
0.69 (0.50-0.95)
Heart failure, stroke, or impaired
renal function
Yes
No
Unknown to GP
1.31 (0.96-1.78)
1.00
1.73 (1.15-2.61)
Variance parameter (proportion)
Intracluster correlation (in final step) 0.40 0.38 0.40 0.30 0.13 0.16 0.10
Explained variance 0.04 0.04 0.04 0.22 0.31 0.31 0.32
a Urban practice location: ³1500 addresses per km2.
b For patients with more than one follow-up visit, each visit was counted separately.
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Variation in action performance rates
The variation in action performance rates of the GPs was considerable. There was
widespread variation (interquartile range between 33% and 67%) in the individual
application of non-pharmacological measures in all four DBP categories. The interquartile
range for prescribing an increase in antihypertensive medication rose with increasing DBP
from 0% to 42%, whereas the interquartile range for follow-up varied from 17% to 50%.
Table 4 shows the variation at a DBP of ³100 mmHg.
Table 4. Action performance rates (%) of general practitionersa (n=127) in follow-up visits (n=733) with a
diastolic blood pressure ³100 mmHg
Action Q1
b Median Q3
c
Discussion of compliance with therapy 67 100 100
Discussion of salt consumption 22   50   80
Discussion of alcohol intake   0   22   40
Discussion of body weight 25   40   67
Increase in antihypertensive medication 25   44   67
Follow-up appointment within six weeks 50   71   88
Increase in antihypertensive medication combined with a follow-up
appointment within six weeks
20   38   58
a GPs who registered ³3 follow-up visits with a DBP of ³100 mmHg.
b 25th percentile.
c 75th percentile.
Discussion
This study addressed the clinical performance of GPs in blood pressure control in treated
hypertensive patients. The median performance rates of the GPs were less than 51% for
most of the recommended actions, even at a DBP of ³100 mmHg. GPs' attention to
potential causes of elevated blood pressure increased gradually with increasing DBP; GPs
seemed not to expect any substantial effect from non-pharmacological treatment on DBP.
GPs started to increase the antihypertensive medication and to make a follow-up
appointment scheduled within six weeks substantially more often at a DBP of ³100
mmHg. There seemed to be a threshold at a DBP of 100 mmHg; this threshold contrasts
with the target level of <90 mmHg recommended in national and international guidelines.
In general, and apart from the DBP level, the patient and GP characteristics in this study
had little effect on clinical performance. Furthermore, there was marked variation in the
action performance rates of the individual GPs, even at a DBP of ³100 mmHg. After
controlling for the DBP and other independent variables, we found that 30-40% of the
variation for non-pharmacological measures and 10-16% of the variation for
pharmacological treatment and for follow-up occurred at the GP level. This means that
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GPs had little influence on the variation in pharmacological treatment and follow-up,
whereas patient determinants were more relevant.
Do these results indicate shortcomings in care? First, the GPs seemed to target their
actions at a DBP of <100 mmHg. This might be one of the reasons why 63% of the
patients in this study had a DBP of ³90 mmHg. Accepting a DBP of between 90 and 100
mmHg does not allow the patient to receive the optimal benefit from the drug treatment.6
Secondly, median performance rates of key actions were below 51%. We must, however,
be careful when speaking in terms of shortcomings, because we did not enquire about GPs’
motivations for seemingly ignoring the recommendations.
The results of this study differ from those reported by Dickerson et al.17 Two-thirds of
125 British GPs answered that they applied a DBP of £90 mmHg as target level for most
patients; 31% applied 91-95 mmHg and 5% applied 96-100 mmHg. British GPs chose their
target level more in line with the guidelines than our Dutch GPs. However, achieved blood
pressure is unrelated to stated target levels.18 Self-reporting of consultations is thought to
be a more appropriate method for assessing actual clinical performance than a
questionnaire.19
The GPs in the study seemed to control blood pressure with reference to the blood
pressure reading alone. The presence or absence of the other risk factors in our study
seemed not to influence the DBP target level. Stratification of patients in terms of their
total cardiovascular risk has been advocated for setting the blood pressure targets that
should be achieved and the intensity with which these targets should be pursued.1 Recent
guidelines provide specific (lower) blood pressure targets for diabetic patients.1,2,3
Former studies have shown marked between-practice variation in the percentage of
treated hypertensive patients with uncontrolled blood pressure.9,20,21 Although guidelines
on hypertension are inconsistent in their recommendations,22 it appears that practices are
either more conservative or more progressive in their management of hypertension,
irrespective of which guideline is applied.21 This suggests that there are other factors that
determine between-practice variation. We found that variation in prescribing an increase in
antihypertensive medication and making a follow-up appointment scheduled within six
weeks occurred predominantly at the patient level. Berlowitz et al. identified several
predictors of an increase in antihypertensive medication: increased levels of both systolic
and diastolic blood pressure at the visit, a change in therapy at the preceding visit, and a
scheduled visit. Blood pressure recorded during previous visits and cardiovascular risk
factors other than hypertension are not associated with an increase in antihypertensive
medication.23 Further research is needed to assess the influence of patient (for example,
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compliance with therapy) and GP determinants on clinical performance and more
specifically on targets set by GPs.
Several factors may have biased our results. The GPs were included after they had
agreed to take part in an intervention project to optimise prevention and management of
cardiovascular disease. They may therefore have had special interest and hence may have
performed more favourably. It is also possible that the GPs selectively recorded visits in
which they had adhered to the guidelines. Self-reporting may positively influence clinical
performance, especially if repeated recording guides the doctor in the required direction. In
all these cases, the observed clinical performance will overestimate actual performance.
In many visits, the GPs in this study accepted DBP levels that were above the
recommended target level of 90 mmHg. The GPs seemed to target their actions at a DBP of
below 100 mmHg. More aggressive therapy by GPs may improve blood pressure control23
and reduce cardiovascular morbidity and mortality.
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Abstract
Background. Adequate care for patients with cardiovascular risks requires an adequate
practice organisation. Educational outreach visits are a promising approach to modify
professional behaviour. We aimed to assess whether the quality of cardiovascular
preventive care in general practice can be improved through a comprehensive intervention
implemented by an educational outreach visitor.
Methods. After baseline measurements general practices (n=124) in the southern half of
the Netherlands were randomly allocated to either intervention or control group. The
intervention, based on the educational outreach model, comprised of 15 practice visits over
a period of 21 months and addressed a large number of issues around task delegation,
availability of instruments and patient leaflets, record keeping and follow-up routines.
Twenty-one months after the start of the intervention, post-intervention measurements
were performed. The difference between ideal and actual practice in each aspect of
organising preventive care was defined as a deficiency score. Primary outcome measure
was the difference in deficiency scores before and after the intervention.
Results. All practices completed both baseline and post-intervention measurements. The
difference in change between intervention and control group adjusted for baseline, was
statistically significant (p<0.001) for each aspect of organising preventive care. The largest
absolute improvement was found for the number of preventive tasks performed by the
practice assistant.
Conclusions. This study showed that a comprehensive intervention implemented by
outreach visitors was effective in improving organisation of cardiovascular preventive care
in general practice.
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Introduction
Cardiovascular diseases are among the most prevalent health problems in general practice;
a major part of all chronic problems are of cardiovascular origin.1 Priority should be given
to implementing preventive measures in patients with established coronary heart disease.2
It is generally accepted that the general practitioner (GP) plays a pivotal role in prevention,
early detection, treatment and surveillance of patients with (a high-risk of) cardiovascular
problems; however general practice is not yet performing these tasks satisfactorily.3-5 A
substantial proportion of high-risk patients remain unrecognised and those being treated
receive sub-optimal care.6 High quality of care for patients with cardiovascular risks or
problems requires an adequate practice organisation7-9 and practice support mechanisms
may produce sustained improvements in physician behaviour.10-12
Well-planned strategies, composed of a variety of interventions and methods, have been
effective in achieving lasting improvements in medical practice.
13-16 Educational outreach
visits (providing individual instruction at the physician’s surgery) are a promising approach
to modify professional behaviour
17
 and to improve professional practices. Outreach visits
are effective in improving record keeping and cardiovascular preventive activities,
18,19
optimising the organisation of services,
20
 prescribing behaviour 
21,22 and in cancer early
detection and preventive services.
23 None of these latter studies, however, included
simultaneous interventions targeting different aspects of organising preventive care.
The present study investigated an educational outreach strategy designed to improve
major aspects of organising prevention of cardiovascular disease in general practice. The
strategy was based on a theoretical model of change distinguishing the subsequent steps of
orientation, insight, acceptance and change.13 We believe there may be an important role
for outreach visitors (facilitators) in implementing such a comprehensive package of
disease management for high-risk cardiovascular patients,24 but the effectiveness of such
an intervention has not yet been evaluated in a randomised controlled trial. We aimed to
assess to what extent improvement of the quality of organising preventive care for patients
with cardiovascular risks or problems in general practice can be achieved through a
comprehensive intervention by trained outreach visitors. In addition, we aimed to identify
practice characteristics related to a successful intervention.
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Methods
General practice in the Netherlands has many similarities to the United Kingdom.
Important difference are that the number of GPs per practice is much lower than in the UK,
with many practices run by a single GP, and the size of ancillary staff is much smaller (on
average less than one full time ancillary staff member per full time GP). This staff, called
practice assistants, usually combines the tasks of a receptionist with some tasks of the
British practice nurse. Most Dutch practice assistants do not have a nursing background.
Design and practices
A randomised controlled trial was performed in the southern half of the Netherlands.
Practices were invited by letter and via regional GP bulletins to participate in the study.
Inclusion criteria were: presence of a computer system (considered necessary for adequate
record keeping and follow-up), ancillary staff present and no major changes planned during
the course of the project. After baseline measurements 124 general practices were
randomly allocated to either intervention group or control group. The study was powered
to detect a difference of 5% between baseline and post-intervention measurements in the
experimental practices as well as a difference of 5% between experimental and control
practices (alpha = 0.05, beta = 0.10). Practices were numbered and the person responsible
for the randomisation process was blinded for the practices’ identity, to ensure allocation
concealment. We stratified (block size: four) with regard to practice type (single-handed
versus partnership). After 21 months of intervention, post-intervention measurements were
performed. Data were collected from November 1996 until February 1999.
Intervention
Box 1 provides a general description of the entire intervention, which comprised both
organisation of prevention and clinical decision-making. The latter is subject of a separate
paper; here we focus on aspects of practice organisation. We considered six aspects
relevant for the organisation of preventive care in general practice. Some of these can be
seen as conditions needed to perform adequate disease management: availability of
instruments and materials, involvement of the practice assistant in preventive tasks,
11,18
presence of separate preventive clinics and teamwork within the practice.8,25,26 Two other
groups of items can be seen as process indicators of actual preventive care, addressing
record keeping and follow-up routines.
From the total 15 visits, the first eight visits of the intervention were dedicated to the
organisation of preventive care. Although the emphasis changed towards clinical decision
making from the ninth visit onward, aspects of organisation of preventive care were
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evaluated until the end of the intervention. For each aspect the outreach visitors followed
the subsequent steps of a theoretical model of change (orientation, insight, acceptance and
change).
13
 The intervention design allowed practice members to draw up and prioritise
their own list of gaps and planned changes, as recommended for continuous quality
improvement. This list was used as guidance throughout the intervention period.
Box 1 General description of the intervention
Aim
The project (CARPE: CArdiovascular Risk reduction in Primary carE) aimed to implement a
comprehensive programme on cardiovascular and diabetes care in general practice. The programme content
was based on national guidelines (Dutch College of General Practitioners) and consensus procedures,13 it
comprised a detailed description of practice organisation and clinical decision-making in an ‘ideal’ practice.
The ‘ideal’ practice is well equipped with optimal computer facilities, materials and leaflets. Risk
profiling of high-risk patients and separate preventive clinics for patients with diabetes or hypertension are
all well organised. There is a system for monitoring follow-up. Staff is intensively involved in preventive
tasks and quality is insured by means of protocols and regular staff meetings. Clinical decision-making is
according to latest evidence-based guidelines. The GPs have the knowledge and skills for appropriate
performance of all stages and aspects of consultations with high-risk patients: diagnosis, assessment and
evaluation of additional risk factors, counselling and education, pharmacological treatment, follow-up, and
referral. Ancillary staff members are well trained to perform their part of patient care.
Implementation strategy
Outreach visitors supported GPs and their staff to implement a comprehensive programme on
cardiovascular and diabetes care in a schedule of 15 outreach visits per practice in a period of 21 months.
Most visitors were former practice assistants and experienced in performing outreach visits. For this study,
they were specially trained in national guidelines on cardiovascular and diabetes care for general practice,
the concept of the ‘ideal’ practice, and the methods and materials of the intervention. The visitors facilitated
implementation of the programme; they were not involved in patient care.
The protocol of the visits was highly structured to limit variation. In the first eight visits the intervention
focused on practice organisation and the last seven visits on clinical decision-making. Subsequent steps in a
theoretical model of change were used to achieve improvement. These steps are: orientation, insight,
acceptance and change.
Individualised feedback reports, including the key recommendations of the national guidelines and the
consensus procedures, were produced to provide orientation and insight. The feedback, based on baseline
data, informed the GPs and their staff about their actual practice organisation and daily clinical decision-
making in relation to the key recommendations. The feedback report was also intended to create awareness
of (gaps in) actual performance in comparison to the ‘ideal’ practice. Acceptance was aimed at by
supporting the practice members to draw up and prioritise a list with gaps and planned changes targeted to
their personal circumstances. Throughout the visits the outreach visitors provided guidance, advice, training
and educational materials for each gap to reach the goals and achieve changes. Progress was evaluated
regularly. During the intervention all gaps in both practice organisation and clinical decision-making were
intended to be discussed.
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Measurements and variables
Data ware collected by questionnaire and through study observers, at baseline and after 21
months. Information on practice characteristics was collected by questionnaire at baseline.
One GP and one practice assistant per practice completed these questionnaires. Answers to
questions about the availability of instruments and materials were checked in the practice
by a study observer. The control practices received baseline and post-intervention
measurements simultaneously with the intervention group, but did not receive any stimuli
between randomisation and post-intervention measurements.
Analysis
The unit of analysis was the practice. In organising prevention of cardiovascular disease,
the proportion of practices that adhered to each aspect was assessed. Data on outcomes
were dichotomised. For each item a score indicating non-adherence (0) or adherence (1)
was given and changes from baseline were tested with Mann-Whitney U tests, because
percentage data are usually not distributed normally. Sumscores were made, composed of
the scores of all individual items for each of the six aspects of preventive care, both at
baseline and after the intervention. These changes were tested using T-tests. In order to
satisfy the assumptions of the linear model, and because practices with high baseline
values have less room for improvement, we computed for each of the six aspects of
preventive care a ‘deficiency score’, i.e. logarithm of the difference between the maximum
possible score minus the actual score, both at baseline and after the intervention period.
The main outcome measure was the difference between the deficiency scores in each
aspect of organising preventive care before and after the intervention, this enabled us also
to consider the ratio of baseline score and post-intervention score.
Comparisons between intervention and control practices were made on an intention-to-
treat basis. In order to compare the intervention and control group for the main outcome
measures, regression analyses with adjustment for baseline deficiency score were
performed. To assess the influence of practice characteristics, multiple linear regression
analyses were performed with each main outcome measure (four practice management
elements and two preventive activities) as dependent variable. Practice characteristics with
p<0.25 in univariate analyses and interactions with the intervention, together with baseline
deficiency scores, entered the model.
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Results
Trial profile
Invitations were sent to 715 practices together with a reply form. We received 414 replies
(response rate: 65%) and all practices in which at least one GP replied positively were
visited (Figure 1). Of these, 130 practices met our inclusion criteria. Six practices withdrew
during baseline measurements, hence were not randomised. All 124 randomised practices
completed both baseline and post-intervention measurement questionnaires and were
included in the analysis.
Figure 1. Trial profile
157 practices visited
130 practices entered baseline measurements
62 assigned intervention 62 assigned control
124 practices randomised
4 withdrawn
during intervention:
- 1 illness GP
- 1 too burdensome
- 2 personnel changes
no withdrawals
62 completed post-intervention
measurements
- 3 did not meet eligibility criteria
- 7 used as pilot practices
- 17 withdrawals
6 withdrawn
62 completed post-intervention
measurements
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Characteristics of study groups
The characteristics of the practices are presented in Table 1. There were only small
differences in baseline characteristics between intervention and control practices.
Table 1. Practice characteristics
Practice characteristic
%
Intervention
practices
(n=62)
%
Control
practices
(n=62)
Setting Single-handed 61 61
List size: number of patients per full-time GP < 2500 35 31
Location of the practice: addresses per km2 Urban = ³ 1000 66 63
Number of GPs    1
   2
³ 3
57
29
14
55
37
  8
Number of practice assistants    1
³ 2
27
73
32
68
Mean age of the GPs (years) £ 45 58 61
Mean age of the practice assistants (years) £ 35 57 66
Mean working experience of the GPs (years) £ 15 57 54
Mean working experience of the practice assistants (years) £ 10 58 55
Employment of all GPs in the practice Part-time 47 52
Employment of all practice assistants in the practice Part-time 82 84
Gender of the GPs Male only
Male and female
Female only
63
29
  8
68
27
  5
Pharmacy attached to the practice   3   3
Involved in vocational training 29 27
Certified practice assistants 82 87
Member of the Dutch College of General Practitioners 84 89
NHS patients £ 60 % 39 42
Adherence to the practice management elements and preventive activities
Final data on adherence to the practice management elements and preventive activities
were gathered 21 months after randomisation. Table 2 shows that there was much variation
in changes in adherence for all items. Most items necessary for the care of patients with
established cardiovascular disease showed improvement. For record keeping, risk factors
(hypertension, smoking and individual cardiovascular history) were recorded more
adequately and there was a significant increase in the proportion of practices making risk
profiles. For follow-up, more practices made appointments immediately after the visit and
the reason for encounter was better identified. Not all cardiovascular patients received
appointment cards. Combining all 58 items of organisation of preventive care, we found
that 50% of the intervention practices adhered to at least 40 of the items after the
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intervention. No single practice adhered to all items; 8% adhered to less than half of the
items.
Table 2. Percentage of practices adhering to separate issues of preventive care
Intervention
(n=62)
Control
(n=62)
Before After Before After
Change
Interv.
Change
Control P value
A. Availability of instruments and materials
1. Instruments Blood pressure meter 100 100   98 100   0   2
Doppler device  44  44   31   34   0   3
Weighing scale 100 100 100 100   0   0
Measuring staff   97 100   97 100   3   3
Glucose meter   98   98 100   98   0  -2
Cholesterol meter   39   42  44   47   3   3
Body mass index table   71   95   76   86 24 10
Nomogram   23   55   28   21 32   7 *
Urine sticks 100 100 100 100   0   0
2. Leaflets Hypertension   82   98   95   92 16  -3 *
Cholesterol   89   98   86   98   9 12
Angina pectoris   36   82   37   47 46 10 *
Peripheral arterial disease   19   76  18   27 57   9 *
Trans. ischaemic attack   15   74  13   32 59 19 *
Diabetes mellitus   82   98  82  94 16 12
Heart failure   36   81  30   41 45 11 *
Smoking   79 100  90   95 21   5    **
Diet   84   97  87   95 13   8
Exercise  44   84  31   42 40 11 *
3. Adequate ancillary staff presentb   55   68  70   68 13  -2 *
4. Separate room for the practice assistantc   95 100  95   92   5  -3
B. Presence of separate preventive clinics
1. Separate clinics for Hypertensive patients   15   55   13   29 40 16 *
Diabetic patients   19   53   26   45 34 19
2. Use of smoking cessation package (MIS)a   16   53   24   16 37  -8 *
C. Preventive tasks performed by the practice assistant
1. Measurements taken:
Blood pressure  77  94  89  87 17  -2 *
Glucose  87  95  95  92   8  -3    **
Cholesterol  34  42  42  45   8   3
Height  15  60  26  27 45   1 *
Weight  40  77  57  63 37   6 *
Body mass index    7  69  19  23 62   4 *
2. History questions asked:
 Cardiovascular history  16  61  31  24 45  -7 *
Cardiovascular family history  15  61  27  24 46  -3 *
Smoking habits  27  77  32  39 50   7 *
Alcohol intake  15  65 8  24 50 16 *
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Intervention
(n=62)
Control
(n=62)
Before After Before After
Change
Interv.
Change
Control P value
3. Advice given on: Diet   52   76   63   66 24   3   **
Smoking   29   60   29   39 31 10   **
Losing weight   32   61   40   45 29   5   **
Exercise   24   58   27   37 34 10   **
Alcohol   11   37   11   16 26   5   **
D. Teamwork in the practice
1. Written protocolsd Diabetes mellitus   27   71   27   39 44 12 *
Hypertension   16   68   26   34 52   8 *
Detecting patients at risk    3   31    5   18 28 13
2. Hold regular, scheduled meetingse   42   66   52   61 23   9
E. Record keeping
1. Computerised patient recordsf  84   94   79   81 10   2
2. Systematic entries concerning four risk factorsg    8   27    3    7 19   4   **
3. Record risk factors separate from the consultation 
notesh
  10   57   10   13 47   3 *
4. Record diagnoses separate from the consultation 
notesi
  50   73   68   77 23   9
5. Risk profile for cardiovascular patientsj    3  40  10    8  37  -2 *
6. Register preventive activities separately  35  53  39  34  18  -5
F. Follow-up
1. Make an appointment immediately after the visit  82  95  87  81  13  -6   **
2. Make an identifiable note  20  68  28  31  48   3 *
3. Provide an appointment card for patients with
Diabetes mellitus  39  75  33  49  36 16 *
Hypertension  37  80  28  44  43 16 *
Cholesterol  22  42  11  24  20 13
Angina pectoris  22  37  17  18  15   1   **
Peripheral arterial disease  22  37  17  16  15  -1 *
Heart failure  22  34  17  18  12   1
4. Contact patients who fail to attend an appointment  65  75  63  68  10   5
* Significant difference between change intervention and control group p<0.01.
** Significant difference between change intervention and control group p<0.05.
a The Minimal Intervention Strategy is a smoking cessation package shown to be feasible and effective.
b Adequate ancillary staff present =  0.8 fte practice assistance per 2500 patients (norm).
c A place to work for the practice assistant = a well equipped consultation room for consulting patients without
being disturbed.
d Written protocols are a support for the practice assistant with her tasks and enables the GP to survey the activities
done by the practice assistant.
e Scheduled meetings are those scheduled in advance and in which the tasks performed by the practice assistant are
evaluated.
f 100% computerised = practices do not use any written medical records: all patient data were entered into the
computer.
g Systematic entries were considered necessary for hypertension, diabetes mellitus, individual and family cardiovascular
history.
h Risk factors that had to be recorded in a recommended location were hypertension, smoking and individual
cardiovascular history.
i The diagnoses concerned are hypertension, cholesterol and diabetes mellitus.
j Risk factors at least present in a risk profile for cardiovascular patients: blood pressure, smoking, individual
history.
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The means of the sumscores for each group of items are presented in Table 3, which
shows that there was much room for improvement on every aspect of organisation of
preventive care at baseline. All aspects improved after intervention. In the intervention
practices, the largest absolute improvement was found for the number of preventive tasks
performed by the practice assistant. The control practices improved on some items, but far
less than the intervention practices. The difference between intervention and control group
as to deficiency score after intervention, adjusted for baseline, was significant (p<0.001)
for all aspects of organising preventive care. The table shows there is still room for
improvement after the intervention period on every aspect. We repeated the analyses
without adjustment for the intervention to gain insight in the contribution the intervention
made to the variation of our outcome measures. For all items, addition of the intervention
doubled the percentage of variance explained.
Multiple linear regression analyses showed that practices with fewer GPs and smaller
list size improved most on record keeping. The percentage explained variance for change
in record keeping activities was 37%. No relation was found between the practice
characteristics and other aspects of organising prevention.
Table 3. Adherence to aspects of practice organisation: number of items adhered to, crude change between baseline and post-intervention and change in 
deficiency score
Intervention practices (n=62) Control practices (n=62)
Number of items Deficiency score Number of items Deficiency score
Aspect of practice organisation
Total
number
of items Before After Change Before After Change Before After Change Before After Change P value
a
Availability of instruments and materials 21 13.9 17.9 4.0 1.9 0.9 -1.0 14.2 15.1 1.0 1.8 1.7 -0.2 <0.001
Presence of separate clinics  3  0.5  1.6 1.1 0.9 0.3 -0.6  0.7  0.9 0.2 0.8 0.6 -0.2 <0.001
Preventive tasks by the practice assistant 15  4.8  9.9 5.1 2.2 1.2 -1.0  6.0  6.5 0.5 2.1 1.9 -0.2 <0.001
Teamwork in the practice  4  0.9  2.3 1.4 1.1 0.6 -0.4  1.1  1.4 0.3 1.0 0.9 -0.1 <0.001
Record keeping  6  1.9  3.4 1.5 1.4 0.8 -0.6  2.1  2.2 0.1 1.3 1.3 -0.0 <0.001
Follow-up  9  2.8  5.2 2.4 1.7 1.2 -0.5  2.7  3.0 0.3 1.7 1.7 -0.0 <0.001
a Significance of the difference in change in deficiency score from baseline between intervention and control practices.
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Discussion
The comprehensive intervention programme using outreach visits was carried out
successfully and proved to be effective in improving organisation of preventive care. We
performed both baseline and post-intervention measurements in all participating practices
and the intervention programme could be implemented completely in almost all
intervention practices. The intervention proved to be effective on all aspects of the
organisation of preventive care, which supports the validity of the theoretical model.
A number of limitations should be mentioned. Inviting practices to participate in a study
may introduce selection bias: motivated practices may be more successful and
implementing changes in less motivated practices may be more difficult. This is inevitable
in studies addressing change in professional behaviour, as willingness to change is a
prerequisite to participate. The assessment of adherence to separate elements of preventive
care was carried out by means of questionnaires. Not all items could be verified by the
observers visiting the practices, hence leaving some room for social desirability bias. As
this would affect practices in the intervention group as well as the control group, we do not
believe this to be a major obstacle in interpreting our findings.
It is unclear which specific parts of the intervention contributed most to the final effects.
We assume that it is the combination of elements of the intervention that is crucial (i.e.
offering practice-tailored support, repeating messages during subsequent visits, involving
the practice team and feeding-back behaviour), since different factors determining actual
preventive care are addressed.
27
In the intervention group each aspect of organising preventive care was successfully
implemented. Concentrating care on high-risk patient groups can influence patient outcome
measures.
28 We found that the proportion of practices that offered separate preventive
clinics for hypertensive patients almost quadrupled in the intervention group. Stop smoking
packages, known to be difficult to implement,
29
 were also used by more practices. Many of
the instruments were already present before the intervention and therefore showed no
change. Record keeping, a very important element in preventive practice organisation,
showed a large increase. As found in other studies,
19,30
 the item of record keeping that
showed the largest change was the recording of cardiovascular risk factors (hypertension,
smoking and individual cardiovascular history) in a recommended location of the file.
Probably more importantly, the proportion of practices making risk profiles (including at
least blood pressure, smoking and individual cardiovascular history) improved from 3 to
40%. Completion of risk profiles is a prerequisite for adequate care, as it allows
comprehensive management of cardiovascular patients. Furthermore, the availability of a
risk profile avoids unnecessary actions and questions at future consultations.
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The intervention practices showed significantly more improvement in adherence to
organisation of preventive care. Control practices also improved, but this change was not
significant. The change in the control practices could be the result of a Hawthorne effect 
31
or due to societal changes. During the study period there was much attention nation-wide
for prevention and cardiovascular risks and diseases; however, the marginal change in the
control practices illustrates that media attention is not sufficient to change behaviour.
32
Even after 21 months of intervention there is still room for improvement. Low
adherence at baseline did not necessarily imply large changes (e.g. Doppler device and
cholesterol meter). Availability of instruments and materials showed relatively little
improvement, but most practices were already well equipped. Most practices did not have
separate preventive clinics before the intervention, afterwards there was still much room
for improvement. This element requires trained personnel and organization skills, which
are capacities that may evolve in time.
A longer intervention period may produce further improvement, although most aspects
of organisation of preventive care were implemented in the first nine months of the
intervention and evaluated during the period thereafter. The costs of the intervention
programme were estimated to be about 4500 euro per practice. This study showed that
implementing a comprehensive intervention by outreach visitors was effective in
optimising cardiovascular preventive care. To assess continuation of effects and cost-
effectiveness a long-term evaluation is needed, which should include patient outcomes.
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Abstract
Problem. The management of patients at high cardiovascular risk in general practice is not
optimal. It remains unclear whether intensive support improves the clinical decision
making of general practitioners (GPs) in cardiovascular care and which practices benefit
most.
Design. Cluster randomised controlled trial with two arms: intensive support versus no
special attention.
Background and setting. 124 practices with a total of 185 GPs in The Netherlands.
Key measures for improvement. Compliance rates for twelve evidence-based indicators for
the actual management of patients with hypertension, hypercholesterolaemia, angina
pectoris, or heart failure. Compliance was assessed via the prospective recording of patient
encounters at the start and end of the study.
Strategies for change. Feedback reports and support from trained non-physicians during
four outreach visits.
Results. The GPs reported 30 101 clinical decisions at baseline and 22 454 decisions at
post-intervention. The intervention resulted in statistically significant improvement for five
of the twelve indicators: assessment of risk factors in patients with hypercholesterolaemia
(odds ratio 2.04; 95% confidence interval 1.44 to 2.88) or angina pectoris (3.07; 1.08 to
8.79), provision of information and advice to patients with hypercholesterolaemia (1.58,
1.17 to 2.13) or hypertension (1.55, 1.35 to 1.77), and checking for clinical signs of
deterioration in patients with heart failure (4.11, 2.17 to 7.77). In particular, single-handed
practices, non-training practices, and practices with older GPs gained benefits from
intervention.
Lessons learnt. Intensive support from facilitators is an effective strategy to alter certain
aspects of the clinical decision making of GPs in cardiovascular care. The strategy
deserves further development and wider application.
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Introduction
This report contributes to the development of effective interventions to improve the clinical
decision making of physicians. Previous studies have shown successful strategies to
improve prescribing and diagnostic test ordering.1,2 The present trial evaluates the
effectiveness of a multifaceted intervention targeted at various aspects of the clinical
management of patients at high cardiovascular risk in general practice. The evaluation
relied on the prospective recording of patient encounters by the participating practitioners.
The trial also therefore provided practical experience with applying such a measurement
tool.
Outline of problem
General practitioners (GPs) are challenged to improve their clinical decision making for
patients at high cardiovascular risk. High-risk patients, such as patients with hypertension
or cardiovascular disease, should be given highest priority in preventive cardiology as they
stand to gain the greatest benefits from medical treatment.3 The management of these
patients in general practice is, however, not optimal.4-6 The clinical decision making of
GPs may be optimised by implementing evidence-based guidelines.
Specific strategies are needed to enhance implementation of clinical guidelines.7
Multifaceted interventions targeting different barriers to change tend to be more effective
than single interventions.8 Educational outreach visits combined with social marketing
appear to be a particularly promising approach to modify health professional behaviour.1 In
primary and secondary prevention of cardiovascular disease, multifaceted interventions
delivered in outreach visits have been found to optimise practice organisation and the
recording of risk factors.9-11 It remains, however, unclear whether intensive and
multifaceted support is effective when targeted at GPs’ decision making in daily
cardiovascular care. It is possible that the complexity and multiplicity of clinical decision
making provide barriers to successful implementation. Furthermore, there is little insight
into which practice characteristics are related to successful implementation. Such insight
can help tailor future interventions.
Study design
We conducted a cluster randomised controlled trial in general practice from 1996 to 1999.
Practices in the southern part of The Netherlands were recruited via bulletins and by letter
until a total of 124 practices were randomised. Inclusion criteria were the presence of a
clinical computer system, employment of practice assistant(s) and no major changes in
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personnel or premises planned during the course of the trial. We considered these criteria
crucial for the conduct of the improvement project.
After baseline measurement, the practices were randomly allocated to receive intensive
support (intervention group) or no special attention (control group). The practices were
numbered and the person responsible for the randomisation process was blind to the
practice identities. A random-number generator was used to select permuted blocks with a
block size of four. We stratified with regard to practice type (single-handed versus
partnership) as this characteristic has been found to predict change in practice
organisation.9
Key measures for improvement
The key measures were the compliance rates for evidence-based indicators for the actual
management of patients with hypertension, hypercholesterolaemia, angina pectoris, or
heart failure. We used the national guidelines issued by the Dutch College of General
Practitioners (DCGP) to identify the indicators.12-15 These guidelines are based on scientific
evidence, broad consensus, and clinical experience.16 We asked a group of five GPs
involved in research and guideline development but not participating in the trial to select
the key recommendations from the national guidelines. The recommendations are detailed
descriptions of specific clinical actions along with the clinical situations calling for those
actions. The selected key recommendations coincide with the recommendations from
international guidelines.3, 17-19 We categorised the key recommendations into performance
indicators. After the trial, we selected all of the indicators which allowed detection of an
absolute difference of 15% in the compliance rates between intervention and control
groups with more than 90% power at a 5% significance level. Changes in care provision
are usually no more than 10%.20 The twelve selected indicators are presented in Table 2.
The smallest difference we would have been able to detect across the indicators was 7% (a
= 0.05, b = 0.10). The post-hoc power estimations take into account the design effect of
cluster randomisation.21
Process of gathering information
Using the key recommendations, we developed forms for the prospective recording of
patient encounters for each of the medical conditions considered in this study. Due to the
high incidence of hypertension, separate forms were created for newly diagnosed versus
already treated (with or without medication) hypertension. The encounter forms included
items pertaining to the age, sex, and clinical characteristics of the patient and also the
decisions regarding the performance (yes/no) of specific clinical actions. While the forms
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were based on the key recommendations, they did not contain any clues to the
recommendations. GPs have been shown to complete similar forms reliably (kappa of 0.79;
Spies TH, personal communication).
Immediately prior to and upon completion of the 21-month implementation period, the
GPs completed encounter forms during routine consultation hours for a period of two
months. The GPs were asked to complete the forms immediately after eligible encounters.
The data from the encounter forms were then entered into a computer by personnel blind to
group allocation.
The characteristics of the participating practices were derived from a questionnaire
completed by one GP per practice at baseline. Data were collected on type of practice
(single-handed versus partnership), practice location, number of GPs and practice
assistants, working hours of each professional, age of GPs, patient list size, and
involvement in GP vocational training,
Analysis
We used the data from the encounter forms to assess the clinical decision making. The
assessment pertained mainly to clinical actions performed during the present patient
encounter. Particular actions were however also taken to be performed, when the GP
reported performance in a previous contact (such as advice on smoking cessation) or within
the recommended period (such as blood pressure measurement within the last 12 months).
Actions with missing data were considered not performed.
The practice was the unit of analysis to describe changes in clinical decision making.
We calculated the mean compliance rate for each performance indicator at baseline and the
mean change from baseline. The compliance rate for an indicator was the number of
decisions in accordance with the recommendations divided by the total number of
decisions made with respect to that indicator.
Multilevel logistic regression analysis (GLMMIX procedure in SAS) was used to assess
the influence of the intervention on clinical decision making and to identify practice
characteristics which were related to success of the intervention.21 Multilevel analysis takes
into account the relatedness of the clinical decisions made within a particular practice. P-
values less than 0.05 were considered statistically significant.
Strategy for change
The GPs in the intervention practices received feedback reports and support from
facilitators to improve clinical decision making for hypertension, hypercholesterolaemia,
angina pectoris, and heart failure. The intervention comprised four outreach visits per
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practice. Each practice received support from one facilitator; in partnerships, the facilitator
could see more than one GP at the same time. Before each visit, all GPs in the practice
received a feedback report on the medical condition to be addressed during the visit. The
feedback reports were based on the baseline performance data and informed the GPs about
their current clinical decision making in relation to the key recommendations from the
DCGP guidelines. During the visit, the facilitator and the GPs discussed the content of the
feedback reports, prioritised specific aspects of decision making for improvement and
made change plans. The facilitator provided guidance, support, and educational materials
to achieve improvement. As part of a next visit, the facilitator and the GPs discussed the
extent to which the plans were carried out and which aspects of decision making needed
further attention.
The intervention was part of a larger implementation project concerned with practice
organisation and clinical decision making with regard to patients at high cardiovascular
risk. The focus of the project was on the implementation of a comprehensive programme of
recommendations derived from the DCGP guidelines and consensus procedures. The
facilitators conducted 15 outreach visits per practice, lasting an average of one hour per
visit, equally distributed across a period of 21 months. The first eight visits concerned
practice organisation; the other seven visits concerned clinical decision making. The
protocol for the visits was highly standardised to limit variation and based on a model of
change.9 The facilitators were specially trained to support the GPs and to carry out the
project protocol. Most of the facilitators had worked as a practice assistant in the past but
none of them were trained physician.
Results
Table 1 shows the baseline characteristics of the 124 participating practices (185 GPs) and
the number of patient encounters. Four intervention practices (4/62 = 6%) did not receive a
per protocol intervention. These practices received feedback but no support from a
facilitator with regard to clinical decision making. Three other practices (3/124 = 2%) were
lost to follow-up (Figure 1).
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Table 1. Practice characteristics at baseline and numbers of patient encounters
Intervention group
n (%)
Control group
n (%)
Practices at baseline
Total    62    62
Single-handed 38 (61) 38 (61)
Mean age of GPs >45 years 26 (42) 24 (39)
<2500 patients per full-time equivalent GP 22 (35) 19 (31)
Urban locationa    26 (42) 25 (40)
Training practice 18 (29) 17 (27)
³0.8 full-time equivalent practice assistant employed per 2500 patients 40 (65) 44 (71)
Patient encounters
Newly diagnosed hypertension
Baseline  122  153
Post-intervention    93  107
Treated hypertension
Baseline 1994 1854
Post-intervention 1605 1725
Hypercholesterolaemia
Baseline  247  288
Post-intervention  174  172
Angina pectoris
Baseline  169  166
Post-intervention  148    97
Heart failure
Baseline  121  115
Post-intervention    75    76
a  ³ 1500 addresses per km2
In general, the ages and gender of the patients were found to be evenly distributed across
the intervention and control groups for the encounters at baseline and post-intervention
measurement. The proportion males with treated hypertension at post-intervention,
however, was lower for the intervention group than the control group (39.2% versus
46.0%, p=0.003, multilevel analysis).
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Figure 1. Trial profile
The GPs reported 30 101 clinical decisions at baseline and 22 454 decisions at post-
intervention (Table 2).
The intervention resulted in statistically significant improvement for five of the twelve
indicators (intention to treat analyses, Table 3): assessment of risk factors in patients with
hypercholesterolaemia or angina pectoris, provision of information and advice to patients
with hypercholesterolaemia or treated hypertension, and checking for clinical signs of
deterioration in patients with heart failure. Exclusion of those practices which did not
provide data for a particular indicator either before or after intervention had marginal
effects on the findings for that indicator. Single-handed practices, non-training practices,
and practices with older GPs benefited most from intensive support on the provision of
information and advice to patients with hypercholesterolaemia or treated hypertension.
Other practice characteristics were found to be associated with effects for only one or no
indicators (Table 4).
Practices assessed for eligibility (n=157)
Allocated to receive intensive support (n=62)
Received intensive support (n=62)
Completed trial (n=61) Completed trial (n=60)
Lost to follow-up (n=1):
Illness of GP
Discontinued intervention (n=4):
Illness of GP (n=1)
Personnel changes (n=2)
Too burdensome (n=1)
Excluded (n=33):
Not meeting inclusion criteria (n=3)
Refused to participate (n=17)
Pilots (n=7)
Did not complete baseline measurement (n=6)
Lost to follow-up (n=2):
Illness of GP (n=1)
Lack of motivation (n=1)
Allocated to receive no special attention (n=62)
Did not receive special attention (n=62)
Randomly allocated (n=124)
Table 2. Baseline mean compliance rates and mean changes in compliance rates across practices, by trial group
Number of practices Number of decisions Compliance rate %
Medical condition; performance indicator (number of key
recommendations included in the indicator) Baseline
Post-
intervention Baseline
Post-
intervention
Baseline mean
(95% CI)
Mean change
(95% CI)
Newly diagnosed hypertension; assessment of risk factors (9)
Intervention 46 40 1098  837 79 (75 to 83) -2 (-9 to 5)
Control 48 44 1377  963 75 (71 to 79)   0 (-6 to 6)
Newly diagnosed hypertension; provision of information and advice (10)
Intervention 46 40  860  688 57 (50 to 65)    5 (-6 to 16)
Control 48 44 1102  742 54 (48 to 60)  -1 (-10 to 8)
Treated hypertension; provision of information and advice (5)
Intervention 62 61 4822 3585 64 (59 to 70)    5 (-1 to 10)
Control 62 60 4567 3991 57 (52 to 63) -3 (-8 to 2)
Treated hypertension; increasing the antihypertensive medicationa (1)
Intervention 62 57  700  446 31 (26 to 37)    8 (-1 to 16)
Control 61 60  681  567 32 (28 to 37)    4 (-3 to 11)
Treated hypertension; scheduling a follow-up appointment (3)
Intervention 62 61 1756 1382 76 (72 to 80)   1 (-4 to 6)
Control 62 60 1615 1551 72 (66 to 77)   0 (-5 to 5)
Hypercholesterolaemia; assessment of risk factors (9)
Intervention 53 51 2223 1566 90 (87 to 93) 5 (2 to 8)
Control 57 53 2592 1548 89 (86 to 92)  2 (-2 to 5)
Hypercholesterolaemia; provision of information and advice (7)
Intervention 53 51 1449 1036 77 (72 to 82)  7 (1 to 13)
Control 57 53 1699 1019 77 (73 to 80)  0 (-6 to 6)
Angina pectoris; assessment of risk factors (2)
Intervention 48 39  292  246 89 (85 to 93)  8 (2 to 15)
Control 46 24  280  170 92 (89 to 96)  0 (-7 to 6)
Angina pectoris; provision of information and advice (4)
Intervention 48 39  341  348 69 (63 to 76)  -7 (-18 to 4)
Control 46 24  325  222 67 (60 to 75)  -9 (-23 to 4)
Angina pectoris; prescribing aspirin and sublingual nitrate (2)
Intervention 49 41  338  296 55 (48 to 62) 10 (-1 to 21)
Control 49 26  332  194 54 (48 to 60)       1 (-14 to 17)
Heart failure; checking for clinical signs of deterioration (4)
Intervention 41 25  460  300 78 (71 to 85) 12 (0 to 25)
Control 36 22  484  304 83 (77 to 89)  -7 (-17 to 2)
Heart failure; provision of information and advice (3)
Intervention 41 25  345  225 80 (73 to 86)  0 (-8 to 8)
Control 36 22  363  228 79 (73 to 85)    6 (-2 to 15)
a Increasing the dosage or starting a drug from a different class in case of a diastolic blood pressure above 90 mmHg.
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Table 3. Effect size of the intervention on clinical decision makinga
Medical condition; performance indicator Odds ratio 95% CI P value ICC
Newly diagnosed hypertension; assessment of risk factors 1.07 0.77 to 1.47   0.696 0.09
Newly diagnosed hypertension; provision of information and advice 1.32 0.94 to 1.86   0.109 0.19
Treated hypertension; provision of information and advice 1.55 1.35 to 1.77 <0.001 0.18
Treated hypertension; increasing the antihypertensive medicationb 0.87 0.61 to 1.24   0.432 0.06
Treated hypertension; scheduling a follow-up appointment 0.96 0.75 to 1.22   0.727 0.11
Hypercholesterolaemia; assessment of risk factors 2.04 1.44 to 2.88 <0.001 0.15
Hypercholesterolaemia; provision of information and advice 1.58 1.17 to 2.13   0.003 0.09
Angina pectoris; assessment of risk factors 3.07 1.08 to 8.79   0.037 0.12
Angina pectoris; provision of information and advice 1.02 0.61 to 1.71   0.929 0.05
Angina pectoris; prescribing aspirin and sublingual nitrate 1.44 0.86 to 2.41   0.168 0.05
Heart Failure; checking for clinical signs of deterioration 4.11 2.17 to 7.77 <0.001 0.21
Heart failure; provision of information and advice 0.85 0.43 to 1.67   0.636 0.15
a Multilevel analysis with adjustments for baseline compliance, practice characteristics, and patients’ age and 
gender.
b Increasing the dosage or starting a drug from a different class in case of a diastolic blood pressure above
90 mmHg.
ICC Intracluster correlation coefficient.
Table 4. Practice characteristics predicting success (P < 0.05) of the interventiona
Medical condition; performance indicator
Practice characteristic Odds ratiob 95% CI P value
Treated hypertension; provision of information and advice
Non-training practice 1.70 1.19 to 2.43   0.004
<2500 patients per full-time equivalent GP 1.52 1.11 to 2.08   0.008
<0.8 full-time equivalent practice assistant employed per 2500 patients 1.42 1.04 to 1.93   0.024
Single-handed 1.42 1.03 to 1.95   0.031
Mean age of GPs >45 years 1.35 1.01 to 1.82   0.046
Hypercholesterolaemia; assessment of risk factors
³0.8 full-time equivalent practice assistant employed per 2500 patients 3.11 1.38 to 6.98   0.006
Hypercholesterolaemia; provision of information and advice
Mean age of GPs >45 years 4.21 2.19 to 8.09 <0.001
Non-training practice 2.87 1.28 to 6.44   0.011
Single-handed 2.66 1.29 to 5.49   0.008
a Multilevel analysis.
b Practice characteristic present versus not present.
Interpretation of results
Intensive support from facilitators improved the clinical decision making of GPs with
regard to the assessment of risk factors and the provision of information and advice for
certain types of patients at high cardiovascular risk, and also the checking for clinical signs
of deterioration in patients with heart failure. The intervention may also ultimately improve
patient outcomes; identification of the presence of risk factors provides opportunities to
reduce risk. The provision of information by doctors has been found to improve
compliance with therapy, satisfaction with the care delivered, and health outcomes,
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whereas lifestyle interventions aimed at patients at high cardiovascular risk have been
shown to reduce morbidity and mortality.22-25 Early detection of deterioration in patients
with heart failure may promote adjustment of the therapy and thereby prevent
hospitalisation.26
Just why the intensive support was effective for five of the twelve indicators remains
unclear. Comparison across the indicators is hindered by differences in the baseline
compliance rates and power across the indicators. Moreover, we do not have insight into
the motives of the GPs for apparently ignoring certain recommendations. All kinds of
professional, patient and environmental barriers may undermine clinical decision making.27
Remarkably, the trial did not show an increase in the prescription of recommended
medication. This lack of an effect is in contrast to the findings of a review showing
outreach visits to reduce inappropriate prescribing.1
Our finding that in particular single-handed practices gained benefits from the intensive
support also contrasts with a previous study. Hulscher et al. found a positive relation
between partnership and improving the organisation of cardiovascular disease prevention.9
One possible explanation for this discrepancy is that partnerships have more people
available to optimise practice organisation while GPs in single-handed practices do not
have to share the support for clinical decision making with other GPs. Partnerships,
training practices, and practices with younger GPs seem to need extra support with respect
to the provision of information and advice.
At post-intervention, the GPs in the intervention group may have selectively recorded
patient encounters in comparison with the control group, because the GPs were not blind to
the allocation of their practice. Selective recording is nevertheless unlikely, because the
groups did not substantially differ with regard to the number of patient encounters, the
mean age of the patients, or the proportion males. Moreover, the intervention did not
improve compliance for all indicators.
Our study has several other limitations. The practices volunteered to participate and may
have been more interested and motivated than other practices. Furthermore, we did not
explore the effects on patient outcome. The outcome measures were nevertheless based on
well-accepted recommendations and detailed assessment of the GPs’ clinical actions in
actual clinical situations.
Lessons learnt and next steps
Prospective recording of patient encounters proved feasible but had nevertheless some
drawbacks. For some indicators, such as the prescription of angiotensin-converting enzyme
inhibitors and other medication to patients with heart failure, a sufficient number of
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decisions to adequately evaluate the effectiveness of the intervention were not available.
The schedule of the trial did not allow us to lengthen the recording period. In addition, the
GPs generally included 25% fewer encounters at post-intervention than at baseline,
possibly due to a lack of motivation. Finally, prospective recording appears to be less
suitable for the assessment of compliance with recommendations for the diagnosis of
diseases and risk factors, because practitioners will obviously fail to include encounters in
which they overlook the diagnosis.
In conclusion, intensive support from non-physicians improved clinical decision making
for some but not all aspects of cardiovascular care. The strategy therefore needs further
development. The facilitators asked the GPs about barriers to change but may need more
intensive training to be able to identify and tackle these barriers. The effectiveness of
support from non-physicians is important in terms of the costs when compared to support
from physicians. Finally, some effects of the intervention were more pronounced for
certain practice characteristics. These findings need confirmation but suggest differences in
the intensity of support required across practices. In our opinion, intensive support from
facilitators evolves from a promising approach to an evidence-based strategy for the
implementation of guidelines.
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Abstract
Aims. To evaluate the effectiveness of a multifaceted intervention to improve the clinical
decision making of general practitioners (GPs) for patients with diabetes. To identify
practice characteristics which predict success.
Methods. Cluster randomised controlled trial with 124 practices and 185 GPs in The
Netherlands. The intervention group received feedback reports and support from a
facilitator; the control group received no special attention. Outcome measures were the
compliance rates with evidence-based recommendations pertaining to discussion of body
weight control, discussion of problems with medication, blood pressure measurement, foot
examination, eye examination, initiating antidiabetic medication or increasing the dosage
in cases of uncontrolled blood glucose, and scheduling a follow-up appointment.
Results. The GPs reported on their clinical decision making in 1410 consultations with
Type 2 diabetic patients at baseline and 1449 consultations after the intervention period.
There was a general trend towards a beneficial outcome for the intervention group when
compared to the control group. The intervention resulted in statistically significant
improvement for foot examination (odds ratio 1.68; 95% confidence interval 1.19 to 2.39)
and eye examination (1.52; 1.07 to 2.16). Discussion of problems with medication showed
a near significant trend towards increased benefit for the intervention group (1.52; 0.99 to
2.32). Practice characteristics were not found to be related to the success of the
intervention.
Conclusions. Feedback reports with support from facilitators appear to increase rates of
foot examination and eye examination in general practice. Alternative interventions should
be explored to improve the pursuit of metabolic control by GPs.
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Introduction
There is considerable potential to improve the process and outcome of diabetes care in
general practice. For instance, 28% of the Type 2 diabetic patients treated in general
practice have poor glycaemic control and 55% have a high body mass index.1 A
comparison of multi-practice audits of diabetes mellitus showed wide variation across audit
groups in the annual examination of fundi (range 58% to 87%) and feet (range 40% to
91%).2 Improvement in diabetes care can presumably be achieved by supporting the
clinical decision making of general practitioners (GPs). Implementation of evidence-based
guidelines may support and thus improve clinical decision making. 
Strategies to implement clinical guidelines vary widely in their effectiveness to change
clinical practice. For instance, passive dissemination of information is generally ineffective
for altering health professional behaviour3 while audit with feedback has a small to
moderate effect.4 Multifaceted interventions targeting different barriers to change tend to
be more effective than single interventions.5 Educational outreach visits combined with
social marketing appear to be a particularly promising approach to modify professional
behaviour.6 In cardiovascular and diabetes care, a multifaceted intervention based on a
theoretical model of change and delivered during outreach visits can optimise practice
organisation and the recording of diabetes variables.7,8 But does this type of intensive
support also optimise the clinical decisions of GPs during daily diabetes care?
The objective of this study was to evaluate the effectiveness of a multifaceted
intervention to improve the process of diabetes care. The intervention targeted key aspects
of the clinical decision making of GPs for patients with Type 2 diabetes mellitus. In order
to tailor future interventions, we also explored a number of practice and patient
characteristics to identify the predictors of success.
Practices and methods
Study design
We conducted a cluster randomised controlled trial in general practice from 1996 to 1999.
Practices in the southern part of The Netherlands were recruited via bulletins and by letter
until a total of 124 practices were randomised. Inclusion criteria were the presence of a
clinical computer system, employment of practice assistant(s) and no major changes in
personnel or premises planned during the course of the trial. We considered these criteria
crucial for the conduct of the improvement project.
After baseline measurement, the practices were randomly allocated to receive a
multifaceted intervention to optimise the management of patients at high cardiovascular
risk (intervention group) or no special attention (control group). The practices were
numbered and the person responsible for the randomisation process was blind to the
102 Chapter 7
practice identities. A random-number generator was used to select permuted blocks with a
block size of four. We stratified with regard to practice type (single-handed versus
partnership) as this characteristic has been found to predict change in practice
organisation.7
Intervention
The GPs in the intervention practices received feedback reports and outreach visits from
facilitators. Each practice received support from one facilitator; in partnerships, the
facilitator could see more than one GP at the same time. As part of a visit, the facilitator
specifically addressed the clinical decision making for patients with Type 2 diabetes
mellitus. Before this visit, each GP in the practice received an individualised feedback
report based on baseline performance data. This report informed the GP about his or her
current clinical decision making with regard to the diabetes guidelines issued by the Dutch
College of General Practitioners (DCGP).9 During the visit, the facilitator and the GPs
discussed the content of the feedback reports, prioritised specific aspects of decision
making to be improved and made change plans. The facilitator provided guidance, support,
and educational materials to facilitate improvement. As part of a next visit, the facilitator
and the GPs discussed the extent to which the plans were carried out and which aspects of
decision making needed further attention.
The intervention was part of a larger implementation project concerned with practice
organisation and clinical decision making with regard to patients at high cardiovascular
risk. The focus of the project was on the implementation of a comprehensive programme of
recommendations derived from the relevant DCGP guidelines and consensus procedures.
The facilitators conducted 15 outreach visits per practice, lasting an average of one hour
per visit, equally distributed across a period of 21 months. The first eight visits concerned
practice organisation; the other seven visits concerned clinical decision making. The
protocol for the visits was highly standardised to limit variation and based on a model of
change.7 The facilitators were specially trained to carry out the project protocol and to
support the GPs. Most of the facilitators had worked as a practice assistant in the past but
none of them were trained physician.
Outcomes and measurement
The outcome measures were the compliance rates for evidence-based indicators for the
actual management of patients with Type 2 diabetes mellitus. We asked a group of five
GPs involved in research and guideline development but not participating in the trial to
select the key recommendations from the DCGP diabetes guidelines. These guidelines are
based on scientific evidence, broad consensus, and clinical experience.10 We used the key
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recommendations to formulate performance indicators. The indicators are detailed
descriptions of the recommended clinical actions along with the clinical situations calling
for those actions. Using the indicators, we developed a form for the prospective recording
of patient encounters concerning Type 2 diabetes mellitus. This encounter form included
items pertaining to the age, sex, and clinical characteristics of the patient and also the
decisions regarding the performance (yes/no) of specific clinical actions. While the form
was based on the performance indicators, it did not contain any clues to the indicators. GPs
have been shown to complete similar encounter forms reliably (kappa of 0.79; Spies TH,
personal communication).
Immediately prior to and upon completion of the 21-month implementation period, the
GPs completed encounter forms during routine consultation hours for a period of two
months. Research assistants visited the practices at the start of the recording period to
explain the use of the forms. The GPs were asked to complete the forms immediately after
a consultation concerning Type 2 diabetes mellitus. The data from the encounter forms
were then entered into a computer by personnel blind to group allocation. We excluded all
encounters with patients using insulin, because no DCGP recommendations were available
for these patients at the time of the study.
After the trial, we selected all of the indicators which allowed detection of an absolute
difference of 15% in the compliance rates between intervention and control groups with
more than 90% power at a 5% significance level. Changes in care provision are usually no
more than 10%.11 The smallest difference we would have been able to detect across the
indicators was 8% (a = 0.05, b = 0.10). The post-hoc power estimations take into account
the design effect of cluster randomisation.12 The selected indicators referred to discussion
of body weight control, discussion of problems with medication, blood pressure
measurement, foot examination, eye examination, initiating antidiabetic medication or
increasing the dosage in cases of uncontrolled blood glucose, and scheduling a follow-up
appointment.
 The characteristics of the participating practices were derived from a questionnaire
completed by one GP per practice at baseline. Data were collected on type of practice
(single-handed versus partnership), practice location, number of GPs and practice
assistants, working hours of each professional, age of GPs, patient list size, and
involvement in GP vocational training.
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Statistical analyses
We used the data from the encounter forms to assess compliance with the content of the
performance indicators. Particular actions were taken to be performed, when the GP
reported performance within the recommended period (see Table 2). Actions with missing
data were considered not to be performed.
The practice was the unit of analysis to describe changes in clinical decision making.
We calculated the mean compliance rate for each performance indicator at baseline and the
mean change from baseline. The compliance rate for each indicator was the number of
decisions in accordance with the guidelines divided by the total number of decisions made
with respect to that indicator.
Multilevel logistic regression analysis (GLMMIX procedure in SAS) was used to
evaluate the influence of the intervention on clinical decision making and to identify
predictors of success. Multilevel analysis takes into account the relatedness of the clinical
decisions made within a particular practice. For each performance indicator, the decisions
were treated as binary dependent variables: either the decision was in accordance with the
guidelines or not. The independent variables were: the practice; phase (baseline/post-
intervention); practice characteristics; patient’s age and gender; allocation to intervention
or control group; and, interaction between phase and allocation.12 In such a manner, the
model adjusts for compliance at baseline. P values less than 0.05 were considered
statistically significant. In the case of a statistically significant intervention effect, we
added interaction terms (phase x allocation x practice characteristic) to identify any
practice characteristics which were related to the success of the intervention.
Results
Practices and patients
A total of 157 practices were recruited from which 33 (21%) practices were excluded
(Figure 1). The baseline characteristics of the participating 124 practices (185 GPs) are
presented in Table 1. Four intervention practices (4/62 = 6%) received feedback but no
support from a facilitator with regard to clinical decision making. Three other practices
(3/124 = 2%) were lost to follow-up. The ages of the patients, the proportions of males and
the proportions of patients with uncontrolled blood glucose were found to be equally
distributed across the intervention and control groups at baseline and post-intervention
measurement (Table 1).
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Figure 1  Trial profile
Practices assessed for eligibility (n=157)
Allocated to receive intensive support (n=62)
Received intensive support (n=62)
Completed trial (n=61) Completed trial (n=60)
Lost to follow-up (n=1):
Illness of GP
Discontinued intervention (n=4):
Illness of GP (n=1)
Personnel changes (n=2)
Too burdensome (n=1)
Excluded (n=33):
Not meeting inclusion criteria (n=3)
Refused to participate (n=17)
Pilots (n=7)
Did not complete baseline measurement (n=6)
Lost to follow-up (n=2):
Illness of GP (n=1)
Lack of motivation (n=1)
Allocated to receive no special attention (n=62)
Did not receive special attention (n=62)
Randomly allocated (n=124)
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Table 1. Characteristics of the practices and patient encounters
Variable
Intervention
group
Control
 group
Practice characteristics at baseline
Number of practices   62   62
Single-handed (%)   61   61
Mean age of GPs >45 years (%)   42   39
³ 2500 patients per full-time equivalent GP (%)   65   69
Urban locationa (%)   42   40
Involvement in GP vocational training (%)   29   27
³ 0.8 full-time equivalent practice assistant employed per 2500 patients (%)   65   71
Patient encounters at baseline
Number of encounters 703 707
Male patients (%)   44.5   44.7
Mean age of the patients, years (SD)   64.8 (11.1)    65.6 (12.1)
Patients with uncontrolled blood glucoseb (%)   39.0   37.1
Patient encounters at post-intervention measurement
Number of encounters 728 721
Male patientsc (%)   45.8   48.0
Mean age of the patients, years (SD)c   64.5 (12.3)   64.4 (11.9)
Patients with uncontrolled blood glucosebc (%)   35.6   33.8
a ³1500 addresses per km2.
b 1989 Dutch College of GPs’ criterion for uncontrolled blood glucose: fasting blood glucose above 8.0 mmol/l or 
blood glucose above 10.0 mmol/l two hours postprandially (combined with hyperglycaemic complaints in case of 
an age of 75 years or above).
c P > 0.3 for the difference between intervention and control groups, multilevel analysis.
Outcomes
The GPs completed 1410 encounter forms at baseline (mean number of forms per practice
11.4, SD 7.6, range 1 to 44) and 1449 forms at post-intervention measurement (12.0, 7.5, 1
to 48). At baseline, the mean compliance rate across the practices was higher than 90% for
the indicator pertaining to blood pressure measurement and lower than 50% for the
indicators pertaining to foot examination and prescribing antidiabetic medication in cases
of uncontrolled blood glucose. In the intervention group, the mean compliance rate
improved significantly for the indicators pertaining to foot examination (mean change
19%, 95% confidence interval 10% to 27%), eye examination (9%, 3% to 15%), and
prescribing antidiabetic medication in cases of uncontrolled blood glucose (11%, 0% to
22%). In the control group, the mean compliance rate improved significantly for foot
examination (9%, 1% to 17%) and blood pressure measurement (3%, 0% to 5%) (Table 2).
The intervention tended to improve compliance for each performance indicator studied
(intention to treat analyses, Table 3). The intervention resulted in statistically significant
improvement for two of the seven indicators: foot examination (odds ratio 1.68, 95%
confidence interval 1.19 to 2.39) and eye examination (1.52, 1.07 to 2.16).
Table 2. Baseline mean compliance rates and mean changes in compliance rates across practices, by trial group
Number of practices Number of decisions Compliance rate %
Performance indicator Baseline
Post-
intervention Baseline
Post-
intervention
Baseline mean
(95% CI)
Mean change
(95% CI)
Foot examination in the last 12 months
Intervention 62 61 703 728 43  (36 to 50)   19  (12 to 27)
Control 62 60 707 721 39  (32 to 47)     9  (1 to 17)
Eye examination (in own practice or referral) in the last 24 months
Intervention 62 61 703 728 70  (65 to 76)     9  (3 to 15)
Control 62 60 707 721 67  (60 to 74)    -2  (-9 to 5)
Discussion of problems with medication when applicable
Intervention 60 59 403 440 65  (58 to 72)     8  (-1 to 17)
Control 60 60 418 449 61  (52 to 70)     5  (-4 to 13)
Blood pressure measurement in the last 12 months (in case patient’s age
£80 years)
Intervention 62 61 659 661 94  (92 to 97)     3  (-1 to 6)
Control 62 60 628 647 92  (88 to 95)     3  ( 0 to 5)
Initiating antidiabetic medication or increasing the dosage in case of
uncontrolled blood glucosea
Intervention 58 56 274 259 33  (26 to 40)   11  (0 to 22)
Control 57 55 262 244 37  (29 to 45)   10  (-3 to 24)
Scheduling a follow-up appointmentb
Intervention 62 61 703 728 70  (63 to 76)    -4  (-12 to 3)
Control 62 60 707 721 70  (65 to 75)    -5  (-10 to 1)
Discussion of body weight control (in case patient’s age <75 years)
Intervention 62 61 567 572 62  (55 to 68)     4  (-4 to 12)
Control 62 60 532 583 59  (52 to 66)     5  (-2 to 11)
a Uncontrolled blood glucose: fasting blood glucose above 8.0 mmol/l or blood glucose above 10.0 mmol/l two hours postprandially (combined with hyperglycaemic 
complaints in case of an age of 75 years or above).
b Scheduling an follow-up appointment after three months in case of a fasting blood glucose below 6.7 mmol/l or blood glucose below 9.0 mmol/l two hours 
postprandially, at most two months in case of uncontrolled blood glucose a, and at most three months in all other cases.
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The indicator for discussion of problems with medication showed a near significant trend
towards increased benefit for the intervention group (1.52, 0.99 to 2.32). Exclusion of
those practices which did not provide data for a particular indicator either before or after
intervention had marginal effects on the findings for that indicator. Practice characteristics
were not found to be related to the success of the intervention (P values were above 0.1).
Table 3. Effect size of the intervention on clinical decision makinga
Performance indicator Odds ratio 95% CI P value ICC
Foot examination in the last 12 months 1.68 1.19 to 2.39 0.004 0.31
Eye examination (in own practice or referral) in the last 24 months 1.52 1.07 to 2.16 0.020 0.18
Discussion of problems with medication when applicable 1.52 0.99 to 2.32 0.057 0.18
Blood pressure measurement in the last 12 months (in case patient’s
age £ 80 years)
1.34 0.70 to 2.54 0.372 0.25
Initiating antidiabetic medication or increasing the dosage in case of
uncontrolled blood glucose b
1.14 0.68 to 1.90 0.612 0.05
Scheduling a follow-up appointment c 1.04 0.75 to 1.45 0.807 0.09
Discussion of body weight control (in case patient’s age < 75 years) 1.01 0.70 to 1.45 0.962 0.14
a Multilevel analysis with adjustments for baseline compliance, practice characteristics, and patients’ age and 
gender.
b Uncontrolled blood glucose: fasting blood glucose above 8.0 mmol/l or blood glucose above 10.0 mmol/l two 
hours postprandially (combined with hyperglycaemic complaints in case of an age of 75 years or above).
c Scheduling a follow-up appointment after three months in case of a fasting blood glucose below 6.7 mmol/l or 
blood glucose below 9.0 mmol/l two hours postprandially, at most two months in case of uncontrolled blood 
glucose b, and at most three months in all other cases.
ICC Intracluster correlation coefficient.
Discussion
Multifaceted support was found to improve key aspects of the clinical decision making for
patients with Type 2 diabetes mellitus in general practice. The intervention consisted of
feedback reports and support (one hour per practice) from facilitators during two outreach
visits, which were part of a comprehensive strategy to improve all different aspects of
cardiovascular and diabetes care. There was a general trend towards a beneficial outcome
for the intervention group. Specific predictors of the success of the intervention could not
be identified.
The intervention resulted in statistically significant improvement for the indicators
pertaining to foot examination and eye examination. Foot care reduces amputation rates
and early treatment of retinopathy prevents blindness.13 The positive effect on foot
examination confirms the results of a British trial in general practice evaluating the
implementation of an integrated diabetic footcare model with use of educational practice
visits.14 Our trial showed that an increase in foot examinations can also be achieved within
a complex programme aimed at all aspects of cardiovascular and diabetes care. A near
significant trend was found towards a positive effect on discussion of problems with
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medication. Improving compliance with drug therapy may ultimately provide better patient
outcome. The intervention had no significant effect on the pursuit of metabolic control via
initiating antidiabetic medication or increasing the dosage. This result is in contrast to the
findings of a review showing outreach visits by facilitators to reduce inappropriate
prescribing.6 The intervention had also no significant effects on discussion of body weight
control and the scheduling of a follow-up appointment. These clinical activities are
considered important in terms of achieving treatment goals. Moreover, there was no
significant effect on compliance with blood pressure measurement, most likely due to the
high levels of quality of care at baseline (the mean compliance rates were above 90%).
Just why the intervention did not improve the compliance for all of the indicators
remains unclear. We did not ask about the motives of the GPs for apparently ignoring the
recommendations. All kinds of professional, patient and environmental barriers may
undermine clinical decision making.15 The facilitators asked the GPs about barriers to
change but may need more intensive training in order to be able to identify and tackle these
barriers.
Our study has several limitations. The practices volunteered to participate and may have
been more interested and motivated than other practices. At post-intervention
measurement, the GPs were not blind to the allocation of their practice to either the
intervention or control group. It is therefore possible that the GPs in the intervention group
selectively recorded patient encounters in comparison with the control group. Selective
recording is nevertheless unlikely, because the groups did not differ in the number of
patient encounters, the mean age of the patients, the proportion males, and the proportion
patients with uncontrolled blood glucose. Furthermore, we did not explore the effects of
improved decision making on patient outcome. The indicators we used are nevertheless
well-accepted measures of the quality of diabetes care.2,16
In conclusion, the GPs in the intervention group were found to improve their clinical
decision making for some aspects of diabetes care as a result of feedback reports and
support from facilitators who were not trained as physicians. The effectiveness of support
from non-physicians is important in terms of the salary costs when compared to support
from physicians. The intervention proved successful for foot examination and eye
examination. Blood pressure measurement showed an already high standard of care at
baseline, and further research is needed to determine whether and how GP’s pursuit of
metabolic control can be improved. Our study adds to the evidence that multifaceted
interventions can enhance the performance of health professionals in managing patients
with diabetes.17
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Introduction
The studies in this thesis focused on improvement in the general-practice management of
patients at high cardiovascular risk. Previous studies have shown ample room for
improvement in the quality of care for these patients.1-7 While the implementation of
evidence-based guidelines may help optimise the quality of care, research on the
effectiveness of different strategies to implement such guidelines is needed.8 We therefore
performed a randomised controlled trial (n=124 practices) called CARPE to assess the
effectiveness of a comprehensive and complex intervention consisting of educational
outreach visits combined with feedback. In addition, we used the baseline data from the
trial to further explore the quality of the cardiovascular and diabetes care provided in
general practice. Patients’ perceptions of absolute cardiovascular risk were also assessed as
insight into such perceptions gives physicians the opportunity to better inform patients
about the benefits of preventive drug treatment. In the present chapter, the main findings
and conclusions from the different studies will be presented and discussed. Based on the
findings, a number of recommendations for researchers, people involved in guideline
development, practitioners, and health policy makers will be provided. Finally, some
ongoing developments in the field of cardiovascular and diabetes care in general practice
will be described.
Major findings and conclusions
QUALITY ASSESSMENT
Structure of care: practice organisation
The management of patients at high cardiovascular risk demands adequate organisation of
the practice. Hypertension, dyslipidaemia, diabetes, and cardiovascular disease are chronic
and progressive conditions and therefore need long-term monitoring. Specific
organisational arrangements are nevertheless needed to insure adequate monitoring, and we
therefore assessed the extent to which such arrangements appear to be in place. The mean
guideline adherence rates across practices was found to be below 40% for the performance
of preventive tasks by the practice assistant, presence of separate clinics, teamwork in the
practice, arrangements for follow-up, and recording of risk factors. The mean rate for the
availability of instruments and materials was found to be 67%. These figures indicate
significant shortcomings in the structure of care.
Process of care: clinical decision making
We assessed the clinical decision making of GPs for cardiovascular and diabetes care;
GPs’ clinical decisions play an important role in the utilisation of health care resources,9
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and incorrect or inadequate decisions can negatively influence patients’ health. The
performance rates varied considerably across the practices and 19 indicators we studied.
Low mean rates (below 60%) were found for the provision of information and advice to
patients with newly diagnosed hypertension, foot examination for patients with diabetes,
initiating or changing drug treatment to control high blood pressure or high blood glucose,
and prescription of aspirin and sublingual nitrate for patients with angina pectoris.
Particularly high mean rates (above 80%) were found for annual blood pressure
measurement of patients with diabetes, assessment of risk factors in patients with
hypercholesterolaemia or angina pectoris, and checking for clinical signs of deterioration
in patients with heart failure.
The clinical performance of GPs with respect to the provision of information and advice
was next explored in greater detail. Many patients at high cardiovascular risk display one
or more unhealthy behaviours2,10 while lifestyle interventions targeted at high-risk patients
have been shown to reduce morbidity and mortality.11 Valid assessments of the provision
of information and advice by GPs are largely lacking, however. Our study showed GPs to
frequently provide patients at high cardiovascular risk with advice on smoking cessation
and specific information (for example, information about alarm symptoms or the aim of
treatment). Low levels of performance (below 60%) were nevertheless found for the
provision of advice on salt consumption, alcohol consumption, weight reduction, and
physical exercise to patients with hypertension. Discussion of compliance with therapy in
cases of hypercholesterolaemia, advice on physical exercise in cases of angina pectoris,
and advice on foot care in cases of peripheral arterial disease also showed performance
levels below 60%. Clinical performance varied considerably across the GPs. The
intracluster correlation coefficient (ICC) or the variance between GPs divided by the total
variance ranged nevertheless between 0.14 and 0.30; that is, the variance occurred
predominantly across the patients. For hypertension, angina pectoris, and peripheral arterial
disease, one fourth of the GPs had performance rates below 60%. In conclusion, although
the GPs frequently provided information and advice, there is considerable room for
improvement across indicators and GPs.
We also explored GPs’ control of hypertension. More than half of the patients with
treated hypertension have an elevated blood pressure and may not receive the optimal
benefit of antihypertensive drug treatment. GPs play a crucial role in decisions concerning
antihypertensive drug treatment and other measures to control blood pressure. Our study
showed GPs to target a diastolic blood pressure (DBP) below 100 mmHg while the
guidelines recommend targeting a DBP below 90 mmHg. The number of additional risk
factors did not influence the GPs’ target levels. Furthermore, the GPs did not expect any
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substantial effect from non-pharmacological treatment on the levels of DBP. The median
performance rates for the key actions to control blood pressure were generally below 51%,
even for a DBP of 100 mmHg or above. In this study, clinical performance again varied
considerably across GPs. The variance nevertheless occurred predominantly across the
patients (ICC between 0.10 and 0.40). Our findings suggest that a more active approach
and more aggressive therapy on the part of GPs may improve blood pressure control and
that targeting a DBP below 100 mm Hg instead of below 90 mm Hg may partly explain
why 63% of the patients in our study were found to have a DBP well over the
recommended target level. In addition, we found GPs 45 years of age or older to apply
non-pharmacological measures more frequently than younger GPs. Conversely, patients
aged 60 years of age or older were given non-pharmacological measures less frequently
than younger patients.
Patients’ risk perceptions
On addition to the key elements of care provision, we also assessed the ability of patients at
moderate to high cardiovascular risk to estimate their absolute cardiovascular risk and the
accuracy of these estimates. The benefits of aspirin. statins and antihypertensive drug
treatment depend on a patient’s absolute cardiovascular risk. A physician can better discuss
treatment decisions with patients, when he or she has greater insight into the patients’ risk
perceptions. Shared decision making is particularly relevant for patients who stand to gain
a moderate reduction in their absolute risk and we therefore studied the risk perceptions of
patients with hypertension or diabetes but no known atherosclerotic disease.
One fourth of the patients did not provide any risk estimations, and these were
particularly older patients, patients with a lower educational level, and patients reporting
no alcohol consumption. Almost half of the remaining patients either overestimated or
underestimated their absolute risk by more than 20%. Women and patients who perceived
their health status as fair or poor were particularly inaccurate. Patients with higher levels
for the attribution of their health to physicians were less able than other patients to estimate
their absolute risk and less accurate when they did provide an estimate. Such patients
appear to prefer a ‘directing’ rather than a ‘sharing’ style of consulting but actually have a
particular need for information on their susceptibility to cardiovascular events. The ICCs
for the level and accuracy of perceived absolute risk were zero, which also indicates that
the GPs had not effectively informed their patients of individual cardiovascular risk. In
conclusion, patients proved to have inadequate risk perceptions and physicians should
therefore try to provide greater or better information on absolute cardiovascular risk when
offering aspirin, statins, or antihypertensive drug treatment.
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QUALITY IMPROVEMENT
There is growing insight into the effectiveness of different strategies for the
implementation of clinical guidelines. Multifaceted interventions targeting different
barriers to implementation tend to be more effective than single interventions.12 Whether or
not intensive and multifaceted support is effective when aimed at all of the key elements of
cardiovascular and diabetes care has yet to be demonstrated, however. It is possible that the
complexity of such intervention actually impedes successful implementation of the
guidelines. We therefore conducted a randomised controlled trial to test the effectiveness
of outreach visits combined with feedback for the implementation of a comprehensive
programme for the management of patients at high cardiovascular risk.
Practice organisation
The intervention resulted in substantial and statistically significant improvement for all six
effect measures related to practice management and organisation of preventive activities.
These measures pertained to preventive tasks by the practice assistant, presence of separate
clinics, availability of instruments and materials, teamwork in the practice, follow-up and
record keeping. The improvements in mean guideline adherence rates across the practices
as a result of the intervention varied between 14% and 31%. After intervention, there was
still ample room for improvement. Very little change was observed in the control group.
Record keeping, including the recording of risk factors, is one of the most important
elements in the practice organisation for cardiovascular disease (CVD) prevention; the
mean adherence rate in the intervention group improved from 32% to 57% (versus 35% to
37% in the control group). Practices with fewer GPs and practices with smaller list size per
full time GP improved most on record keeping.
Clinical decision making
The intervention resulted in statistically significant improvement for 7 out of the 19
indicators: assessment of risk factors in patients with hypercholesterolaemia or angina
pectoris, provision of information and advice to patients with hypercholesterolaemia or
treated hypertension, checking for clinical signs of deterioration in patients with heart
failure, and foot and eye examination for patients with diabetes. The improvements in the
mean performance rates across the practices as a result of the intervention varied between
3% and 19%. Among other indicators, there was no effect on initiating or changing drug
treatment to control high blood pressure or high blood glucose. Single-handed practices,
non-training practices, and practices with older GPs were positively associated with the
effect on the provision of information and advice to patients with hypercholesterolaemia or
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treated hypertension. There were virtually no changes in the control group. In conclusion,
intensive support from non-physicians can improve clinical decision making for patients at
high cardiovascular risk although the effects are not yet optimal.
Discussion
BARRIERS
Our studies indicate a number of shortcomings in the quality of care and show the
implementation of guidelines to be less than completely effective. The barriers to high
quality care and improvement may be related to the care providers (such as attitude,
knowledge, and skills), the social context (such as attitudes of colleagues and reactions of
patients), the organisational context (such as time and resources) and the guidelines
themselves (such as complexity and scientific evidence).13 Clear identification of the
barriers provides us with an opportunity to achieve improvement and we will now
postulate several important barriers to better cardiovascular and diabetes care.
With respect to practice organisation, a lack of clinical evidence, suitable software and
time appear to be barriers. The clinical evidence calling for specific organisational
arrangements is not always clear, and a lack of evidence negatively influences the adoption
of recommendations.14 Almost half of the GPs in the intervention group disagreed with the
necessity of separate clinics for patients at high cardiovascular risk and one fourth did not
agree with the recall of patients who failed to attend a follow-up appointment.15 Lack of
clinical evidence may have contributed to these negative attitudes. Furthermore, the
majority of the GPs agreed with the assessment of risk factors in high-risk patients, 15 but
the current soft-ware packages in Dutch general practice are not completely adequate for
easy and efficient recording of risk factors.16 The GPs also agreed with task delegation to
the practice assistant, 15 but such tasks demand additional time on the part of the already
busy practice assistants. Practices with more GPs or more patients per full time GP
particularly appeared to need more time and more suitable software to better organise the
recording of risk factors (see Chapter Five). The absence of such resources probably
explains the smaller effects of the intervention on record keeping for the practices in
question when compared to the other intervention practices.
With respect to clinical decision making, the behaviour of patients and a lack of time,
knowledge and skills on the part of the GPs appear to be barriers. Patients strongly
influenced clinical decision making (see Chapters Two, Four, Six and Seven), and their
opinions and behaviour regarding CVD prevention may therefore hinder improved
decision making. In addition, GPs have often observed that working according to the
guidelines simply takes too much time15-18 and also report a hesitation to intervene in a
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patient’s lifestyle or a lack of training in lifestyle counselling.18-21 Our finding that older
hypertensive patients were less likely to receive relevant information and advice than
younger hypertensive patients indicates certain shortcomings in the knowledge or attitudes
of GPs, moreover. Current guidelines on hypertension recommend the use of non-
pharmacological measures irrespective of age. Elderly hypertensives respond just as well
as younger hypertensives to non-pharmacological measures intended to lower blood
pressure and may even benefit more than younger patients due to the fact that
cardiovascular risk increases with age.22,23 A special issue in the provision of medical
information is clinical risk communication. We found patients to have inadequate
perceptions of their absolute cardiovascular risk, and other studies have shown physicians
to also misclassify patients’ absolute risk.24-28 Cardiovascular risk charts and computer
programs can help assess cardiovascular risk, but GPs also need special training for risk
communication because the understanding and interpretation of risk by patients vary
greatly.29 Decision aids may support risk communication and shared decision making, but
the effects of these aids are not yet completely clear.30 Finally, GPs appear to need better
training with respect to antihypertensive drug treatment to control blood pressure. They
appear to be made more aware of the fact that many hypertensive patients require
aggressive treatment with several drugs to achieve blood pressure targets.31
EFFECTIVE IMPLEMENTATION
We will now discuss the strategy of the intensive support, delivery of the support, and
receipt of the support. Such factors determine how well the intervention solves the barriers
to change. On the basis of this information we will then offer some suggestions for further
improvement in the intervention.
The implementation strategy
A multifaceted and intensive implementation strategy with special attention to potential
barriers to change is a requisite for improvement. We did not compare the intensive
support provided here with moderate support, but outreach visits combined with written
feedback have been found in other research to alter practice organisation and risk factor
recording for CVD prevention while written feedback alone proved ineffective.32,33
Reviews have shown multifaceted strategies to be particularly effective 8,12,34-36 while
recent trials have highlighted the need to explicitly address potential barriers to change.37,38
The effects of the intervention in our trial were not completely optimal, which also
underlines the absolute need for intensive support to achieve change. In addition, the
practice organisation and clinical decision making in the control group hardly changed,
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which further emphasises the need for intensive support. The GPs in the control group did
not receive any special attention but were free to follow postgraduate courses and
undertake improvement activities. In the Netherlands, in fact, GPs must follow 40-hours of
postgraduate training per year to receive renewed certification. Apparently, the usual
activities of GPs to improve the structure and process of cardiovascular and diabetes care
had no clear effects after two years. During the study period, moreover, attention was
devoted nationwide to the prevention of cardiovascular disease and a number of revised
guidelines for cardiovascular and diabetes care were issued, but these activities apparently
did not alter the behaviour of the GPs in our control group. While the intensity of the
support and in particularly the number of outreach visits are important in terms of costs,
the comprehensiveness of the programme to be implemented and the multiplicity of the
barriers to change do not, in our opinion, allow for less intensive intervention. The process
evaluation provides additional evidence for this as half of the GPs in the intervention
practices expressed difficulties with the changing of old routines.15
We chose to focus on practice organisation during the first period of the intervention
and clinical decision making during the second period. We assumed that an appropriate
practice organisation is a prerequisite for good clinical decision making. This assumption is
nevertheless open to debate; that is, it may be more effective to simultaneously address
both organisation and decision making for the implementation of such items as the
assessment of risk factors or the scheduling of follow-up. We also assumed that a
facilitator and a GP must become comfortable with each other before they can effectively
discuss the GP’s decision making; it is possible that a GP perceives his/her decision
making as a personal affair. Based on interviews with the facilitators, we have the
impression that the assumption regarding comfort is correct. Furthermore, practice
organisation changed more than decision making and it is always stimulating to start with
successful items, so, we still recommend proceeding in the sequence used.
Delivery of the intervention
The intervention was delivered as planned. In accordance with the protocol, the facilitators
made an average of 15 visits (SD 3, range 4 to 17) per practice.39 Only four practices (6%)
discontinued the intervention due to illness or changes in staff. Almost all of the GPs in the
intervention practices read the feedback reports and educational materials and were present
at outreach visits.15 This shows the protocol to be feasible and also that the observed
effects of the intervention are based on a precise execution of the protocol.
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Receipt of the intervention
The practice teams in the intervention group provided useful information on the receipt of
the intervention.15 In general, they highly valued the feedback reports and the support
provided by the facilitators. Individual feedback on clinical decision making (as provided
for hypertension, hypercholesterolaemia, and diabetes) was more highly valued than group
feedback (as provided for the different cardiovascular diseases). In addition, the GPs
valued the capacity of the facilitator to provide support with regard to practice organisation
more than with regard to clinical decision making. Furthermore, 18% to 29% of the GPs
and even 51% to 64% of the practice assistants declared that the feedback reports,
educational materials, and visits took too much time. Actually, the GPs in the intervention
group spent an average of 28 hours per GP to prepare and attend the visits, while the
practice assistants spent an average of 21 hours per assistant.39 Such amount of time
appears to be rather small for a 21-month intervention period and obviously the health care
professionals had problems to find time for the project. Lack of time is very difficult to
change but nevertheless stresses the importance of managing change plans according to the
quality circle. This management tool helps to effectively use the time available for quality
improvement, because it forces the users to set priorities and make proper plans. Lack of
time can easily frustrate change plans and one of the reasons for the effectiveness of our
intervention may thus be that the monthly visits served as a stimulus to carry on.
Improving the implementation strategy
The aforementioned barriers to change and the findings regarding the receipt of the
intervention can help us adapt and thereby improve our implementation strategy. For
example, patients strongly influenced decision making and further exploration of
interventions explicitly involving patients in the change process may be useful. The
addition of patient education has been found to improve the process and outcome of
diabetes care.35 A second example concerns the facilitators who were non-physicians and
received a training of only several days with respect to the guidelines on clinical decision
making. The capacity of a facilitator to influence the clinical decision making of GPs may
increase when he or she receives a more intensive medical training including a training
period to observe GPs in actual patient encounters.
The effectiveness of implementation strategies can also perhaps be improved by taking
account of the practice characteristics associated with success. For example, practices with
older GPs improved more regarding the provision of information and advice to treated
hypertensive patients than practices with younger GPs. This finding is particularly
alarming because the younger GPs were found to have lower scores at baseline than the
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older GPs (see Chapters Two and Four). We also found that single-handed practices
benefited more from the support programme for the recording of risk factors and provision
of information and advice than partnerships. In contrast, Hulscher et al. have found a
positive relation between group practices and improved organisation of the practice for
cardiovascular disease prevention.32 One possible explanation for this discrepancy is that
group practices have more people available to optimise their practice organisation while
GPs in single-handed practices do not have to share the support for clinical decision
making with other GPs. The associations between practice characteristics and the effects of
the intervention suggest that the effectiveness of the intervention increases when the
amount and type of support is adapted to the specific characteristics of the practice. This
hypothesis nevertheless needs confirmation.
The effects of the intervention clearly varied across the different indicators. Comparison
is, however, hindered by differences in baseline compliance rates and different amounts of
power across the indicators. The effects on practice organisation were generally higher
than the effects on clinical decision making. We can only speculate as to the reasons for
this, but differing knowledge and skills on the part of the facilitators for the two topics is
one possibility. It is also possible that GPs benefit in particular from the excellent help of
practice assistants when it comes to changing the organisation of the practice. In any case,
the evidence for a positive effect of intensive support on practice organisation is strong and
confirmed by other research.16,32,33,40 Further experiments with such support should
therefore focus on clinical decision making although the baseline compliance rates for
several indicators were already very high (for example, annual blood pressure
measurement for patients with diabetes; 93%). This means that further improvement
cannot be expected for such indicators. Remarkably, the intervention had no effect on drug
treatment to control hypertension or hyperglycaemia. Research is therefore particularly
needed to explore why GPs hesitate to use more aggressive therapy and how the
implementation strategies for this specific item can be improved. We suggest utilisation of
a more patient-oriented approach, for instance in the form of an individual chart to be kept
by the patient in order to monitor the levels of blood pressure, blood glucose and other
parameters.
Discussion 121
PATIENT OUTCOME
While the research reported on in this thesis does not address the effects of the intervention
on patient outcome, the indicators are based on evidence-based guidelines or rigorous
consensus procedures. The positive effects of the intensive support on the structure and
process of care may therefore ultimately improve patient health parameters as well.
Multifaceted health care interventions combined with patient education or an enhanced role
for nurses have been shown to improve health outcomes for patients with diabetes.35 The
implementation of management protocols have also been found to improve outcomes for
patients at high cardiovascular risk.41,42 Moreover, clear identification of the presence of
risk factors provides opportunities to reduce risk. Lifestyle interventions targeted at
patients with high cardiovascular risk are known to reduce morbidity and mortality11 while
the provision of information to patients has been found to improve compliance with
therapy, satisfaction with the care delivered, and health outcomes.43-45 Foot care has been
shown to reduce amputation rates while early treatment of retinopathy has been shown to
prevent blindness.46 Early identification of deterioration of heart failure can promote
adjustment of the therapy and thereby prevent hospitalisation.47 In addition, in a different
study of our group, the intensive support in the CARPE trial was found to positively affect
the quality of life for patients at high cardiovascular risk (n=2412). The differences in
change were statistically significant for three domains (+1.9 points for bodily pain, +1.2 for
vitality, and +2.2 for mental health on the Medical Outcomes Study Short-Form Health
Survey-36).39
Despite improvements in the quality of care and the positive patient outcomes
mentioned above, several trials evaluating educational outreach visits showed no
favourable effects on outcomes for patients with CVD48,49 or diabetes50. In The
Netherlands, a multifaceted quality improvement programme in general practice improved
the provision of diabetes care but this was also not accompanied by any effect on patient
outcomes.51 Improvement interventions generally change health care outcomes to a lesser
extent than the structure and process of care provision.52 The reasons for this include
patients not accepting physicians recommendations and frequently the limited effectiveness
of the clinical interventions themselves. Moreover, the effectiveness of clinical
interventions in daily practice may be lower than the efficacy found in clinical trials due to
differences in, for example, co-morbidity and the socio-economic and educational status of
the included patients. In other words, small changes in the structure and process of care
will usually not improve patient outcome, which underlines the need for implementation
strategies with at least moderate effects on care provision. Such effects are attained with
good planning and a combination of different interventions as in the present trial.53
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METHODOLOGICAL CONSIDERATIONS
Assessment of practice organisation and clinical decision making
The selection of the practices may have produced an overestimation of current quality of
care in Dutch general practice. The practices volunteered to participate in the study and
may therefore have had a special interest in cardiovascular or diabetes care. High selection
of GPs is, however, unlikely because we studied a large group of GPs (n=195) and these
GPs were representative for the Netherlands with respect to age, sex, type of practice and
practice location.
Practice organisation was assessed using primarily self-report. One GP and one practice
assistant per practice provided information about the practice management and the
organisation of preventive activities. Practice management activities and arrangements can
easily be observed, so we therefore had no great doubts about the reliability and validity of
these data. The data with respect to record keeping and follow-up may be less accurate,
however, because the performance of such preventive activities can vary across the GPs
within a group practice. There is also a variable association between what GPs report and
what they actually do.54 With respect to the trial, it is nevertheless unlikely that such
variation differed systematically for the intervention versus control groups.
The method used to assess the clinical decision making of GPs guarantees, in our
opinion, robust results. The prospective recording of patient encounters provided detailed
and thereby valid information on the GPs’ clinical actions in actual clinical situations.
Moreover, the method relied on evidence-based guidelines. It is possible that the recording
of patient encounters may have influenced the clinical performance of the GPs although the
encounter forms do not refer to the evidence-based guidelines and most GPs are probably
too busy to actually adapt their performance to what the forms specifically mention.
Selective recording of encounters also seems unlikely because the GPs gained nothing with
better results. Both of these possible limitations may have produced some overestimation
of actual performance but underestimation is very unlikely. The assessment did not provide
information about GPs’ motivations for apparently ignoring the recommendations while
GPs may have good reasons not to comply. For example, it appears inappropriate to
provide a patient with advice on smoking cessation when he or she is obviously not
motivated to stop smoking. GPs’ compliance with the recommendations will thus seldom
be 100%. Furthermore, the assessment was quantitatively and did thus not give insight into
the consulting styles of GPs while the physician-patient interaction appears to influence
patient outcome.45
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Assessment of patients’ risk perceptions
The method used to assess the patients’ perceptions of their absolute cardiovascular risk
has some limitations. We assessed absolute risk perception via self-report ratings along a
visual analogue scale while the psychometric properties of this assessment method are not
yet known. Furthermore, we addressed the risk perceptions for myocardial infarction and
stroke while the current recommendations regarding preventive cardiology address the
absolute risk of coronary heart disease (CHD) or CVD. Myocardial infarction and stroke
are nevertheless important components of CHD and CVD and patients may not understand
what CHD and CVD are.
Effect evaluation
The effects of the intervention were assessed in a randomised controlled trial taking the
design effect of cluster randomisation into account. Nevertheless, the results of the trial
have a number of potential limitations.
· The practices volunteered to participate. They may therefore have been more
interested and motivated to adopt the intervention than other practices.
· At post-intervention measurement, the GPs and practice assistants provided the data
to assess the effectiveness of the intervention but were not blind to the allocation of
their practice to the intervention versus control group. An objective examination of
the medical records from the participating practices nevertheless confirmed that the
intervention indeed improved the recording of the different risk factors (absolute
differences in change between the trial groups of 5% to 21%).39 With respect to
clinical decision making, we did not find any consistent indications of selective
recording of patient encounters (see Chapters Six and Seven)
· The follow-up period for the trial was 21 months. We simply do not know about the
more long-term maintenance of the effects. In a previous study, favourable changes
due to support by facilitators were found to last only for the period of intervention.55
COSTS
The costs of the intervention were an average of 4300 Euro per practice (excluding the
costs for generating the feedback reports and training the facilitators); that is, 1500 Euro
for salary and travelling of the facilitators and 2800 Euro for the time spent by the GPs and
their practice assistants for preparing and attending the visits.39 The costs of the
intervention are, in our opinion, in balance with the benefits of the intervention; intensive
support is costly but also, as aforementioned, a requisite to actually achieve at least
moderate improvement. The intervention will probably increase the number and length of
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patient encounters, but the costs of this have not been included in our calculations.
Hippisley et al have shown that many GPs will be faced with a substantial increase in their
workload when they appropriately identify and manage all patients at high cardiovascular
risk.56 This extra workload demands extra resources to employ, for example, additional
practice nurses or practice assistants and the careful setting of priorities. In case of a lack of
resources, those patients at highest cardiovascular risk should obviously have highest
priority: first those with atherosclerotic disease and diabetes and then those patients with
multiple other risk factors.
Implications and recommendations
RESEARCH
It is not completely clear why the intervention was successful for some but not all of the
indicators of clinical decision making. The intervention aimed at the identification and
elimination of the barriers to change. The practice teams may, however, not always be
aware of specific barriers or not discuss them with the facilitators. While our process
evaluation highlighted a number of factors which appear to prevent improvement,15 it did
not address specific barriers for each recommendation. A detailed assessment demands a
more intensive research design than the cross-sectional postal survey which we used. Such
detailed information is nevertheless needed to develop more effective implementation
strategies. It would, for example, be worthwhile to examine why, exactly, GPs do not
intensify antihypertensive drug treatment to control hypertension. Are certain GPs simply
unaware of the recommended target levels for blood pressure? Do certain GPs think that
the benefits of high-dosage antihypertensive medication may not exceed the adverse
effects? Do certain patients simply refuse to take more medication? The answers to such
questions will certainly help us determine where and how to best intervene.
The implementation strategies themselves also need further improvement. We therefore
recommend analyses to examine the associations between practice, professional and
intervention characteristics and successful change. Definite identification of successful
implementation calls, however, for randomised trials. For example, multifaceted
interventions without educational outreach visits have also been found to enhance the
management of patients at high cardiovascular risk35,57 which means that randomised trials
with multiple arms should be conducted to compare the effects of different strategies.
When possible, quality improvement trials should evaluate patient outcome. We state
‘when possible’, because such evaluations demand considerable resources and time,
especially in the case of CVD prevention. Many patients must be studied as the reductions
in health parameters are usually small and cluster randomisation introduces an inflation
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factor. Changes in morbidity and mortality also take considerable time to reveal
themselves. The use of intermediate outcome measures, such as the actual level of risk
factors or the actual use of certain drugs, appears to constitute an acceptable alternative as
associations of such intermediate measures to morbidity and mortality have been
demonstrated in numerous clinical trials. However, high-risk patients have frequently
multiple risk factors. When doctors and patients distribute their activities across multiple
risk factors, the effectiveness of therapy for each single factor may be smaller and less than
the effectiveness of therapy focused on a single factor as in most clinical trials. Small
changes in multiple risk factors may nevertheless all influence morbidity and mortality
which makes the measurement of morbidity and mortality most preferable.
It is also very worthwhile to expand the investigations. It would be very useful to repeat
the measurement one or two years after the intervention. In the meantime, new evidence
from clinical trials may call the validity of the effect measures originally used into question
or introduce new issues. The evidence-based recommendations which we used in our trial
appear to be firmly in place, however. It is also possible that our intervention influenced
the practice management and clinical decision making for patients with other conditions.
For example, team work, the recording of health parameters, the provision of lifestyle
advice, and arrangements for follow-up are all very relevant for patients with asthma or
COPD. It is therefore useful to investigate whether intensive support for the management
of patients at high cardiovascular risk indirectly improves the quality of care for patients
with astma/COPD as well.
GUIDELINES
Our findings provide useful information for people involved in guideline development.
Those recommendations showing low performance scores can be checked, clarified,
emphasised or revised. One can carefully consider, for example, the extent to which the
benefits indeed exceed the side-effects of prescribing a combination of two high-dosage
antihypertensive drugs to achieve blood pressure targets. And just how useful is a
prompted recall system for patients with diabetes?
PRACTITIONERS
Our results have at least two implications for daily practice. First, our quality assessment
can give practitioners insight into their actual performance. We showed, for example, the
performance of foot examinations for patients with diabetes and the pursuit of controlled
hypertension and controlled hyperglycaemia to clearly need improvement. Physicians
should also provide patients with greater and better information on absolute cardiovascular
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risk when sharing decisions about aspirin, statins, or antihypertensive drug treatment.
Second, the use of a multifaceted intervention to improve guideline implementation was
shown to be effective. In order to improve certain aspects of cardiovascular or diabetes
care, professionals should not rely on just educational materials or meetings but try to find
and appropriate mix of methods which may include the help of a facilitator. The amount of
time invested by the GPs (an average of 28 hours per GP to prepare and attend the visits) is
probably more than what they normally invest in postgraduate education for cardiovascular
and diabetes care across a two-years period of time. The difference is certainly not extreme
and, more importantly, the amount of time invested by the control group did not lead to
actual changes. Finally, it is recommended that the ‘quality circle’ (as described in Chapter
One) is always be used to manage change plans. The hectics of daily practice alone
demand careful planning and even more so the setting of priorities and identification of any
barriers to change.
HEALTH POLICY
Our results indicate that health policy makers who want to improve the structure and
process of cardiovascular or diabetes care in general practice must provide the resources
for multifaceted interventions. From such a perspective, the provision of intensive support
by non-physicians is a good choice in particular regarding the improvement of the structure
of care. Such an intervention is costly but effective and certainly less expensive than
intensive support provided by physicians. In addition, single interventions have been
shown to have limited effectiveness and to even be a waste of time and money in many
cases. The exact effects of intensive support on patient outcomes are not as yet completely
clear and therefore constitute a critical topic for future research. Resources should thus also
be allocated to further investigate the effects of intensive support on various health
parameters and also to further develop the strategy of intensive support to improve the
process of care.
A critical barrier to change is a lack of time among health care professionals.
Improvement of health care therefore demands resources to employ additional practice
nurses and practice assistants and also the development of better software packages for
general-practice care. Just providing more staff and better equipment appears nevertheless
to be insufficient; multifaceted interventions are needed to actually improve the quality of
care. Without additional staff and equipment, any attempts to improve the quality of care
appear to produce at most moderate effects, however.
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Ongoing developments
GUIDELINES
Recent Dutch guidelines regarding hypertension recommend targeting a DBP below 90
mmHg and a systolic blood pressure (SBP) below 140 mmHg.58 However, the SBP target
is set to a level of below 160 mmHg for patients with an age of 60 years or more and no
diabetes, kidney disease, cardiovascular disease, or familial hypercholesterolaemia.
Moreover, recent national and international guidelines recommend a DBP of 85 mmHg or
below for patients with diabetes.59,60 The GPs in our study were not found to adapt their
targets to the presence and number of additional risk factors, which means that the
implementation of the recent recommendations for different patient groups needs
additional and perhaps special attention.
QUALITY IMPROVEMENT
A new topic was added to the national Tailor Made Prevention project. This nationwide
project was carried out by the National Association of GPs (NAGP) and the Dutch College
of GPs (DCGP) since 1995 and aimed at the improvement of influenza vaccination and
cervical cancer screening. The positive results of the existing programme and the positive
experiences with CARPE and other Dutch projects (see Chapter One) on CVD prevention
have prompted the professional organisations to proceed further. A three-year programme
to improve the assessment and recording of cardiovascular risk factors in high-risk patients
has been launched in 1998 with financial support of the Ministry of Health. One thousand
out of the 7000 GPs in The Netherlands have been recruited to participate. The intervention
‘mix’ consisted of educational meetings, educational materials, and four outreach visits per
practice. The intervention has proved feasible and been found to be highly appreciated by
the participating GPs and practice assistants.16 In two-years time, the targeted elements of
practice management have improved by an average of 30% and the recording of risk
factors by an average of 20% relative to a control group.16 In 2000, the NAGP decided not
to continue the CVD prevention project due to the already high and increasing workload of
GPs and despite the positive results of the project. In other words, the workload of GPs
constitutes a major barrier to improved quality of care.
As opposed to the Tailor Made Prevention project, future initiatives to improve the
general-practice management of patients at high cardiovascular risk should be in line with
the contents of the CARPE project and thus aim at all elements of such management.
Improving total management appears to be more effective in terms of patient outcome than
just improving the assessment of risk factors. Projects to improve the total management
may, however, produce even higher workload and the local groups of GPs should therefore
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be free to make their own time schedules and choose the target patient population (for
example, only patients with atherosclerotic disease or patients with diabetes). The NAGP
and the DCGP have not yet adopted plans for alternative projects and The Ministry of
Health has not yet provided grants for such plans while sustained political support is
another important requisite for the success of implementation efforts.
In sum, intensive support from facilitators was found to improve the general-practice
management of patients at high cardiovascular risk. At baseline, practice organisation and
clinical decision making showed ample room for improvement and the quality of care was
found to vary considerably across patients, practitioners, and practices. The provision of
feedback and support by non-physicians was found to improve practice organisation
substantially; the effects for clinical decision making were less pronounced. The results of
the CARPE trial thus justify outreach visits aimed at improved practice organisation on a
large scale. The strategy of having a non-physician help GPs to improve their clinical
decision making merits further development; particularly, the provision of a more intensive
training to the facilitators may increase the effectiveness of the strategy. We need also
further insight into the barriers to change and the effects on patient outcome. Multifaceted
and intensive support appeared to be a requisite to actually achieve improvement, in part
because of a lack of time among health care professionals. Without additional practice staff
and other resources, the effects of intensive strategies to implement guidelines will
probably remain moderate at most. The present study nevertheless clearly proved that
intensive support by non-physicians can improve essential elements of cardiovascular and
diabetes care in general practice.
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Summary
The focus of the present thesis is on improvement in the general-practice management of
patients at high cardiovascular risk. Medical priority for the prevention of cardiovascular
disease is given to high-risk patients precisely because these patients stand to gain the most
from preventive treatment. In many countries, moreover, the preventive treatment of
patients at high cardiovascular risk belongs to the domain of general practice. We therefore
explored the current quality of a number of the essential elements of cardiovascular and
diabetes care in general practice. We also conducted a randomised controlled trial to assess
the effectiveness of providing intensive support in the form of outreach visits to improve
the quality of care. In the following, a brief summary of the different chapters in this thesis
will be presented.
In Chapter 1, the background, objectives, methods and research questions for this thesis
are presented. Previous studies in general practice have shown substantial gaps in the
quality of care for patients with hypertension, diabetes or cardiovascular disease. In
addition, a number of the essential aspects of cardiovascular and diabetes care in general
practice have not been studied very extensively. The first objective of this thesis was
therefore to explore a number of the important elements in the care process in greater detail
(quality assessment). The second objective was to test the effectiveness of a multifaceted
and intensive support programme to optimise the management of patients at high
cardiovascular risk (quality improvement).
The studies on quality assessment encompassed the clinical decision making of general
practitioners (GPs) and the risk perceptions of patients. We assessed clinical decision
making via prospective recording of patient encounters by the GPs themselves. The
measurement pertained to evidence-based indicators and provided detailed information on
both the GPs’ clinical actions and the clinical situations. The assessment therefore enabled
us to draw valid conclusions about the quality of clinical decision making. Of particular
interest were the GPs’ provision of information and advice to patients at high
cardiovascular risk. The provision of information and lifestyle advice is an essential
element of cardiovascular disease prevention, but the methodological quality of previous
assessment studies appear to be less than optimal. The ability of high-risk patients to
estimate their absolute cardiovascular risk and the accuracy of these estimates were
investigated next. The exact benefits of aspirin, statins, and antihypertensive drug
treatment depend on a patient’s absolute risk of cardiovascular disease, and a physician can
therefore better discuss treatment decisions with patients, when he or she has greater
insight into the patients’ risk perceptions. We also explored the extent to which GPs try to
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achieve blood pressure control in treated hypertensive patients. More than half of these
patients have an elevated blood pressure and may therefore fail to benefit fully from their
drug treatment.
In three other studies, the effectiveness of multifaceted and intensive support to improve
the structure and process of cardiovascular and diabetes care was investigated. It was
assumed that improvement can be achieved via effective implementation of evidence-
based guidelines. Based on the results of previous quality improvement projects, we
designed a trial to test the effectiveness of an innovative implementation strategy. The key
elements in this trial (called CARPE: CArdiovascular Risk reduction in Primary carE)
were:
· a randomised controlled design;
· aimed at improving the management (i.e., the structure and process of care) of
patients at high cardiovascular risk;
· use of clear recommendations based on the national guidelines from the Dutch
College of General Practitioners and consensus procedures;
· application of a multifaceted implementation strategy involving feedback and
outreach visits from trained non-physicians;
· protocol based on a stepwise and cyclic model for quality improvement; and
· evaluation of the effects on practice organisation, clinical decision making, and
patient outcome.
The trial ran from 1996 to 1999 with a total of 124 practices, 185 GPs, and about 250
practice assistants. The intervention group (62 practices) received intensive support and the
control group (62 practices) received no special attention. The intervention programme
consisted of 15 outreach visits per practice across a period of 21 months.
In the different studies in this thesis, we also estimated the influence of various patient,
practitioner, and practice characteristics on the outcome measures. Insight into the
predictors of the quality of care and effectiveness of implementation strategies may help us
select the most appropriate means for improvement and tailor future interventions to
specific circumstances.
The following research questions were formulated.
1. To what extent do GPs provide information and advice to patients at high
cardiovascular risk? Which patient and GP characteristics relate to this performance?
2. Are patients with hypertension or diabetes but no known atherosclerotic disease able to
estimate their absolute risk of cardiovascular events and, if so, what are the levels and
accuracy of these estimations? Which patient characteristics relate to patient risk
perceptions?
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3. How and to what extent do GPs try to control diastolic blood pressure in treated
hypertensive patients? Which patient and GP characteristics relate to this performance?
4. What are the effects of a multifaceted outreach-visits intervention on practice
management and the organisation of preventive activities in cardiovascular and diabetes
care? Which practice characteristics relate to effective implementation?
5. What are the effects of a multifaceted outreach-visits intervention on the clinical
decision making of GPs for patients with hypertension, hypercholesterolaemia, angina
pectoris, or heart failure? Which practice characteristics relate to effective
implementation?
6. What are the effects of a multifaceted outreach-visits intervention on the clinical
decision making of GPs for patients with diabetes? Which practice characteristics relate
to effective implementation?
In Chapter 2, the results of an assessment of GPs’ provision of information and advice to
patients with hypertension, hypercholesterolaemia, or cardiovascular disease are presented.
Many patients at high cardiovascular risk display one or more unhealthy behaviours and
lifestyle interventions targeted at such patients have been shown to reduce morbidity and
mortality for these patients. The provision of information on the content and management
of the risk factors and the disease itself has been found to improve compliance with therapy
and health outcomes. Previous studies of the provision of information and advice by GPs
relied on questionnaires or retrospective data collection and may not be very valid. In our
study, 195 GPs prospectively recorded 5330 patient encounters with a total of 16,616
situations calling for the provision of specific information or advice. The GPs frequently
provided advice on smoking cessation or information (for example, information about
alarm symptoms or the aim of treatment). Low levels of performance (below 60%) were
nevertheless found for the provision of advice on salt consumption, alcohol consumption,
weight reduction, and physical exercise to patients with hypertension. Discussion of
compliance with therapy in cases of hypercholesterolaemia, advice on physical exercise in
cases of angina pectoris, and advice on foot care in cases of peripheral arterial disease also
showed low performance rates. Clinical performance varied considerably across GPs but
was found to depend predominantly on the patients; the intracluster correlation coefficient
(ICC) or the variance between the GPs divided by the total variance was found to range
from 0.14 to 0.30. For hypertension, angina pectoris, and peripheral arterial disease, one
fourth of the GPs showed performance rates below 60%. The individual GP and patient
characteristics examined in this study contributed very little to clinical performance. In
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conclusion, although the GPs frequently provided information and advice, considerable
room for improvement across indicators and GPs was discerned.
In Chapter 3, the ability of patients at moderate to high cardiovascular risk to estimate
their absolute cardiovascular risk and the accuracy of these estimates are described. The
benefits of aspirin, statins, and antihypertensive drug treatment depend on a patient’s
absolute risk of cardiovascular disease. A physician can better involve patients in the
decisions concerning such treatment when he or she has insight into the patients’ risk
perceptions. Shared decision making is particularly relevant for patients who stand to
moderately benefit from treatment, and we therefore studied the risk perceptions of patients
with hypertension or diabetes but no known atherosclerotic disease. Via a postal survey
questionnaire, patients were asked to estimate their personal 10-year risk of myocardial
infarction and stroke along a 100-millimeter visual analogue scale with 0% and 100% at
the ends of the continuum. The response rate was 86.3% and 1557 patients fulfilled the
inclusion criteria. One fourth of the patients provided no risk estimations whatsoever, and
these patients appeared to be older patients, patients with a lower educational level, and
patients reporting no alcohol consumption in particular. Almost half of the remaining
patients either overestimated or underestimated their absolute risk by more than 20%, and
the patients who did this were mostly those who perceived their health status as fair or
poor. Patients with higher levels for the attribution of their health to physicians were less
able than other patients to estimate their absolute risk and less accurate when they did
provide an estimate. Such patients appear to prefer a ‘directing’ rather than a ‘sharing’
style of consulting but actually have a particular need for information on their
susceptibility to cardiovascular events. The ICCs for the level and accuracy of perceived
absolute risk were found to be zero, which also indicates that the GPs had not effectively
informed their patients of personal cardiovascular risk. In conclusion, patients were found
to have inadequate risk perceptions, which means that physicians should provide greater or
better information with regard to risk when offering aspirin, statins, or antihypertensive
drug treatment.
In Chapter 4, GPs’ control of hypertension is considered. More than 50% of patients with
pharmacologically treated hypertension still have elevated blood pressure levels and may
therefore not benefit fully from antihypertensive drug treatment. GPs play a crucial role in
decisions regarding antihypertensive drug treatment and any other measures to control
blood pressure. In order to assess the associations between patients’ diastolic blood
pressure (DBP) and GPs’ clinical actions, we investigated follow-up visits (n=3704) with
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treated hypertensive patients. These visits were prospectively recorded by 195 GPs. The
GPs appeared to target a DBP of below 100 mmHg while the guidelines recommend
targeting a DBP of below 90 mmHg. The presence and number of additional risk factors
did not influence the target levels adopted by the GPs. In addition, the GPs appeared not to
expect the provision of information and advice to exert much of an effect on DBP. The
median performance rates for the key actions used to control blood pressure were generally
below 51% for even a DBP of 100 mmHg or above. Clinical performance varied
considerably across GPs but was found to depend predominantly on the patients (ICC
between 0.10 and 0.40). Apart from the DBP level, specific GP and patient characteristics
contributed little to the differences in clinical performance. Our findings suggest that more
aggressive treatment by GPs may improve blood pressure control, because targeting a DBP
of below 100 mmHg instead of below 90 mm Hg may be one of the reasons why 63% of
the patients in this study were found to have a DBP well above the recommended target
level.
In Chapter 5, the effects of facilitators providing intensive support on practice
organisation are described. The management of patients at high cardiovascular risk
demands adequate practice organisation in part because hypertension, dyslipidaemia,
diabetes, and cardiovascular disease all require long-term monitoring. The effects of the
intervention were assessed in a randomised controlled trial. Information on the actual
organisation of the practice was gathered via self-administered questionnaires and direct
observation by research-assistants. Adherence scores for six indicators before and after the
intervention were calculated. At baseline, the mean adherence scores across the practices
were found to be below 40% for performance of preventive tasks by the practice assistants,
presence of separate clinics, teamwork in the practice, arrangements for follow-up, and
record keeping. The mean score for the availability of instruments and materials was 67%
at baseline. The intervention resulted in substantial and statistically significant
improvement for all six indicators. The absolute increase in the mean scores as a result of
the intervention varied from 14% to 31%. Practices with fewer GPs and practices with
smaller list sizes per full time GP improved the most on the preventive activity ‘record
keeping’. There was very little improvement in the control group, and still ample room for
improvement in the intervention group after the intensive support.
In Chapter 6, the effects of facilitators providing intensive support on the clinical decision
making of GPs for patients with hypertension, hypercholesterolaemia, or cardiovascular
disease are considered. Physicians’ clinical decisions play an important role in the
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utilisation of health care resources, and inadequate decisions may negatively influence
patients’ health. The effects of the intervention were assessed in a randomised controlled
trial. Information on the GPs’ clinical decision making was gathered via the prospective
recording of patient encounters by the GPs themselves. Adherence scores for 12 evidence-
based indicators before and after the intervention were calculated. At baseline, the
performance rates were found to vary considerably across practices and indicators.
Particularly low mean rates (below 60%) were found for the provision of information and
advice to patients with newly diagnosed hypertension, increasing the medication in cases
of uncontrolled blood pressure, and prescribing aspirin and sublingual nitrate to patients
with angina pectoris. Particularly high mean rates (above 80%) were found for the
assessment of risk factors in patients with hypercholesterolaemia or angina pectoris, and
the checking for clinical signs of deterioration in patients with heart failure. The
intervention produced improvement for 10 out of the 12 indicators. Statistically significant
improvement was found for five of the indicators: assessment of risk factors in patients
with hypercholesterolaemia or angina pectoris, provision of information and advice to
patients with hypercholesterolaemia or treated hypertension, and checking for clinical signs
of deterioration in patients with heart failure. The significant increases in the mean
performance rates as a result of the intervention varied from 3% to 19%. Among other non-
effects, there was no effect on increasing the medication to control high blood pressure.
Single-handed practices, non-training practices, and practices with older GPs were
positively associated with improved provision of information and advice to patients with
hypercholesterolaemia or treated hypertension. Very little improvement was observed for
the control group.
In Chapter 7, the effects of the provision of intensive support by facilitators on the clinical
decision making of GPs for patients with diabetes mellitus are described. GPs’ clinical
decisions play an important role in the prevention of diabetic complications. The effects of
the intervention were assessed in a randomised controlled trial. Information on the GPs’
clinical decision making was gathered via the prospective recording of patient encounters
by the GPs themselves. Adherence scores for seven evidence-based indicators before and
after the intervention were calculated. At baseline, the performance rates were found to
vary considerably across practices and indicators. Particularly low mean rates (below 50%)
were found for foot examination and initiating or changing medication in cases of
uncontrolled blood glucose. A particularly high mean rate (93%) was found for annual
blood measurement. The intervention produced improvement for all of the seven
indicators. Statistically significant improvement was found for foot examination and eye
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examination; the increases in the mean performance rates as a result of the intervention
were 10% and 11%, respectively. Among other non-effects, there was no effect on the
initiation or changing of drug treatment to control high blood glucose. Practice
characteristics did not predict effects of intervention. The control group improved
significantly for foot examination (+9%; versus +19% in the intervention group) and
annual blood pressure measurement (+3%; versus +3% in the intervention group) but not
for the other indicators.
In Chapter 8, the preceding results are reflected on, a number of conclusions are drawn,
and several recommendations are made. Practice organisation and some essential aspects
of the clinical decision making for patients at high cardiovascular risk were not found to be
optimal, and patients’ perceptions of their absolute cardiovascular risk were also found to
be inadequate. Intensive support from non-physicians improved practice organisation and,
to a lesser extent, clinical decision making. The quality of care in the control group hardly
changed. The practice teams cited time constraints as an important barrier to change, but
some elements of the implementation strategy were also less than optimal (such as the
actual capacity of the facilitators to support clinical decision making). We therefore
recommend additional detailed investigation of just what motivates and blocks the
provision of evidence-based cardiovascular and diabetes care. Insight into those factors
related to good quality care can help us model and thereby improve implementation
strategies. The results of our CARPE trial justify outreach visits aimed at improved
practice organisation on a large scale; the support for clinical decision making merits
further development and more intensive training of the facilitators appears to be a good
choice. The present multifaceted intervention is costly, but the use of an intensive approach
based on the ‘quality circle’ appears to be a prerequisite for real change. Further research is
clearly needed to examine the effects of intensive support on patient health outcomes.
Evaluations of the process of CARPE and other interventions show the current workload in
general practice to require special attention, resources, and personnel or the quality of care
may not or only partly improve.
In conclusion, the current general-practice management of patients at high cardiovascular
risk is not optimal. Intensive support from non-physicians can improve practice
organisation and to a lesser extent the clinical decision making of GPs, while the usual
quality improvement activities appear to be rather ineffective.
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Samenvatting
Het onderwerp van dit proefschrift is het verbeteren van de huisartsenzorg aan patiënten
met een hoog risico op hart- en vaatziekten (HVZ). Bij preventie van HVZ richten artsen
zich in de eerste plaats op hoogrisicopatiënten, omdat deze patiënten het meeste profijt
hebben van preventieve maatregelen. In veel landen behoort de preventieve zorg aan
patiënten met een hoog cardiovasculair risico tot de taken van de huisarts. Daarom
onderzochten we de kwaliteit van een aantal cruciale aspecten van HVZ preventie in de
huisartspraktijk. Bovendien deden we een gerandomiseerd experiment om vast te stellen
wat de effecten zijn van intensieve ondersteuning door consulenten op de kwaliteit van
zorg. Deze samenvatting geeft een weergave van de acht hoofdstukken van het
proefschrift.
Hoofdstuk 1 beschrijft de achtergronden, doelstellingen, opzet en onderzoeksvragen van
het proefschrift. Eerdere studies lieten belangrijke tekortkomingen zien in de zorgverlening
van huisartsen aan patiënten met hypertensie, diabetes of HVZ. Bovendien zijn een aantal
essentiële aspecten van de huisartsenzorg aan deze patiënten nauwelijks onderzocht.
Daarom was een doel van dit proefschrift om de kwaliteit vast te stellen van een aantal
belangrijke elementen van het zorgproces (kwaliteitstoetsing). Het tweede doel was te
onderzoeken wat het effect is van een gecombineerd en intensief ondersteunings-
programma op de zorgverlening aan patiënten met een hoog cardiovasculair risico
(kwaliteitsverbetering).
De studies die betrekking hadden op kwaliteitstoetsing, richtten zich op het medisch
handelen van huisartsen en de risicopercepties van patiënten. Het medisch handelen
toetsten we aan de hand van gegevens die de huisartsen zelf prospectief registreerden naar
aanleiding van patiëntencontacten. De gegevensverzameling was gebaseerd op evidence-
based indicatoren en leverde gedetailleerde informatie over de klinische handelingen van
huisartsen en de klinische situaties. Uit de resultaten konden daarom valide conclusies
worden getrokken over de kwaliteit van het medisch handelen. Een van de
aandachtspunten was de voorlichting die huisartsen geven aan patiënten met een hoog
cardiovasculair risico. Het geven van informatie en leefstijladviezen is een essentieel
onderdeel van preventie van HVZ, maar de methodologie van eerdere kwaliteitstoetsingen
was niet optimaal. Ook werd onderzocht in hoeverre hoogrisicopatiënten in staat zijn hun
absoluut risico op HVZ te schatten en hoe nauwkeurig de schattingen zijn. De effectiviteit
van aspirine, statines en antihypertensiva is afhankelijk van het absoluut cardiovasculair
risico van de patiënt. Een arts is daarom beter in staat patiënten bij medische beslissingen
over dergelijke middelen te betrekken, als hij of zij inzicht heeft in de risicopercepties van
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patiënten. Ook onderzochten we in welke mate huisartsen proberen de bloeddruk te regelen
bij patiënten die medicamenteus behandeld worden voor hypertensie. Meer dan de helft
van deze patiënten heeft een verhoogde bloeddruk en daardoor mogelijk geen maximaal
voordeel van de medicatie.
In drie andere studies deden we onderzoek naar de effectiviteit van gecombineerde en
intensieve ondersteuning voor het verbeteren van de structuur en het proces van de
zorgverlening aan patiënten met een hoog cardiovasculair risico. De hypothese was dat
effectieve implementatie van evidence-based richtlijnen tot verbetering leidt. Op basis van
de resultaten van eerdere projecten voor kwaliteitsverbetering ontwierpen we een
experiment en evalueerden daarmee de effectiviteit van een innovatieve implementatie-
strategie. Het experiment kreeg de naam CARPE (CArdiovascular Risk reduction in
Primary carE) en had als hoofdelementen:
· een gerandomiseerde studie;
· gericht op het verbeteren van het management (de structuur en het proces van de
zorgverlening) van patiënten met een hoog cardiovasculair risico;
· gebruik van heldere richtlijnen gebaseerd op de Standaarden van het Nederlands
Huisartsen Genootschap en consensusprocedures;
· toepassen van een gecombineerde implementatiestrategie bestaande uit feedback en
praktijkbezoeken door speciaal opgeleide consulenten (niet-artsen);
· een protocol gebaseerd op een stapsgewijs en cirkelvormig model voor
kwaliteitsverbetering; en
· evaluatie van de effecten op de organisatie van de praktijk, het medische handelen en
patiëntparameters.
Het experiment vond plaats van 1996 tot 1999 en omvatte 124 praktijken met 185
huisartsen en ongeveer 250 praktijkassistenten. De interventiegroep (62 praktijken) kreeg
intensieve ondersteuning en de controlegroep (62 praktijken) kreeg geen speciale
begeleiding. Het interventieprogramma bestond uit 15 bezoeken per praktijk verdeeld over
21 maanden.
In de verschillende studies gingen we ook na in hoeverre de uitkomstmaten verband
hielden met allerlei kenmerken van de patiënten, huisartsen en praktijken. Inzicht in de
voorspellers van goede zorg en effectieve implementatiestrategieën kan ons helpen om de
meest geschikte verbeteringsmethoden te kiezen en toekomstige interventies aan te passen
aan de specifieke omstandigheden.
De volgende onderzoeksvragen werden geformuleerd:
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1. In welke mate besteden huisartsen aandacht aan het geven van voorlichting aan
patiënten met een hoog cardiovasculair risico? Welke patiënt- en huisartskenmerken
hangen samen met het geven van voorlichting?
2. Zijn patiënten met hypertensie of diabetes maar zonder HVZ in staat om hun absoluut
cardiovasculair risico te schatten en zo ja, wat is de uitkomst en de nauwkeurigheid van
deze schattingen? Welke patiëntkenmerken hangen samen met de risicopercepties van
3. Hoe en in welke mate proberen huisartsen de diastolische bloeddruk te regelen bij
patiënten die reeds voor hypertensie worden behandeld? Welke patiënt- en
huisartskenmerken hangen samen met dit medisch handelen?
4. Welk effect heeft een gecombineerde interventie door consulenten op de
praktijkorganisatie voor patiënten met een hoog cardiovasculair risico? Welke
praktijkkenmerken hangen samen met effectieve implementatie?
5. Welk effect heeft een gecombineerde interventie door consulenten op het medisch
handelen van huisartsen bij patiënten met hypertensie, hypercholesterolemie, angina
pectoris of hartfalen? Welke praktijkkenmerken hangen samen met effectieve
implementatie?
6. Welk effect heeft een gecombineerde interventie door consulenten op het medisch
handelen van huisartsen bij patiënten met diabetes? Welke praktijkkenmerken hangen
samen met effectieve implementatie?
Hoofdstuk 2 beschrijft in welke mate huisartsen aandacht besteden aan het geven van
voorlichting aan patiënten met hypertensie, hypercholesterolemie of HVZ. Veel patiënten
met een hoog cardiovasculair risico hebben een of meer ongezonde leefgewoonten en het
geven van leefstijladviezen aan deze patiënten bleek in eerder onderzoek de morbiditeit en
mortaliteit in de groep te verlagen. Ook is aangetoond dat het geven van informatie over de
achtergronden en behandeling van risicofactoren en aandoeningen een gunstig effect heeft
op therapietrouw en gezondheidskenmerken. Eerdere studies over het geven van dergelijke
voorlichting door huisartsen waren gebaseerd op vragenlijsten of retrospectieve
gegevensverzameling en zijn daardoor mogelijk niet valide. In onze studie registreerden
195 huisartsen prospectief 5330 patiëntencontacten met daarin 16616 situaties waarin
volgens de richtlijnen bepaalde informatie of advies moet worden gegeven. De huisartsen
bleken vaak advies te geven over stoppen met roken en ook gaven zij vaak informatie
(bijvoorbeeld informatie over alarmsymptomen of het doel van behandeling). Lage scores
(lager dan 60 procent) werden echter gevonden voor het geven van advies over
zoutgebruik, alcoholgebruik, afvallen en lichaamsbeweging aan patiënten met hypertensie.
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Het bespreken van therapietrouw met patiënten met hypercholesterolemie, het geven van
advies over lichaamsbeweging aan patiënten met angina pectoris en het geven van advies
over voetverzorging aan patiënten met perifeer arterieel vaatlijden toonden ook lage scores.
Het medisch handelen varieerde sterk tussen de huisartsen maar hing vooral af van de
patiënten; de intracluster-correlatiecoëfficiënt (ICC) ofwel de variantie tussen de huisartsen
gedeeld door de totale variantie liep uiteen van 0,14 tot 0,30. In de patiëntencontacten voor
hypertensie, angina pectoris en perifeer arterieel vaatlijden had steeds een kwart van de
huisartsen een score lager dan 60 procent. Het medisch handelen hield heel weinig verband
met de bestudeerde huisarts- en patiëntkenmerken. De conclusie luidde dat de huisartsen
weliswaar vaak informatie en advies gaven, maar dat er voor bepaalde indicatoren en
bepaalde huisartsen nog veel ruimte was voor verbetering.
Hoofdstuk 3 beschrijft in welke mate patiënten met een matig tot hoog risico op HVZ in
staat zijn om hun absoluut cardiovasculair risico te schatten en hoe nauwkeurig de
schattingen zijn. De effecten van aspirine, statines en antihypertensiva hangen af van het
absoluut cardiovasculair risico van de patiënt. Een arts is beter in staat om patiënten bij
beslissingen over dergelijke medicijnen te betrekken, als hij of zij inzicht heeft in de
risicopercepties van patiënten. Gezamenlijke besluitvorming is vooral belangrijk voor
patiënten die matig voordeel hebben van medicamenteuze behandeling en daarom
bestudeerden we de risicopercepties van patiënten met hypertensie of diabetes maar zonder
HVZ. Patiënten ontvingen per post een vragenlijst met onder andere de vraag om op een
analoge schaal lopend van 0 tot 100 procent hun individueel risico te schatten om in de
komende tien jaar respectievelijk een hartinfarct en een beroerte te krijgen. De respons was
86,3 procent en 1557 patiënten voldeden aan de inclusiecriteria. Een kwart van de
patiënten bleek niet in staat te zijn een risicoschatting te maken, met name oudere
patiënten, patiënten met een lager opleidingsniveau en patiënten die aangaven geen alcohol
te gebruiken. Bijna de helft van de overige patiënten schatten hun absoluut risico meer dan
20 procent te hoog of te laag (vooral patiënten die hun gezondheidstoestand matig of slecht
vonden). Patiënten met een hogere score voor het toeschrijven van gezondheid aan artsen
waren minder goed in staat dan andere patiënten om hun absoluut risico te schatten en als
zij een schatting maakten, was deze minder nauwkeurig. Dergelijke patiënten geven
mogelijk meer voorkeur aan een ‘sturende’ dan een ‘delende’ stijl van consultvoering maar
verdienen in feite extra aandacht bij het geven van informatie over het cardiovasculair
risico. De ICC’en voor de hoogte en nauwkeurigheid van de risicoschattingen waren nul en
ook dat wijst erop dat de huisartsen hun patiënten niet effectief hadden geïnformeerd over
het individueel risico voor HVZ. De conclusie luidde dat de patiënten geen goede perceptie
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hadden van hun absoluut cardiovasculair risico en dat huisartsen meer en betere informatie
moeten geven over dit risico wanneer zij patiënten behandeling met aspirine, een statine of
een antihypertensivum aanbieden.
Hoofdstuk 4 gaat over het regelen van verhoogde bloeddruk door huisartsen. Meer dan 50
procent van de patiënten die medicamenteus behandeld worden voor hypertensie, hebben
toch nog een verhoogde bloeddruk en daardoor waarschijnlijk niet het maximale voordeel
van de bloeddrukverlagende medicatie. Huisartsen spelen een belangrijke rol bij
beslissingen over antihypertensiva en andere maatregelen om de bloeddruk te verlagen.
Om de relatie vast te stellen tussen de diastolische bloeddruk (DBD) van patiënten en de
klinische handelingen van huisartsen, onderzochten we controleconsulten (n=3704) met
patiënten die reeds medicamenteus voor hypertensie werden behandeld. Deze consulten
waren prospectief geregistreerd door 195 huisartsen. De huisartsen bleken te streven naar
een DBD beneden 100 mmHg, terwijl richtlijnen adviseren de DBD te verlagen tot
beneden 90 mmHg. Het aantal aanwezige risicofactoren bleek geen invloed te hebben op
de streefwaarden van de huisartsen. Bovendien leken de huisartsen niet te verwachten dat
de DBD veel zou dalen door het geven van informatie en advies. De gemiddelde scores
voor de handelingen om de bloeddruk te verlagen waren in het algemeen lager dan 51%,
zelfs bij een DBD van 100 mmHg of hoger. Het medisch handelen varieerde sterk tussen
de huisartsen maar hing voornamelijk af van de patiënten (ICC tussen 0,10 en 0,40). Het
medisch handelen hield weinig verband met de bestudeerde huisarts- en patiëntkenmerken,
met uitzondering van de hoogte van de DBD. Streven naar een DBD beneden 100 mmHg
in plaats van beneden 90 mmHg kan een van de redenen zijn waarom in 63 procent van de
consulten de DBD hoger was dan de aanbevolen waarde. De resultaten geven daarom de
indruk dat agressievere behandeling door huisartsen kan leiden tot beter geregelde
bloeddrukwaarden.
Hoofdstuk 5 beschrijft de effecten van intensieve ondersteuning door consulenten op de
praktijkorganisatie. De zorg voor patiënten met een hoog cardiovasculair risico vereist een
goede praktijkorganisatie, onder andere omdat hypertensie, vetstofwisselingsstoornissen,
diabetes en HVZ om langdurige begeleiding vragen. De effecten van de interventie werden
vastgesteld in een gerandomiseerd experiment. Gegevens over de praktijkorganisatie
werden verzameld door middel van vragenlijsten voor de praktijkmedewerkers en
observaties door onderzoeksassistenten. Zowel voor als na de interventie werden scores
bepaald voor het al dan niet voldoen aan zes indicatoren. Vóór de interventie waren de
scores van de praktijken gemiddeld lager dan 40 procent voor het verrichten van
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preventieve taken door de praktijkassistenten, het houden van aparte spreekuren, teamwork
in de praktijk, het bijhouden van de patiëntendossiers en de aanwezigheid van een
afsprakensysteem. De gemiddelde score was 67 procent voor de aanwezigheid van
instrumentarium en andere materialen. De interventie leidde tot sterke en statistisch
significante verbeteringen voor alle zes indicatoren. De absolute toename in de gemiddelde
scores als gevolg van de interventie varieerde van 14 tot 31 procent. Het bijhouden van de
patiëntendossiers verbeterde het meest voor praktijken met minder huisartsen en praktijken
met minder patiënten per fulltime huisarts. Er was maar heel weinig verbetering in de
controlegroep en ook in de interventiegroep bleef na de intensieve ondersteuning nog veel
ruimte voor verbetering.
Hoofdstuk 6 beschrijft de effecten van intensieve ondersteuning door consulenten op het
medisch handelen van huisartsen bij patiënten met hypertensie, hypercholesterolaemie of
HVZ. Het medisch handelen van artsen heeft een belangrijke invloed op het gebruik van de
voorzieningen in de gezondheidszorg en onjuiste beslissingen kunnen de gezondheid van
patiënten schaden. De effecten van de interventie werden vastgesteld in een
gerandomiseerd experiment. Het medisch handelen van de huisartsen werd getoetst aan de
hand van gegevens die de huisartsen zelf proespectief verzamelden naar aanleiding van
patiëntencontacten. Zowel voor als na de interventie werden scores bepaald voor het al dan
niet voldoen aan 12 evidence-based indicatoren. Bij de voormeting bleken de scores van de
verschillende praktijken en indicatoren sterk te variëren. Opvallend lage gemiddelde scores
(lager dan 60 procent) werden gevonden voor het geven van informatie en advies aan
patiënten bij wie hypertensie werd vastgesteld, het aanpassen van de bloeddrukverlagende
medicatie bij patiënten met te hoge bloeddruk en het voorschrijven van aspirine en
sublinguale nitraten aan patiënten met angina pectoris. Erg hoge gemiddelde scores (hoger
dan 80 procent) werden gevonden voor het nagaan van risicofactoren bij patiënten met
hypercholesterolemie of angina pectoris en het controleren op achteruitgang in de klinische
toestand bij patiënten met hartfalen. De interventie leidde tot verbetering voor tien van de
twaalf indicatoren. De verbetering was statistisch significant voor vijf indicatoren: het
nagaan van risicofactoren bij patiënten met hypercholesterolemie of angina pectoris, het
geven van voorlichting aan patiënten met hypercholesterolemie of reeds behandelde
hypertensie en het controleren op achteruitgang in de klinisch toestand bij patiënten met
hartfalen. De significante stijgingen in de gemiddelde scores als gevolg van de interventie
varieerden van 3 tot 19 procent. Er werden geen effecten gevonden op onder andere het
aanpassen van de bloeddrukverlagende medicatie bij patiënten met te hoge bloeddruk. Het
geven van voorlichting aan patiënten met hypercholesterolemie of hypertensie verbeterde
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het meest in praktijken met oudere huisartsen, solopraktijken en praktijken die niet
betrokken waren bij de beroepsopleiding voor huisartsen. Er was maar heel weinig
verbetering in de controlegroep.
Hoofdstuk 7 beschrijft de effecten van intensieve ondersteuning door consulenten op het
medisch handelen van huisartsen bij patiënten met diabetes mellitus. Het medisch handelen
van artsen speelt een belangrijke rol bij de preventie van diabetische complicaties. De
effecten van de interventie werden vastgesteld in een gerandomiseerd experiment. Het
medisch handelen van de huisartsen werd getoetst aan de hand van gegevens die de
huisartsen zelf proespectief verzamelden naar aanleiding van patiëntencontacten. Zowel
voor als na de interventie werden scores bepaald voor het al dan niet voldoen aan zeven
evidence-based indicatoren. Bij de voormeting bleken de scores voor de verschillende
praktijken en indicatoren aanzienlijk te variëren. Opvallend lage gemiddelde scores (lager
dan 50 procent) werden gevonden voor het onderzoeken van de voeten en het starten of
aanpassen van bloedsuikerverlagende medicatie bij een te hoog bloedsuikergehalte. Een
erg hoge gemiddelde score (93 procent) werd gevonden voor het jaarlijks meten van de
bloeddruk. De interventie leidde tot verbetering voor alle zeven indicatoren. De verbetering
was statistisch significant voor het onderzoeken van de voeten en het onderzoeken van de
ogen; de toename in de gemiddelde scores als gevolg van de interventie was respectievelijk
10 procent en 11 procent. Er werden geen effecten gevonden op onder andere het starten of
aanpassen van bloedsuikerverlagende medicatie bij een te hoog bloedsuikergehalte. De
effecten van de interventie hielden geen verband met de bestudeerde praktijkkenmerken.
De controlegroep verbeterde significant voor het onderzoeken van de voeten (+9 procent;
tegen +19 procent in de interventiegroep) en het jaarlijks meten van de bloeddruk (+3
procent; tegen eveneens +3 procent in de interventiegroep) maar niet voor de andere
indicatoren.
In hoofdstuk 8 worden de resultaten besproken, conclusies getrokken en een aantal
aanbevelingen gedaan. De praktijkorganisatie en een aantal essentiële aspecten van het
medisch handelen voor patiënten met een hoog cardiovasculair risico bleken niet optimaal
te zijn en ook de percepties van patiënten over hun absoluut cardiovasculair risico waren
niet erg adequaat. Intensieve ondersteuning door consulenten (die geen arts waren)
verbeterde de praktijkorganisatie en, in mindere mate, het medisch handelen. De kwaliteit
van zorg in de controlegroep veranderde nauwelijks. De praktijkmedewerkers noemden
gebrek aan tijd een belangrijk knelpunt om te veranderen, maar bepaalde aspecten van de
implementatiestrategie waren ook niet optimaal (zoals de kennis en vaardigheden van de
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consulenten om ondersteuning te bieden voor het medisch handelen). Een aanbeveling is
nauwkeurig te onderzoeken welke factoren goede zorgverlening aan patiënten met een
hoog cardiovasculair risico bevorderen of belemmeren. Goed inzicht in de factoren die de
kwaliteit van zorg bepalen, kan ons helpen implementatiestrategieën aan te passen en
daardoor te verbeteren. De resultaten van het CARPE project rechtvaardigen om
consulentenbezoeken op grote schaal toe te passen voor de verbetering van de
praktijkorganisatie; de ondersteuning voor het medisch handelen verdient verdere
ontwikkeling waarbij intensievere training van de consulenten een goede keuze is. De
gecombineerde interventie die in het project werd toegepast, is duur, maar een intensieve
benadering gebaseerd op de ‘kwaliteitscirkel’ lijkt een voorwaarde te zijn voor verbetering.
Verder onderzoek is beslist ook nodig om vast te stellen wat het effect is van intensieve
ondersteuning op de gezondheid van patiënten. Evaluaties van de uitvoering van CARPE
en andere interventies laten zien dat de kwaliteit van zorg waarschijnlijk niet of slechts
gedeeltelijk zal verbeteren als geen speciale aandacht en extra middelen worden besteed
aan de bestaande werkbelasting in de huisartspraktijk.
De conclusie is dat de huidige huisartsenzorg voor patiënten met een hoog cardiovasculair
risico niet optimaal is. Intensieve ondersteuning kan de praktijkorganisatie en, in mindere
mate, het medisch handelen van huisartsen verbeteren, terwijl de algemeen gebruikelijke
activiteiten voor kwaliteitsverbetering vrijwel geen effect sorteren.
Klaar
Is ie klaar
Gaat hij naar beneden
fff wat drinken
En weer naar boven
werken maar
Maar wat hoor ik nu
Hij is al klaar
Wat raar maar wel knap
Leuke pap
is dat
Lisanne Frijling (10 jaar)
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Dankwoord
Het traditionele dankwoord past niet goed bij dit proefschrift. U zou als lezer namelijk de
indruk kunnen krijgen dat veel mensen waardevolle ondersteuning hebben gegeven maar
dat de verdienste toch vooral bij mij ligt. Die indruk zou niet juist zijn. CARPE was een
megaproject waar enkele duizenden mensen aan hebben meegewerkt en zij verdienen de
pluim voor het slagen van het project. Ik was slechts een radertje in het geheel; dat is geen
cliché of valse bescheidenheid maar nuchter feit. Ik gebruik dit dankwoord dan ook vooral
om de betrokkenen aan u voor te stellen. Ik ben allen zeer erkentelijk voor de mogelijkheid
die zij mij gaven om dit proefschrift te schrijven. Zij verdienen echter ook de dank van
allen die nu of in de toekomst profijt trekken van het project.
Ruim 200 huisartsen en 250 praktijkassistenten brachten de ideeën tot werkelijkheid. Zij
zijn zonder uitzondering drie jaar lang loyaal geweest aan de inspanningen die het project
vroeg. Mijn contacten met hen waren altijd heel prettig. Veel deelnemers gaven als
boodschap dat zij het project niet alleen belangrijk maar ook plezierig en stimulerend
vonden. De ruim 3000 patiënten die belangeloos en zeer trouw de vragenlijsten invulden,
verdienen lof en bijzondere dank.
Lya Euser, Marianne van Hemert, Nel de Jonge, Janine Keegstra, Kitty Keysers, Mieke
Lijn, Franca van Nunen en Margriet Straver waren de consulenten. Zij bezochten de
praktijken en waren dan, naar eigen zeggen, de stok achter de deur. Het was geen
makkelijk opdracht om met de huisartsen over het medisch handelen te gaan praten, maar
de consulenten hebben dat vol durf en uitstekend gedaan. Hun verhalen over de
praktijkbezoeken waren voor mij inspirerend en erg leerzaam. Janine is de nestor van de
Nederlandse consulenten en ik ben blij dat zij als paranimf het teamwork van het project
voortzet en symboliseert.
Het uitvoeren van een dergelijk project staat of valt met het werk van de
onderzoeksassistenten. Geert Schattenberg en Myriam Kassies hebben bergen verzet en de
enorme logistiek tot een goed einde gebracht.
Claudia Lobo en ik mochten onder supervisie van Marlies Hulscher en Hans van der
Wouden aan het roer staan. Claudia was voortrekker bij het organiseren van de interventie
en een grote stimulans door haar doortastendheid en voortvarendheid. Marlies en Hans
brachten hun kennis als onderzoekers in en hielpen onvermoeid tegenslagen en knelpunten
weg te nemen.
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Reinier Akkermans, Willem van Gerwen, Henk van den Hoogen en ook Roos Bernsen,
Inge Keus en Kathleen Jenks deden de statistische analyses. Henk, Willem en Reinier
kregen ongetwijfeld wel eens een sik van mijn betweterij. Maar, heren, ik heb genoten van
de statistiek en zonder jullie goede lessen had ik de getallen nooit gesnapt.
Richard Grol was de kapitein of zeg maar gerust, de wijze admiraal. Zijn kennis over
kwaliteit van zorg en implementatie zijn waarschijnlijk ongeëvenaard en ik vond het een
voorrecht met hem te mogen werken. Hij stuwt je voort, geduldig en nauwkeurig, en is een
groot leermeester.
Ad Prins, Jozé Braspenning, Bernard van Drenth, Teun Spies, Henk Mokkink, Hans
Severens en Arno Hoes hebben belangrijke stenen bijgedragen. Zij waren de onmisbare
raadgevers op momenten dat specifieke expertise nodig was.
De begeleidingscommissie onder leiding van Jan van der Feen heeft geholpen belangrijke
knopen door te hakken. Zeker in de beginfase wisten wij regelmatig niet of het roer nu
links of rechts om moest, maar een vergadering met de commissie bracht ons steevast op
koers.
De Nederlandse Hartstichting gaf de subsidie voor het project. Het ging om een aanzienlijk
bedrag en daarmee getuigt de Hartstichting van visie op effectieve implementatie.
Jolanda van Haren wil ik bedanken voor de lay-out van het proefschrift en haar steun
tijdens de laatste maanden van het promotietraject. Judith Abma en vooral Lee Ann Weeks
corrigeerden mijn Engels (of wat daar voor doorging) en Gemma Stekelenburg realiseerde
mijn wensen voor de omslag van het proefschrift.
Speciaal noem ik nog mijn paranimf en lid van de begeleidingscommissie Ton Drenthen.
Als preventiedeskundige en groots manager heeft hij mij veel geleerd. Wij hebben intensief
samengewerkt in het fantastische LHV/NHG project hart- en vaatziekte, maar toen we op
het laatst zelfs in hetzelfde colbert rondliepen, was het tijd voor afscheid. Het schip van het
LHV/NHG project is gezonken, maar, Ton, dat is niet abnormaal bij innovatieve
constructies en leidt er alleen maar toe dat het volgende schip sterker is.
Tot slot wil ik, ook in het openbaar, mijn gezin bedanken: Corine, Thijs, Lisanne en Julia,
heel erg bedankt dat jullie mij de ruimte gaven om dit proefschrift te maken.
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Curriculum vitae
Bernard Frijling werd geboren op 28 november 1954 in Hardenberg en groeide op in
Velp (Gld). Hij behaalde in 1973 het diploma gymnasium B aan het Christelijk
Lyceum in Arnhem. Daarna verhuisde hij naar Utrecht waar hij het kandidaatsexamen
farmacie behaalde (1976), de militaire dienstplicht vervulde (1977) en de studie
geneeskunde voltooide (1984). 
Hij werkte van 1984 tot 1988 als arts-assistent op achtereenvolgens de afdeling
chirurgie van het Ziekenhuis Velp en de afdeling cardiopulmonale chirurgie van het
Academisch Ziekenhuis Maastricht. Aansluitend volgde hij in Utrecht de eenjarige
beroepsopleiding tot huisarts. Daarna werkte hij enkele jaren als waarnemend huisarts
en vestigde zich in 1992 in een solopraktijk in Almelo.
Van 1995 tot 2001 was hij parttime onderzoeker bij de Werkgroep Onderzoek
Kwaliteit in Nijmegen en stelde hij dit proefschrift samen. In 1998 droeg hij de
praktijk in Almelo over en kwam in dienst bij het Nederlands Huisartsen Genootschap
(NHG) in Utrecht. Bij het NHG was hij vooral betrokken bij het landelijke project
‘Preventie: maatwerk, hart- en vaatziekten’. Na afsluiting van het landelijke project in
2001 werd hij medisch coördinator voor de eerstelijnsdiagnostiek in het Ziekenhuis
Rivierenland Tiel. Daarnaast hervatte hij in 2002 het werk als huisarts in een
groepspraktijk in Rhenen. Hij is getrouwd met Corine van Keulen en vader van Thijs,
Lisanne en Julia.
